Rank	Title	Status	Study Results	Conditions	Interventions	Locations	URL
1	Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoid Leukemia	Drug: Inotuzumab Ozogamicin (IO)	Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona- Sod Clinica Ematologica, Ancona, Italy|As Dell'Alto Adige, Ospedale Centrale Di Bolzano - Ematologia E Centro Trapianto Midollo Osseo, Bolzano, Italy|Irccs Aou San Martino - Genova - Uo Clinica Ematologica, Genova, Italy|Asl Lecce, Ospedale 'V. Fazzi' - Uo Ematologia, Lecce, Italy|I.R.S.T. Srl Irccs - Meldola - Sc Oncologia Medica, Meldola, Italy|Istituto Europeo Di Oncologia Irccs - Milano - Divisione Di Oncoematologia, Milano, Italy|Ao Ospedali Riuniti Villa Sofia Cervello - Palermo - Uo Ematologia Con Utmo, Palermo, Italy|Fondazione Ircss Policlinico San Matteo - Pavia - Uo Ematologia, Pavia, Italy|Asl Pescara, Presidio Ospedaliero 'Spirito Santo' - Uoc Ematologia Clinica, Pescara, Italy|Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia, Rimini, Italy|Asl Roma 2, Ospedale S. Eugenio- Ospedale S.Eugenio - Uoc Ematologia, Roma, Italy|Università Degli Studi Di Roma "Sapienza" - Dipartimento Di Medicina Traslazionale E Di Precisione - U.O.C. Ematologia, Roma, Italy|Aou "San Giovanni Di Dio E Ruggi D'Aragona" - Salerno - Uoc Ematologia E Trapianti Di Cellule Staminali Emopoietiche, Salerno, Italy|Aou Senese - Uoc Ematologia E Trapianti, Siena, Italy|Aou Città Della Salute E Della Scienza, Ospedale S. Giovanni Battista Molinette - Torino - Sc Ematologia 2, Torino, Italy|Unità Operativa Di Ematologia - Presidio Ospedaliero Di Treviso - Azienda Ulss N.2 Marca Trevigiana, Treviso, Italy|Asui Di Udine - Presidio Ospedaliero "Santa Maria Della Misericordia" - Clinica Ematologica, Udine, Italy|Aou Integrata Di Verona, Policlinico G.B. Rossi - Uoc Ematologia, Verona, Italy	https://ClinicalTrials.gov/show/NCT03610438
2	Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015)	Recruiting	No Results Available	Childhood Acute Lymphoblastic Leukemia	Drug: Dexamethasone continuous|Drug: Dexamethasone intermittent|Drug: Dexamethasone|Drug: Methylprednisolone|Drug: Daunorubicin|Drug: Idarubicin|Drug: Bortezomib|Drug: Second phase of induction|Drug: Standard induction therapy|Drug: Standard consolidation therapy	prof. R.O.Eolyan Hematology Center, Ereván, Armenia|Republican Research and Practical Center of Radiation Medicine and Human Ecology, Gomel, Belarus|Republic Research and Practical Center of Pediatric Oncology, Hematology and Immunology, Minsk, Belarus|Mogilev Regional Children's Hospital, Mogilev, Belarus|National Oncology and Hematology Center, Ministry of Health of the Kyrgyz Republic, Bishkek, Kyrgyzstan|Arkhangelsk Regional Clinical Children's Hospital, Arkhangelsk, Russian Federation|Regional Clinical Children's Hospital, Astrakhan, Russian Federation|Altay Regional Clinical Children's Hospital, Barnaul, Russian Federation|Amur Regional Clinical Children's Hospital, Blagoveshchensk, Russian Federation|Bryansk Regional Children's Hospital, Bryansk, Russian Federation|Chelyabinsk Regional Clinical Children's Hospital, Chelyabinsk, Russian Federation|Transbaikal Regional Oncology Dispensary, Chita, Russian Federation|Irkutsk Regional Children Clinical Hospital, Irkutsk, Russian Federation|Ivanovo Regional Clinical Hospital, Ivanovo, Russian Federation|Republic Clinical Children's Hospital, Izhevsk, Russian Federation|Regional Clinical Children's Hospital, Khabarovsk, Russian Federation|Kirov Research Institute of Hematology and Blood Transfusion, Kirov, Russian Federation|Regional Clinical Children's Hospital, Krasnodar, Russian Federation|Krasnoyarsk Territorial Clinical Children's Hospital, Krasnoyarsk, Russian Federation|Kurgan Regional Clinical Children's Hospital, Kurgan, Russian Federation|Regional Clinical Children's Hospital, Kursk, Russian Federation|Regional Children's Hospital, Lipetsk, Russian Federation|Republic Children's Clinical Hospital, Makhachkala, Russian Federation|Morozov Children's Municipal Clinical Hospital, Moscow, Russian Federation|Research Institute of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev, Moscow, Russian Federation|Russian Children's Clinical Hospital, Moscow, Russian Federation|Murmansk Clinical Children's Hospital, Murmansk, Russian Federation|Republic Clinical Children's Hospital, Nal'chik, Russian Federation|Nizhnevartovsk Regional Clinical Children's Hospital, Nizhnevartovsk, Russian Federation|Regional Clinical Children's Hospital, Nizhny Novgorod, Russian Federation|Novokuznetsk Municipal Clinical Children's Hospital N4, Novokuznetsk, Russian Federation|Novosibirsk Central District Clinical Hospital, Novosibirsk, Russian Federation|Orenburg Regional Clinical Oncology Dispensary, Orenburg, Russian Federation|Regional Clinical Children's Hospital, Orël, Russian Federation|Perm Territorial Clinical Children's Hospital, Perm, Russian Federation|Regional Clinical Children's Hospital, Rostov-on-Don, Russian Federation|Rostov Research Institute of Oncology, Rostov-on-Don, Russian Federation|N. Dmitrieva Ryazan Regional Clinical Children's Hospital, Ryazan, Russian Federation|Almazov National Medical Research Center, Saint Petersburg, Russian Federation|Children's Municipal Hospital N1, Saint Petersburg, Russian Federation|Municipal Clinical Hospital N31, Saint Petersburg, Russian Federation|N.N.Petrov National Medical Research Oncology Center, Saint Petersburg, Russian Federation|R. Gorbacheva Research Institute of Pediatric Hematology and Transfusiology; Pavlov First Saint-Petersburg State Medical University, Saint Petersburg, Russian Federation|Municipal Clinical Children's Hospital N1, Samara, Russian Federation|Regional Children's Clinical Hospital, Stavropol, Russian Federation|Surgut Regional Clinical Hospital, Surgut, Russian Federation|Republic Clinical Children's Hospital, Syktyvkar, Russian Federation|Tomsk Regional Clinical Hospital, Tomsk, Russian Federation|Tula Regional Clinical Children's Hospital, Tula, Russian Federation|Republic Clinical Children's Hospital, Ulan-Ude, Russian Federation|Ulyanovsk Regional Children's Clinical Hospital, Ulyanovsk, Russian Federation|Regional Children's Clinical Hospital N1, Territorial Children's Hematological Center, Vladivostok, Russian Federation|Vologda Regional Clinical Children's Hospital, Vologda, Russian Federation|Voronezh Regional Clinical Children's Hospital N1, Voronezh, Russian Federation|Republic Hospital N1 - National Medicine Centre, Yakutsk, Russian Federation|Regional Clinical Children's Hospital, Yaroslavl, Russian Federation|Regional Clinical Children's Hospital N1; Children Oncology and hematology Center, Yekaterinburg, Russian Federation|Research Institute of Hematology and Blood Transfusion, Tashkent, Uzbekistan	https://ClinicalTrials.gov/show/NCT03390387
3	Anti-CD19 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphomas	Recruiting	No Results Available	Acute Lymphoblastic Leukemia ,Lymphomas	Biological: Anti-CD19 CAR-T	The First Affiliated Hospital of Nangchang University, Nanchang, Jiangxi, China	https://ClinicalTrials.gov/show/NCT04196205
4	An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Lymphoblastic Leukemia	Drug: IM JZP-458|Drug: IV JZP-458	Children's of Alabama, Birmingham, Alabama, United States|Phoenix Children's Hospital, Phoenix, Arizona, United States|Arkansas Children's Hospital, Little Rock, Arkansas, United States|Kaiser Permanente - Orange County - Anaheim Medical Center, Anaheim, California, United States|Kaiser Permanente - Downey Medical Center, Downey, California, United States|Kaiser Permanente - Fontana Medical Center, Fontana, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|MemorialCare Miller Children's and Women's Hospital Long Beach, Long Beach, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Kaiser Permanente- Los Angeles Medical Center, Los Angeles, California, United States|Benioff Children's Hospital Oakland, Oakland, California, United States|Kaiser Permanente - Oakland Medical Center, Oakland, California, United States|Children's Hospital of Orange County Main Campus - Orange, Orange, California, United States|Kaiser Permanente - Roseville Medical Center, Roseville, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Kaiser Permanente - San Diego Medical Center, San Diego, California, United States|University of California San Francisco Benioff Children's Hospital - Mission Bay, San Francisco, California, United States|Kaiser Permanente - Santa Clara Medical Center, Santa Clara, California, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Smilow Cancer Hospital - New Haven, New Haven, Connecticut, United States|Nemours Alfred I. Dupont Hospital for Children, Wilmington, Delaware, United States|Children's National Health System, Washington, District of Columbia, United States|Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States|Memorial Medical Office Centre, Hollywood, Florida, United States|Nemours Children's Specialty Care Jacksonville, Jacksonville, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States|Scottish Rite Hospital, Atlanta, Georgia, United States|Kapi'olani Medical Center for Women and Children, Honolulu, Hawaii, United States|Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Norton Children's Hospital, Louisville, Kentucky, United States|Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, United States|C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States|Children's Minnesota, Minneapolis, Minnesota, United States|Masonic Cancer Center, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Washington University School of Medicine in Saint Louis, Saint Louis, Missouri, United States|Alliance for Childhood Diseases, Las Vegas, Nevada, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Morristown Medical Center, Morristown, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Cohen Children's Medical Center, New Hyde Park, New York, United States|NYU - Stephen D. Hassenfeld Children's Center for Cancer and Blood Disorders, New York, New York, United States|Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Memorial Sloan-Kettering Cancer Center - New York, New York, New York, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|The Children's Hospital at Oklahoma University Medical Center, Oklahoma City, Oklahoma, United States|Oregon Health and Science University, Portland, Oregon, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center - Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|East Tennessee Children's Hospital, Knoxville, Tennessee, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Children's Blood and Cancer Center, Austin, Texas, United States|Medical City Dallas Hospital, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Texas Children's Hospital, Houston, Texas, United States|Methodist Hospital - San Antonio, San Antonio, Texas, United States|Primary Children's Hospital, Salt Lake City, Utah, United States|Inova Medical Group - Fairfax Hospital, Falls Church, Virginia, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, United States|Massey Cancer Center, Richmond, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Providence Sacred Heart Medical Center, Spokane, Washington, United States|CancerCare Manitoba - McDermot and Urgent Care Site, Winnipeg, Manitoba, Canada|McMaster Children's Hospital, Hamilton, Ontario, Canada|Victoria Hospital & Children's Hospital, London, Ontario, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|SickKids - The Hospital for Sick Children, Toronto, Ontario, Canada|Centre Hospitalier Universitaire Sainte-Justine, Montréal, Quebec, Canada|The Montreal Children's Hospital, Montréal, Quebec, Canada	https://ClinicalTrials.gov/show/NCT04145531
5	Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-cells to Target CD19	Recruiting	No Results Available	Leukemia, Lymphoblastic, Acute, Lymphoma	Biological: CD19CAT-41BBZ CAR T-cells	University College London Hospital, London, United Kingdom	https://ClinicalTrials.gov/show/NCT02935257
6	Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Not yet recruiting	No Results Available	Acute Lymphoblastic Leukemia	Drug: Dasatinib|Drug: Ponatinib|Drug: Berlin-Frankfurt-Münster Chemotherapy|Drug: Methotrexate and Cytarabine	University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States	https://ClinicalTrials.gov/show/NCT04845035
7	Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)	Recruiting	No Results Available	Lymphoblastic Leukemia|Acute Lymphoblastic Leukemia|ph+ Acute Lymphoblastic Leukemia	Drug: Inotuzumab ozogamicin|Drug: Dasatinib|Drug: Dexamethasone|Drug: Methotrexate|Drug: Vincristine|Drug: Ponatinib|Drug: Methotrexate for Injection|Procedure: Allogenic Stem Cell Transplantation	University of Chicago Medical Center, Chicago, Illinois, United States	https://ClinicalTrials.gov/show/NCT04747912
8	Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma	Recruiting	No Results Available	Lymphoma, Lymphoblastic	Drug: induction phase1|Drug: induction phase2|Drug: protocol M|Drug: maintenance therapy|Drug: reinduction phase1|Drug: reinduction phase2|Drug: Intrathecal (IT)	Sun Yat-sen University Cancer Center, GuangZhou, Guangdong, China	https://ClinicalTrials.gov/show/NCT02396043
9	CTA101 UCAR-T Cell Injection for Treatment of Relapsed or Refractory CD19+ B-cell Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Biological: CTA101	Affiliated hospital of Xuzhou medical college, Xuzhou, Jiangsu, China	https://ClinicalTrials.gov/show/NCT04154709
10	Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Lymphoblastic Leukemia, Acute Adult	Biological: TBI-1501	University Of Fukui Hospital, Yoshida, Fukui, Japan|Kyushu University Hospital, Higashi-ku, Fukuoka, Japan|Hokkaido University Hospital, Sapporo-shi, Hokkaido, Japan|Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan|Mie University Hospital, Tsu-shi, Mie, Japan|Tohoku University Hospital, Sendai, Miyagi, Japan|Jichi Medical University hospital, Shimotsuke-shi, Tochigi, Japan|Cancer Institute Hospital Of JFCR, Kōto, Tokyo, Japan|The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan|Akita University Hospital, Akita, Japan|Okayama University Hospital, Okayama, Japan	https://ClinicalTrials.gov/show/NCT03155191
11	PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia	Recruiting	No Results Available	Acute B-Cell Lymphoblastic Leukaemia	Drug: Spectrila®	Universidade Estadual de Campinas, Campinas, Brazil|Hospital das Clínicas da UFG, Goiânia, Brazil|Hospital de Clínicas Porto Alegre, Pôrto Alegre, Brazil|INCA Instituto Nacional do Cancer, Rio de Janeiro, Brazil|Hospital Estadual Mario Covas, Santo André, Brazil|Hospital de Base de Sáo José, São José, Brazil|Hospital das Clínicas São Paulo USP, São Paulo, Brazil	https://ClinicalTrials.gov/show/NCT03156790
12	Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Drug: Asparaginase	Aou Integrata Di Verona, Policlinico G.B. Rossi - Uoc Ematologia, Verona, Italy	https://ClinicalTrials.gov/show/NCT03668392
13	A Study of Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Acute Lymphoblastic Leukemia (ALL)	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Drug: Blinatumomab|Drug: AMG 404|Drug: Dexamethasone Premedication	City of Hope National Medical Center, Duarte, California, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Royal Adelaide Hospital, Adelaide, South Australia, Australia|The Royal Melbourne Hospital, Parkville, Victoria, Australia|Ordensklinikum Linz Elisabethinen, Linz, Austria|Hôpital Saint Louis, Paris, France|Centre Hospitalier Lyon Sud, Pierre-Benite, France|Klinikum und Fachbereich Medizin Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany|Universitätsklinikum Schleswig-Holstein, Kiel, Germany|Azienda Ospedaliera Universitaria di Bologna Policlinico S Orsola Malpighi, Bologna, Italy|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia, Italy|Universitair Medisch Centrum Groningen, Groningen, Netherlands|Hospital Universitari Germans Trias i Pujol, Badalona, Cataluña, Spain|Hospital Clinic i Provincial de Barcelona, Barcelona, Cataluña, Spain	https://ClinicalTrials.gov/show/NCT04524455
14	Phase 1 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)	Recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia	Biological: UCART22	University of California, Los Angeles (UCLA) - Medical Center, Los Angeles, California, United States|University of Chicago, Chicago, Illinois, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Weill Medical College of Cornell University, New York, New York, United States|MD Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT04150497
15	Study Evaluating the Efficacy and Safety With CD19CAR-T for Relapsed or Refractory Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Relapsed Acute Lymphoblastic Leukemia|Refractory Acute Lymphoblastic Leukemia	Combination Product: CD19 CART	Shenzhen University General Hospital, Shenzhen, China	https://ClinicalTrials.gov/show/NCT04012879
16	Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Drug: Cladribine|Drug: G-CSF|Drug: Cytarabine|Drug: Pegaspargase	Sun Yat-sen University Cancer Center, GuangZhou, Guangdong, China	https://ClinicalTrials.gov/show/NCT03318419
17	A Study of Subcutaneous Blinatumomab Administration in Acute Lymphoblastic Leukemia (ALL) Patients	Recruiting	No Results Available	B Cell Precursor Acute Lymphoblastic Leukemia	Drug: Blinatumomab	University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States|Universitaetsklinikum Allgemeines Krankenhaus Wien, Wien, Austria|Centre Hospitalier Regional Universitaire de Lille - Hopital Claude Huriez, Lille, France|Centre Hospitalier Universitaire de Nice, Nice cedex 3, France|Institut Universitaire du Cancer Toulouse Oncopole, Toulouse cedex 9, France|Charite Universitätsmedizin Berlin Campus Benjamin Franklin, Berlin, Germany|Universitaetsklinikum Leipzig Anstalt des oeffentlichen Rechts, Leipzig, Germany|Universitatsklinikum Tubingen, Tübingen, Germany|Universitatsklinikum Ulm, Ulm, Germany|Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia, Italy|IRCCS Ospedale San Raffaele, Milano, Italy|Azienda Ospedaliera Policlinico Umberto I, Roma, Italy|Hospital Clinico Universitario de Salamanca, Salamanca, Castilla León, Spain|Clinica Universidad de Navarra, Pamplona, Navarra, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain	https://ClinicalTrials.gov/show/NCT04521231
18	CD19-CAR-T2 Cells for CD19 Positive Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia, in Relapse|Acute Lymphoblastic Leukemia Not Having Achieved Remission|Acute Lymphoblastic Leukemia, Adult	Biological: CD19-CAR-T2 Cells	Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China	https://ClinicalTrials.gov/show/NCT04605666
19	Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Biological: CAR-T cells	Department of Hematopoietic Stem Cell Transplantation, Beijing, China	https://ClinicalTrials.gov/show/NCT02186860
20	Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy	Recruiting	No Results Available	Acute Lymphoid Leukemia	Drug: ARI-0001 cells	Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Clínica Universidad de Navarra, Pamplona, Navarra, Spain|Hospital Clinic of Barcelona, Barcelona, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Hospital Clínico Universitario Virgen de La Arrixaca, Murcia, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital U. Virgen del Rocío, Sevilla, Spain|Hospital La Fe, Valencia, Spain	https://ClinicalTrials.gov/show/NCT04778579
21	Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma	Biological: Blinatumomab|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dexamethasone|Drug: Doxorubicin Hydrochloride|Biological: Inotuzumab Ozogamicin|Other: Laboratory Biomarker Analysis|Drug: Mercaptopurine|Drug: Methotrexate|Biological: Ofatumumab|Drug: Prednisone|Biological: Rituximab|Drug: Vincristine Sulfate	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT02877303
22	A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)	Recruiting	No Results Available	Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia	Biological: AUTO1	City of Hope National Medical Center, Duarte, California, United States|University of California San Diego Health (UCSD), La Jolla, California, United States|University of California Davis (UC Davis), Sacramento, California, United States|University of California San Francisco (UCSF), San Francisco, California, United States|Colorado Blood Cancer Institute (CBCI), Denver, Colorado, United States|University of Miami, Miami, Florida, United States|H Lee Moffitt Cancer Center, Tampa, Florida, United States|Winship Cancer Institute of Emory University, Atlanta, Georgia, United States|University of Chicago, Chicago, Illinois, United States|University of Kansas, Kansas City, Kansas, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Mayo Clinic, Rochester, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|University of Nebraska, Omaha, Nebraska, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|Cleveland Clinic, Cleveland, Ohio, United States|Ohio State University Cancer Center, Columbus, Ohio, United States|TriStar Centennial Medical Center (SCRI), Nashville, Tennessee, United States|Baylor Scott & White Research Institute, Dallas, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States|TTI-Methodist (Texas Transplant Institute) (SCRI), San Antonio, Texas, United States|Swedish Cancer Center, Seattle, Washington, United States|Wisconsin Cancer Center, Milwaukee, Wisconsin, United States|University College London Hospitals NHS Foundation Trust, London, Greater London, United Kingdom|King's College Hospital, London, Greater London, United Kingdom|Manchester Royal Infirmary Hospital, Manchester, Greater Manchester, United Kingdom|Queen Elizabeth University Hospital, Glasgow, Scotland, United Kingdom|Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Tyne And Wear, United Kingdom|University Hospitals Birmingham NHS Foundation Trust, Birmingham, West Midlands, United Kingdom|University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), Bristol, United Kingdom	https://ClinicalTrials.gov/show/NCT04404660
23	Study to Test AKR1C3-Activated Prodrug OBI-3424 (OBI-3424) in Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL)	Recruiting	No Results Available	Recurrent T Acute Lymphoblastic Leukemia|Refractory T Acute Lymphoblastic Leukemia	Drug: AKR1C3-activated Prodrug OBI-3424	Kingman Regional Medical Center, Kingman, Arizona, United States|PCR Oncology, Arroyo Grande, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Loyola Center for Health at Burr Ridge, Burr Ridge, Illinois, United States|Northwestern University, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park, Illinois, United States|UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States|Loyola Center for Cancer Care and Research, Orland Park, Illinois, United States|University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States|Mary Greeley Medical Center, Ames, Iowa, United States|McFarland Clinic PC - Ames, Ames, Iowa, United States|McFarland Clinic PC-Boone, Boone, Iowa, United States|McFarland Clinic PC-Trinity Cancer Center, Fort Dodge, Iowa, United States|McFarland Clinic PC-Jefferson, Jefferson, Iowa, United States|McFarland Clinic PC-Marshalltown, Marshalltown, Iowa, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Minnesota Oncology - Burnsville, Burnsville, Minnesota, United States|Cambridge Medical Center, Cambridge, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|Monticello Cancer Center, Monticello, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|Fairview Northland Medical Center, Princeton, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, United States|Carson Tahoe Regional Medical Center, Carson City, Nevada, United States|Cancer and Blood Specialists-Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, United States|OptumCare Cancer Care at Seven Hills, Henderson, Nevada, United States|21st Century Oncology-Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, United States|Las Vegas Urology - Green Valley, Henderson, Nevada, United States|Las Vegas Urology - Pebble, Henderson, Nevada, United States|Urology Specialists of Nevada - Green Valley, Henderson, Nevada, United States|Las Vegas Urology - Pecos, Las Vegas, Nevada, United States|Desert West Surgery, Las Vegas, Nevada, United States|OptumCare Cancer Care at Charleston, Las Vegas, Nevada, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Hope Cancer Care of Nevada, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Central, Las Vegas, Nevada, United States|21st Century Oncology, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway, Las Vegas, Nevada, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-San Martin, Las Vegas, Nevada, United States|Las Vegas Prostate Cancer Center, Las Vegas, Nevada, United States|Las Vegas Urology - Sunset, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, United States|21st Century Oncology-Vegas Tenaya, Las Vegas, Nevada, United States|Ann M Wierman MD LTD, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-Tenaya, Las Vegas, Nevada, United States|Las Vegas Urology - Cathedral Rock, Las Vegas, Nevada, United States|Las Vegas Urology - Smoke Ranch, Las Vegas, Nevada, United States|OptumCare Cancer Care at MountainView, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Northwest, Las Vegas, Nevada, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, United States|21st Century Oncology-Fort Apache, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Southwest, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, United States|University Cancer Center, Las Vegas, Nevada, United States|Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Saint Mary's Regional Medical Center, Reno, Nevada, United States|Radiation Oncology Associates, Reno, Nevada, United States|University of Rochester, Rochester, New York, United States|University of Cincinnati/Barrett Cancer Center, Cincinnati, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|Overlake Medical Center, Bellevue, Washington, United States|Valley Medical Center, Renton, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States|University of Washington Medical Center - Montlake, Seattle, Washington, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States	https://ClinicalTrials.gov/show/NCT04315324
24	Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma	Drug: Rituximab|Drug: Nelarabine|Drug: PEG-Asparaginase|Procedure: Cranial irradiation|Drug: Imatinib|Drug: Idarubicin|Drug: Dexamethasone|Drug: Cyclophosphamide|Drug: Fludarabine|Drug: Vincristine|Drug: Mercaptopurine|Drug: VP16|Drug: Daunorubicin (DNR)|Drug: Methotrexate|Procedure: Stem cell transplantation|Drug: Cytarabine|Drug: Vindesine|Drug: Adriamycin|Drug: Prednisolone	University Hospital of Frankfurt (Main), Frankfurt (Main), Germany	https://ClinicalTrials.gov/show/NCT02881086
25	Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Recurrent B Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia	Drug: Palbociclib|Drug: Dexamethasone	Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States	https://ClinicalTrials.gov/show/NCT03472573
26	Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia, Adult	Drug: Gemcitabine|Drug: Busulfan|Drug: Cyclophosphamide|Procedure: Allogeneic Hematopoietic Stem Cell Transplantation	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Distrito Federal, Mexico	https://ClinicalTrials.gov/show/NCT03339700
27	A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Drug: Fludarabine|Drug: Melphalan|Drug: Alemtuzumab|Drug: Cyclophosphamide|Drug: Mesna|Radiation: Total Body Irradiation (8Gy)	Heart of England Nhs Foundation Trust, Birmingham, United Kingdom|University Hospitals Birmingham Nhs Foundation Trust, Birmingham, United Kingdom|University Hospitals Bristol Nhs Foundation Trust, Bristol, United Kingdom|Cambridge University Hospitals Nhs Foundation Trust, Cambridge, United Kingdom|Cardiff and Vale University Health Board, Cardiff, United Kingdom|NHS Greater Glasgow and Clyde, Glasgow, United Kingdom|Leeds Teaching Hospitals Nhs Trust, Leeds, United Kingdom|University Hospitals of Leicester Nhs Trust, Leicester, United Kingdom|The Clatterbridge Cancer Centre Nhs Foundation Trust, Liverpool, United Kingdom|Barts Health Nhs Trust, London, United Kingdom|University College London Hospitals Nhs Foundation Trust, London, United Kingdom|Kings College Hospital, London, United Kingdom|The Royal Marsden Nhs Foundation Trust, London, United Kingdom|Imperial College Healthcare Nhs Trust, London, United Kingdom|The Christie Nhs Foundation Trust, Manchester, United Kingdom|Central Manchester University Hospitals Nhs Foundation Trust, Manchester, United Kingdom|The Newcastle Upon Tyne Hospitals Nhs Foundation Trust, Newcastle, United Kingdom|Nottingham University Hospitals Nhs Trust, Nottingham, United Kingdom|Oxford University Hospitals Nhs Foundation Trust, Oxford, United Kingdom|Plymouth Hospitals Nhs Trust, Plymouth, United Kingdom|Sheffield Teaching Hospitals Nhs Foundation Trust, Sheffield, United Kingdom|University Hospital Southampton Nhs Foundation Trust, Southampton, United Kingdom	https://ClinicalTrials.gov/show/NCT03821610
28	Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia（R/R-ALL）	Recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia	Combination Product: IFN-α combined with CAR-T cell therapy	The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China	https://ClinicalTrials.gov/show/NCT04534634
29	Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 OVERALL	Not yet recruiting	No Results Available	CD20-positive Acute Lymphoblastic Leukemia	Drug: Obinutuzumab|Drug: Rituximab	Klinika Hematologii z Pododziałem Chorób Naczyń Uniwersyteckiego, Białystok, Poland|Oddział Hematologii Onkologicznej Podkarpacki Ośrodek Onkologiczny, Brzozów, Poland|Klinika Hematologii i Transplantologii Gdańskiego Uniwersytetu Medycznego, Gdańsk, Poland|Klinika Transplantacji Szpiku i Onkohematologii Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Oddział w Gliwicach, Gliwice, Poland|Klinika Hematologii i Transplantacji Szpiku, Samodzielny Publiczny Szpital Kliniczny, Katowice, Poland|Klinika Hematologii i Transplantacji Szpiku, Świętokrzyskie Centrum Onkologii, Kielce, Poland|Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellońskiego, Kraków, Poland|Oddział Hematologiczny Wojewódzkiego Szpitala Specjalistycznego w Legnicy, Legnica, Poland|Klinika Hematoonkologii I Transplantacji Szpiku, Uniwersytet Medyczny w Lublinie, Lublin, Poland|Oddział Kliniczny Hematologii Samodzielnego Publicznego Zakładu Opieki Zdrowotnej MSWiA z Warmińsko-Mazurskim Centrum Onkologii w Olsztynie, Olsztyn, Poland|Klinika Hematologii i Chorób Rozrostowych Układu Krwiotwórczego Uniwersytetu Medycznego w Poznaniu, Poznań, Poland|Klinika Hematologii, Kliniczny Szpital Wojewódzki nr 1, Rzeszów, Poland|Klinika Hematologii Pomorskiego Uniwersytetu Medycznego, Szczecin, Poland|Oddział Hematologii, Specjalistyczny Szpital Miejski, Toruń, Poland|Klinika Chorób Wewnętrznych i Hematologii Wojskowy Instytut Medyczny, Warszawa, Poland|Klinika Hematologii, Instytut Hematologii i Transfuzjologii, Warszawa, Poland|Klinika Hematologii, Onkologii i Chorób Wewnętrznych Warszawskiego Uniwersytetu Medycznego, Warszawa, Poland|Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku, Wrocław, Poland|Oddział Hematologiczny Z Oddziałem Nowotworów Krwi Dolnośląskie Centrum Transplantacji Komórkowych Z Krajowym Bankiem Dawców Szpiku, Wrocław, Poland	https://ClinicalTrials.gov/show/NCT04920968
30	Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)	Not yet recruiting	No Results Available	B-precursor Acute Lymphoblastic Leukemia	Drug: Blinatumomab	Research Site, Orange, California, United States|Research Site, Orlando, Florida, United States|Research Site, Winston-Salem, North Carolina, United States|Research Site, Greenville, South Carolina, United States	https://ClinicalTrials.gov/show/NCT04506086
31	Blinatumomab and Pembrolizumab for Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia With High Marrow Lymphoblasts	Recruiting	No Results Available	B-Cell Acute Lymphoblastic Leukemia, Adult	Drug: blinatumomab|Drug: pembrolizumab	UC San Diego Moores Cancer Center, La Jolla, California, United States|UC Irvine Health Chao Family Comprehensive Cancer Center, Orange, California, United States|UCSF Comprehensive Cancer Center, San Francisco, California, United States	https://ClinicalTrials.gov/show/NCT03160079
32	Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Relapsed or Refractory Acute Lymphoblastic Leukemia	Genetic: ssCART-19 Cells|Drug: Fludarabine|Drug: Cyclophosphamide	Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd., Shanghai, Shanghai, China	https://ClinicalTrials.gov/show/NCT04825496
33	De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL)	Recruiting	No Results Available	Precursor Cell Lymphoblastic Leukemia-Lymphoma	Procedure: Autologous HSCT	National Research Center for Hematology, Moscow, Russian Federation	https://ClinicalTrials.gov/show/NCT03462095
34	Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Relapsed or Refractory Acute Lymphoblastic Leukemia	Biological: single dose of CNCT19	Beijing Boren Hospital, Beijing, Beijing, China|Xinqiao Hospital of TMMU, Chongqing, Chongqing, China|Yanda hospital, Hebei medical university, Sanhe, Hebei, China|Henan Cancer Hospital, Zhengzhou, Henan, China|The affiliated hospital of Xuzhou medical university, Xuzhou, Jiangsu, China|Tongji Hospital of Tongji University, Shanghai, Shanghai, China|West China Hospital，Sichuan University, Chengdu, Sichuan, China|Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin, China|The First Affiliated Hospital, Zhejiang University school of Medicine, Hangzhou, Zhejiang, China	https://ClinicalTrials.gov/show/NCT04684147
35	A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Relapsed or Refractory Acute Lymphoblastic Leukemia	Biological: single dose of CNCT19	Henan Cancer Hospital, Zhengzhou, Henan, China|Institute of Hematology & Blood Diseases Hospital, Tianjin, China	https://ClinicalTrials.gov/show/NCT04230473
36	Leukemia-Specific Immune Cells (BAFFR- CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia	Biological: BAFFR-CAR T cells	City of Hope Medical Center, Duarte, California, United States	https://ClinicalTrials.gov/show/NCT04690595
37	Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1	Biological: Blinatumomab|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dasatinib|Drug: Dexamethasone|Drug: Doxorubicin Hydrochloride|Drug: Mesna|Drug: Methotrexate|Drug: Ponatinib Hydrochloride|Drug: Prednisone|Drug: Vincristine Sulfate	Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Anchorage Radiation Therapy Center, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Community Cancer Institute, Clovis, California, United States|University Oncology Associates, Clovis, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Augusta University Medical Center, Augusta, Georgia, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States|Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States|Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States|Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States|Saint Anthony's Health, Alton, Illinois, United States|Loyola Center for Health at Burr Ridge, Burr Ridge, Illinois, United States|Northwestern University, Chicago, Illinois, United States|Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|Loyola Center for Cancer Care and Research, Orland Park, Illinois, United States|Mary Greeley Medical Center, Ames, Iowa, United States|McFarland Clinic PC - Ames, Ames, Iowa, United States|McFarland Clinic PC-Boone, Boone, Iowa, United States|McFarland Clinic PC-Trinity Cancer Center, Fort Dodge, Iowa, United States|McFarland Clinic PC-Jefferson, Jefferson, Iowa, United States|McFarland Clinic PC-Marshalltown, Marshalltown, Iowa, United States|Central Care Cancer Center - Garden City, Garden City, Kansas, United States|Central Care Cancer Center - Great Bend, Great Bend, Kansas, United States|LSU Health Sciences Center at Shreveport, Shreveport, Louisiana, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Henry Ford Cancer Institute-Downriver, Brownstown, Michigan, United States|Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan, United States|Henry Ford Medical Center-Fairlane, Dearborn, Michigan, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|Allegiance Health, Jackson, Michigan, United States|Henry Ford Medical Center-Columbus, Novi, Michigan, United States|Henry Ford Macomb Health Center - Shelby Township, Shelby, Michigan, United States|Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|Freeman Health System, Joplin, Missouri, United States|Mercy Hospital Joplin, Joplin, Missouri, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercy Hospital South, Saint Louis, Missouri, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, United States|Siteman Cancer Center at Christian Hospital, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Mercy Hospital Washington, Washington, Missouri, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|University of Rochester, Rochester, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|University of Cincinnati/Barrett Cancer Center, Cincinnati, Ohio, United States|MetroHealth Medical Center, Cleveland, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|University Pointe, West Chester, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States|Saint Charles Health System, Bend, Oregon, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States|Bay Area Hospital, Coos Bay, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Saint Charles Health System-Redmond, Redmond, Oregon, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States|Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina, United States|Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States|Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina, United States|Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, United States|Vanderbilt-Ingram Cancer Center Cool Springs, Franklin, Tennessee, United States|Vanderbilt Breast Center at One Hundred Oaks, Nashville, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, United States|Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States|Providence Regional Cancer Partnership, Everett, Washington, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States|Kadlec Clinic Hematology and Oncology, Kennewick, Washington, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, United States|PeaceHealth Saint John Medical Center, Longview, Washington, United States|Pacific Gynecology Specialists, Seattle, Washington, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|Swedish Medical Center-Cherry Hill, Seattle, Washington, United States|PeaceHealth United General Medical Center, Sedro-Woolley, Washington, United States|Providence Regional Cancer System-Shelton, Shelton, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States|Providence Regional Cancer System-Yelm, Yelm, Washington, United States|Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin, United States|Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States|Marshfield Clinic Stevens Point Center, Stevens Point, Wisconsin, United States|Marshfield Medical Center - Weston, Weston, Wisconsin, United States|Shaare Zedek Medical Center, Jerusalem, Israel	https://ClinicalTrials.gov/show/NCT04530565
38	A Feasibility and Safety Study of CD38 CAR-T Cell Immunotherapy for Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T Adoptive Cellular Immunotherapy	Recruiting	No Results Available	Relapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T ACI	Biological: Specificity CD38 CAR-T Cells	Biotherapeutic Department and Hematology Department of Chinese PLA, Beijing, Beijing, China	https://ClinicalTrials.gov/show/NCT03754764
39	Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Lymphoid Leukemia|Acute Lymphoblastic Leukemia|Refractory Acute Lymphoblastic Leukemia|Relapsed Acute Lymphoblastic Leukemia	Drug: CPX-351	H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States	https://ClinicalTrials.gov/show/NCT03575325
40	Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia	Recruiting	No Results Available	Cluster of Differentiation Antigen (CD22)-Positive Acute Lymphoblastic Leukemia	Drug: Inotuzumab Ozogamicin	Memorial Sloan Kettering Cancer Center, New York, New York, United States|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States|Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States	https://ClinicalTrials.gov/show/NCT03104491
41	BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma	Recruiting	No Results Available	T-Acute Lymphoblastic Leukemia|Adult T Lymphoblastic Lymphoma	Drug: BL-8040|Drug: Nelarabine	City of Hope, Duarte, California, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|The Ohio State University Wexner Medical Center, James Cancer Hospital, Columbus, Ohio, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT02763384
42	CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia	Recruiting	No Results Available	T-lymphoblastic Lymphoma|NK/T Cell Lymphoma|Acute Lymphocytic Leukemia	Drug: CD7 CAR-T cells infusion	First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China	https://ClinicalTrials.gov/show/NCT04004637
43	A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)	Drug: Ponatinib|Drug: Imatinib|Drug: Vincristine|Drug: Dexamethasone|Drug: Cytarabine|Drug: Methotrexate|Drug: Prednisone	University of Alabama at Birmingham, Birmingham, Alabama, United States|City of Hope - Duarte, Duarte, California, United States|University of California Los Angeles, Los Angeles, California, United States|Augusta University Georgia Cancer Center, Augusta, Georgia, United States|Indiana University, Indianapolis, Indiana, United States|Indiana Blood & Marrow Transplantation, Indianapolis, Indiana, United States|University of Kansas Medical Center Research Institute, Kansas City, Kansas, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Monter Cancer Center, New Hyde Park, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|Oregon Health and Science University, Portland, Oregon, United States|Saint Francis Cancer Center, Greenville, South Carolina, United States|Saint Francis Hospital Cancer Center, Greenville, South Carolina, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Methodist Hospital, San Antonio, Texas, United States|Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina|Sanatorio Allende, Cordoba, Argentina|Hospital Privado Centro Medico de Cordoba, Cordoba, Argentina|Royal North Shore Hospital, Saint Leonards, New South Wales, Australia|Box Hill Hospital, Box Hill, Victoria, Australia|Monash Medical Centre, Clayton, Victoria, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|Ordensklinikum Linz Elisabethinen, Linz, Upper Austria, Austria|Hanusch Krankenhaus Wiener Gebietskrankenkasse, Wien, Vienna, Austria|Universitaetsklinik Fuer Innere Medizin I, Vienna, Austria|Republican Research Centre for Radiation Medicine and Human Ecology, Gomel, Homyelrskaya, Belarus|Minsk Scientific and Practical Center of Surgery, Transplantation and Haematology, Minsk, Belarus|Republican Scientific and Practical Center of Children's Oncology, Hematology and Immunology, Minsk, Belarus|Hospital Sao Rafael-Monte Tabor, Salvador, Bahia, Brazil|Eurolatino Juiz de Fora Pesquisas Medicas, Juiz De Fora, Minas Gerais, Brazil|Hospital Erasto Gaertner, Curitiba, Parana, Brazil|Hospital da Cidade, Passo Fundo, RIO Grande DO SUL, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, RIO Grande DO SUL, Brazil|Hemocentro Campinas Unicamp, Campinas, SAO Paulo, Brazil|Fundacao Doutor Amaral Carvalho, Jau, SAO Paulo, Brazil|Hospital das Clinicas da Faculdade de Medicina da Riberao Preto da Universidade de Sao Paulo, Ribeirao Preto, SAO Paulo, Brazil|HEMORIO Instituto Estadual de Hematologia, Rio de Janeiro, Brazil|Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil|Fundacao Antonio Prudente - A.C.Camargo Cancer Center, Sao Paulo, Brazil|University Multiprofile Hospital for Active Treatment Saint Ivan Rilski, Sofia, Sofiya, Bulgaria|University Multiprofile Hospital for Active Treatment Dr. Georgi Stranski, Pleven, Bulgaria|855 West 12th Avenue, Vancouver, British Columbia, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|Hopital Charles-LeMoyne, Greenfield Park, Quebec, Canada|Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada|Henan Cancer Hospital, Zhengzhou, Henan, China|The First Affiliated Hospital of Soochow University/Suzhou First People's Hospital, Suzhou, Jiangsu, China|The First Hospital of Jilin University, Changchun, Jilin, China|The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China|Institute of Hematology & Blood Diseases Hospital of CAMS & PUMC, Tianjin, China|Helsingin ja Uudenmaan sairaanhoitopiiri, Helsinki, Finland|Oulun Yliopistollinen Sairaala, Oulu, Finland|Turku University Hospital, Turku, Finland|Hopital Haut-Leveque, Pessac Cedex, Aquitaine, France|Centre Hospitalier de Versailles Hopital Andre Mignot, Le Chesnay, Ile-de-france, France|Hopital Saint Louis, Paris Cedex 10, Ile-de-france, France|Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse Cedex 09, Midi-pyrenees, France|Center Hospitalier Universitaire d'Angers, Angers Cedex 9, PAYS DE LA Loire, France|Centre Hospitalier Lyon Sud, Pierre Benite Cedex, Rhone-alpes, France|Evaggelismos General Hospital, Athens, Attica, Greece|General Hospital of Athens G. Gennimatas, Athens, Attica, Greece|University General Hospital of Athens Attikon, Chaidari, Attica, Greece|University General Hospital of Heraklion Panepistimiako Geniko Nosokomeio Irakleiou, Heraklion, Crete, Greece|General Hospital of Thessaloniki George Papanikolaou, Thessaloniki, Macedoni, Greece|University General Hospital of Patras Panagia I Voithia, Patra, Peloponnese, Greece|University General Hospital of Larissa, Larissa, Thessaly, Greece|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Forli-cesena, Italy|Azienda Policlinico San Martino, Genova, Liguria, Italy|Azienda Ospedaliera San Gerardo di Monza, Monza, Monza E Brianza, Italy|Arcispedale Santa Maria Nuova, Reggio Emilia, Reggio Nella Emilia, Italy|Ospedale dell'Angelo, Mestre, Venezia, Italy|Azienda Ospedaliero Universitaria di Bologna Policlinico Sant'Orsola-Malpighi, Bologna, Italy|Azienda Ospedaliera Vito Fazzi, Lecce, Italy|Istituto Scientifico Universitario San Raffaele, Milano, Italy|Azienda Ospedaliero-Universitaria di Modena Policlinico, Modena, Italy|Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy|Azienda USL della Romagna, Ravenna, Italy|Centro di Ematologia Policlinico Umberto I Universita Sapienza di Roma, Roma, Italy|Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy|The Catholic University of Korea St. Vincent's Hospital, Suwon, Gyeonggi-do, Korea, Republic of|Kyungpook National University Hospital, Daegu, Gyeongsangbuk-do, Korea, Republic of|Keimyung University Dongsan Hospital, Daegu, Gyeongsangbuk-do, Korea, Republic of|Chonbuk National University Hospital, Jeonju, Jeollabuk-do, Korea, Republic of|Inje University Busan Paik Hospital, Busan, Korea, Republic of|Inje University Haeundae Paik Hospital, Busan, Korea, Republic of|Yeungnam University Hospital, Daegu, Korea, Republic of|Daegu Catholic University Medical Center, Daegu, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of|Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo LEON, Mexico|Avenida Vasco de Quiroga # 15 Seccion XVI, Ciudad de Mexico, Mexico|Uniwersytecki Szpital Kliniczny we Wroclawiu, Wroclaw, Dolnoslaskie, Poland|Samodzielny Publiczny Szpital Kliniczny Number 1 w Lublinie, Lublin, Lubelskie, Poland|Szpital Uniwersytecki w Krakowie, Krakow, Malopolskie, Poland|Uniwersyteckie Centrum Kliniczne, Gdansk, Pomorskie, Poland|Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie - Oddzial w Gliwicach, Gliwice, Slaskie, Poland|Samodzielny Publiczny Zaklad Opieki Zdrowotnej Ministerstwa Spraw Wewnetrznych z Warminsko-Mazurs, Olsztyn, Warminsko-mazurskie, Poland|Spitalul Clinic Municipal de Urgenta Timisoara, Timisoara, Timis, Romania|Spitalul Clinic Colentina, Bucuresti, Romania|Spitalul Universitar de Urgenta Bucuresti, Bucuresti, Romania|Institutul Regional de Oncologie Iasi, Iasi, Romania|City Clinical Hospital named after Vikentiy Vikentyevich Veresaev, Moscow, Moscow CITY, Russian Federation|Sverdlovsk Regional Clinical Hospital #1, Ekaterinburg, Sverdlovsk, Russian Federation|City Clinical Hospital No. 52 of the Moscow Healthcare Department, Moscow, Russian Federation|National Research Center for Hematology, Dept. of Hematology/Oncology and BMT, Moscow, Russian Federation|Almazov Federal North-West Medical Research Centre of Department of Health of Russian Federation, Saint Petersburg, Russian Federation|Institut Catala d'Oncologia Badalona - Hospital Germans Trias i Pujol, Badalona, Cataluna, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Spain|Hualien Tzu Chi Hospital, Hualien City, Hualien, Taiwan|China Medical University Hospital, Taichung, Taichung CITY, Taiwan|National Cheng Kung University Hospital, Tainan, Tainan CITY, Taiwan|Cukurova Universitesi, Adana, Turkey|Ankara Universitesi Tp Fakultesi, Ankara, Turkey	https://ClinicalTrials.gov/show/NCT03589326
44	Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	Recruiting	No Results Available	T Acute Lymphoblastic Leukemia|T Lymphoblastic Lymphoma	Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dexamethasone|Drug: Doxorubicin Hydrochloride|Drug: Mercaptopurine|Drug: Methotrexate|Drug: Nelarabine|Drug: Pegaspargase|Drug: Prednisone|Drug: Venetoclax|Drug: Vincristine Sulfate	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT00501826
45	Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoid Leukemia|Philadelphia Chromosome-Negative B-Cell Precursor	Drug: Chemotherapy + Blinatumomab	AOU Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI, Ancona, Italy|U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno, Ascoli Piceno, Italy|Az.Ospedaliera S.G.Moscati, Avellino, Italy|UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro, Bari, Italy|UOC di Ematologia - Istituto Tumori - Giovanni Paolo II, Bari, Italy|UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli", Barletta, Italy|Azienda Ospedaliera - Papa Giovanni XXIII, Bergamo, Italy|Istituto di Ematologia "Lorenzo e A. Seragnoli" - Policlinico S. Orsola - Malpighi, Bologna, Italy|Comprensorio Sanitario di Bolzano - Azienda Sanitaria dell'Alto Adige - Ematologia e Centro TMO - Ospedale S.Maurizio, Bolzano, Italy|Spedali Civili - Brescia - Azienda Ospedaliera - U.O. Ematologia, Brescia, Italy|Divisione di Ematologia Ospedale A. Perrino, Brindisi, Italy|ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO, Cagliari, Italy|Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto", Catania, Italy|S.C. Ematologia ASO S. Croce e Carle, Cuneo, Italy|Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio, Firenze, Italy|IRCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11°piano- lato ponente, Genova, Italy|UOC di Ematologia con trapianto Ospedale S. Maria Goretti, Latina, Italy|ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE, Lecce, Italy|UOS Ematologia Ospedale Versilia ATNO, Lido Di Camaiore, Italy|Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori- IRST, Meldola, Italy|A.O.U. - Policlinico G. Martino Messina Oncologia Medica - U.O.C. Ematologia, Messina, Italy|U.O. di Ematologia- Ospedale dell'Angelo - Mestre, Mestre, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia, Milano, Italy|Ospedale Niguarda " Ca Granda" - SC Ematologia, Milano, Italy|U.O. Ematologia e Trapianto di MIdollo - Ist.Scientifico Ospedale San Raffaele, Milano, Italy|UO Ematologia - AOU Policlinico di Modena, Modena, Italy|Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli", Napoli, Italy|Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia, Napoli, Italy|S.C.D.U. Ematologia - Università del Piemonte Orientale Amedeo Avogadro, Novara, Italy|U.O. CTMO Ematologia - Osp. S.Francesco, Nuoro, Italy|S.C.D.U.Medicina Interna a indirizzo ematologico, Orbassano, Italy|Università degli Studi di Padova - Ematologia ed Immunologia Clinica, Padova, Italy|Oncoematologia -plesso ospedaliero "A. Tortora" di Pagani, Pagani, Italy|Ospedali Riuniti "Villa Sofia-Cervello", Palermo, Italy|U.O. di Ematologia con trapianto - Centro di Riferimento Regionale per le coagulopatie rare nel bambino e nell'adulto - A.U. Policlinico "Paolo Giaccone", Palermo, Italy|Day Hospital dell'U.O.C di Ematologia e CTMO Padiglione 1, Parma, Italy|S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy|Sezione di Ematologia ed Immunologia Clinica - Ospedale S.Maria della Misericordia, Perugia, Italy|U.O. Ematologia Clinica - Azienda USL di Pescara, Pescara, Italy|U.O. Ematologia - AUSL Ospedale G. da Saliceto, Piacenza, Italy|Dipartimento Oncologico - Ospedale S.Maria delle Croci, Ravenna, Italy|Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli", Reggio Calabria, Italy|Ospedale "Infermi", Rimini, Italy|Az. Ospedaliera "Sant' Andrea"-Università la Sapienza II Facoltà di Medicina e Chirurgia, Roma, Italy|Complesso Ospedaliero S. Giovanni Addolorata, Roma, Italy|Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo, Roma, Italy|S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena, Roma, Italy|U.O.C. Ematologia - Ospedale S. Eugenio, Roma, Italy|Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, Roma, Italy|Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari - Divisione di Ematologia, Roma, Italy|Università degli Studi - Policlinico di Tor Vergata, Roma, Italy|Sezione di Ematologia Cancer Center Humanitas, Rozzano, Italy|UOC di Ematologia - AOU San Giovanni di Dio e Ruggi D'Aragona, Salerno, Italy|Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy|U.O.C. Ematologia - A.O. Senese - Policlinico " Le Scotte", Siena, Italy|U.O.C. di Ematologia - A.O. " SS Annunziata" - P.O. S.G. Moscati, Taranto, Italy|Divisione di Ematologia dell'Università di Torino - "Città della Salute e della Scienza", Torino, Italy|Ematologia e Terapie Cellulari- A.S.O. Ordine Mauriziano, P.O. Umberto I-Ospedale, Torino, Italy|S.C. Ematologia 2 A.O. Città della Salute e della Scienza di Torino San Giovanni Battista, Torino, Italy|Struttura Complessa Ematologia - Azienda Ospedaliera Universitaria Integrata-Ospedale Maggiore, Trieste, Italy|Clinica Ematologica-Centro Trapianti e Terapie cellulari AOU,, Udine, Italy|Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi, Verona, Italy|ULSS N.6 Osp. S. Bortolo, Vicenza, Italy	https://ClinicalTrials.gov/show/NCT03367299
46	A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients	Recruiting	No Results Available	Leukemia|Precursor b-Cell Lymphoblastic Leukemia-Lymphoma|ACUTE LYMPHOBLASTIC LEUKEMIA	Drug: inotuzumab ozogamicin-dose level 2|Drug: Inotuzumab ozogamicin-dose level 1	Keck Hospital of USC-Norris Comprehensive Cancer Center (HC3), Los Angeles, California, United States|Keck Hospital of USC, Los Angeles, California, United States|LAC+USC Medical Center, Los Angeles, California, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States|Children's Hospital of Orange County, Orange, California, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Maryland- Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States|Nebraska Medicine - Village Pointe Cancer Center, Omaha, Nebraska, United States|UNMC Investigational Pharmacy, Omaha, Nebraska, United States|University of Nebraska Medical Center/Nebraska Medicine, Omaha, Nebraska, United States|Westchester Medical Center, Valhalla, New York, United States|Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Seattle Cancer Care Alliance, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington, United States|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Alfred Health, Melbourne, Victoria, Australia|Institut Jules Bordet, Brussels, Belgium|CHU Liege, Liege, Belgium|Semmelweis Egyetem, Budapest, Hungary|Del-pesti Centrumkorhaz-Orszagos Hematologiai es Infektologiai Intezet, Budapest, Hungary|Debreceni Egyetem Klinikai Központ, Orvosi Kepalkotó Klinika, Radiológia, Debrecen, Hungary|Debreceni Egyetem Klinikai Központ, Pathológiai lntézet, Debrecen, Hungary|Petz Aladar Megyei Oktato Korhaz, II. Belgyogyaszat - Hematologiai Osztaly, Gyor, Hungary|Szabolcs-Szatmar Bereg Megyei Korhazak es Egyetemi Oktatokorhaz, Josa Andras Korhaz, Hematologia, Nyiregyhaza, Hungary|Artemis Hospital, Gurugram, Haryana, India|Sahyadri Clinical Research and Development Centre, Pune, Maharashtra, India|Sahyadri Super Speciality Hospital, Pune, Maharashtra, India|Sahyadri Super Speciality Hospital Nagar Road, Pune, Maharashtra, India|Sahyadri Super Speciality Hospital, Pune, Maharashtra, India|Christian Medical College, Vellore, Tamil Nadu, India|Klinika Hematologii i Transplantologii, Uniwersyteckie Centrum Kliniczne, Gdansk, Poland|Instytut Hematologii i Transfuzjologii, Warsaw, Poland|Uniwersytecki Szpital Kliniczny im. Jana Mikulicza - Radeckiego we Wroclawiu, Wroclaw, Poland|Apteka Centralna, Wroclaw, Poland|National University Hospital, Singapore, Singapore|Pharmacy @ NCIS, National University Hospital, Singapore, Singapore|Singapore General Hospital, Singapore, Singapore|Raffles Hospital, Singapore, Singapore|Raffles Radiology, Singapore, Singapore|Mount Elizabeth Novena Hospital, Singapore, Singapore|Parkway Cancer Centre, Singapore, Singapore|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Institut Catala d' Oncologia de Badalona - Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitari Son Espases, Palma, Illes Balears, Spain|Institut Catala d' Oncologia de Badalona - Hospital Universitari Germans Trias i Pujol, Badalona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Clinico Universitario de Valencia, Valencia, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Spain|Changhua Christian Hospital, Changhua, Taiwan|Clinical Research Pharmacy, Changhua Christian Hospital, Changhua, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Anadolu Health Center Hospital, Gebze, Istanbul, Turkey|Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Clinical Research Center, Ankara, Turkey|Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Hematology Department, Ankara, Turkey|Hacettepe University Faculty of Medicine Hospital Internal Diseases Hematology Div., Ankara, Turkey|Ankara University Faculty of Medicine Cebeci Hospital Hematology Department, Ankara, Turkey|Private Medstar Antalya Hosp. Hematology and Stem Cell Transplantation Center, Antalya, Turkey|Marmara University Pendik Training and Research Hospital Hematology Unit, Istanbul, Turkey|Ege University Medical Faculty, Izmir, Turkey|Dokuz Eylul University Medical Faculty, Izmir, Turkey|Medicalpark Izmir Hospital, Izmir, Turkey|Erciyes Universitesi Tip Fakultesi Hastaneleri, Kayseri, Turkey|Ondokuz Mayis University Faculty Of Medicine Hospital, Samsun, Turkey	https://ClinicalTrials.gov/show/NCT03677596
47	Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia|Recurrent Acute Lymphoblastic Leukemia|Refractory Acute Lymphoblastic Leukemia	Biological: CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T-lymphocytes|Biological: CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes|Other: Laboratory Biomarker Analysis	City of Hope Medical Center, Duarte, California, United States	https://ClinicalTrials.gov/show/NCT02146924
48	The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)	Recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia (B-ALL)|Safety and Efficacy of CD19 UCAR-T Cells	Biological: CD19 UCARTcells	The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China	https://ClinicalTrials.gov/show/NCT04166838
49	Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia|Recurrent B Acute Lymphoblastic Leukemia	Biological: Inotuzumab Ozogamicin	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03441061
50	Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Philadelphia Chromosome-Positive	Biological: Blinatumomab|Drug: dasatinib|Drug: dexamethasone|Drug: methotrexate	Northwestern University, Evanston, Illinois, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States	https://ClinicalTrials.gov/show/NCT04329325
51	Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Hyperbilirubinemia	Dietary Supplement: Levocarnitine|Drug: Vitamin B Complex	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03564678
52	Inotuzumab Ozogamicin and Blinatumomab in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative|Recurrent B Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia	Biological: Blinatumomab|Biological: Inotuzumab Ozogamicin	University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Anchorage Radiation Therapy Center, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Kingman Regional Medical Center, Kingman, Arizona, United States|Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States|PCR Oncology, Arroyo Grande, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Community Cancer Institute, Clovis, California, United States|University Oncology Associates, Clovis, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Stanford Cancer Institute Palo Alto, Palo Alto, California, United States|Beebe South Coastal Health Campus, Frankford, Delaware, United States|Beebe Medical Center, Lewes, Delaware, United States|Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, United States|Helen F Graham Cancer Center, Newark, Delaware, United States|Medical Oncology Hematology Consultants PA, Newark, Delaware, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States|Beebe Health Campus, Rehoboth Beach, Delaware, United States|TidalHealth Nanticoke / Allen Cancer Center, Seaford, Delaware, United States|Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Holy Cross Hospital, Fort Lauderdale, Florida, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States|Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States|Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States|Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States|Saint Anthony's Health, Alton, Illinois, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, United States|Loyola Center for Health at Burr Ridge, Burr Ridge, Illinois, United States|Illinois CancerCare-Canton, Canton, Illinois, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, United States|SIH Cancer Institute, Carterville, Illinois, United States|Illinois CancerCare-Carthage, Carthage, Illinois, United States|Centralia Oncology Clinic, Centralia, Illinois, United States|Northwestern University, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States|Decatur Memorial Hospital, Decatur, Illinois, United States|Illinois CancerCare-Dixon, Dixon, Illinois, United States|Crossroads Cancer Center, Effingham, Illinois, United States|Illinois CancerCare-Eureka, Eureka, Illinois, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, United States|Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States|Illinois CancerCare-Macomb, Macomb, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States|Loyola Center for Cancer Care and Research, Orland Park, Illinois, United States|University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, United States|Illinois CancerCare-Pekin, Pekin, Illinois, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, United States|Illinois CancerCare-Peoria, Peoria, Illinois, United States|OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria, Illinois, United States|Methodist Medical Center of Illinois, Peoria, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|Illinois CancerCare-Peru, Peru, Illinois, United States|Valley Radiation Oncology, Peru, Illinois, United States|Illinois CancerCare-Princeton, Princeton, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Springfield Clinic, Springfield, Illinois, United States|Memorial Medical Center, Springfield, Illinois, United States|Central Care Cancer Center - Garden City, Garden City, Kansas, United States|Central Care Cancer Center - Great Bend, Great Bend, Kansas, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|Mercy Medical Center, Springfield, Massachusetts, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|IHA Hematology Oncology Consultants-Brighton, Brighton, Michigan, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, United States|IHA Hematology Oncology Consultants-Canton, Canton, Michigan, United States|Saint Joseph Mercy Canton, Canton, Michigan, United States|Caro Cancer Center, Caro, Michigan, United States|IHA Hematology Oncology Consultants-Chelsea, Chelsea, Michigan, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, United States|Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, United States|Newland Medical Associates-Clarkston, Clarkston, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan, United States|Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan, United States|Genesee Hematology Oncology PC, Flint, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan, United States|Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan, United States|Michigan Breast Specialists-Grosse Pointe Woods, Grosse Pointe Woods, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Hope Cancer Clinic, Livonia, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan, United States|Michigan Breast Specialists-Macomb Township, Macomb, Michigan, United States|Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan, United States|21st Century Oncology-Pontiac, Pontiac, Michigan, United States|Hope Cancer Center, Pontiac, Michigan, United States|Newland Medical Associates-Pontiac, Pontiac, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Great Lakes Cancer Management Specialists-Rochester Hills, Rochester Hills, Michigan, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, United States|Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States|Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, United States|Ascension Saint Joseph Hospital, Tawas City, Michigan, United States|Advanced Breast Care Center PLLC, Warren, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan, United States|Macomb Hematology Oncology PC, Warren, Michigan, United States|Michigan Breast Specialists-Warren, Warren, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States|Huron Gastroenterology PC, Ypsilanti, Michigan, United States|IHA Hematology Oncology Consultants-Ann Arbor, Ypsilanti, Michigan, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, United States|Cox Cancer Center Branson, Branson, Missouri, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, United States|Southeast Cancer Center, Cape Girardeau, Missouri, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|Parkland Health Center - Farmington, Farmington, Missouri, United States|Capital Region Southwest Campus, Jefferson City, Missouri, United States|Freeman Health System, Joplin, Missouri, United States|Mercy Hospital Joplin, Joplin, Missouri, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercy Hospital South, Saint Louis, Missouri, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Siteman Cancer Center at Christian Hospital, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, United States|Mercy Hospital Washington, Washington, Missouri, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|Nebraska Medicine-Village Pointe, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Carson Tahoe Regional Medical Center, Carson City, Nevada, United States|Cancer and Blood Specialists-Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, United States|OptumCare Cancer Care at Seven Hills, Henderson, Nevada, United States|21st Century Oncology-Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, United States|Las Vegas Urology - Green Valley, Henderson, Nevada, United States|Las Vegas Urology - Pebble, Henderson, Nevada, United States|Urology Specialists of Nevada - Green Valley, Henderson, Nevada, United States|Las Vegas Urology - Pecos, Las Vegas, Nevada, United States|Desert West Surgery, Las Vegas, Nevada, United States|OptumCare Cancer Care at Charleston, Las Vegas, Nevada, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Hope Cancer Care of Nevada, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Central, Las Vegas, Nevada, United States|21st Century Oncology, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway, Las Vegas, Nevada, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-San Martin, Las Vegas, Nevada, United States|Las Vegas Prostate Cancer Center, Las Vegas, Nevada, United States|Las Vegas Urology - Sunset, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, United States|21st Century Oncology-Vegas Tenaya, Las Vegas, Nevada, United States|Ann M Wierman MD LTD, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-Tenaya, Las Vegas, Nevada, United States|Las Vegas Urology - Cathedral Rock, Las Vegas, Nevada, United States|Las Vegas Urology - Smoke Ranch, Las Vegas, Nevada, United States|OptumCare Cancer Care at MountainView, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Northwest, Las Vegas, Nevada, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, United States|21st Century Oncology-Fort Apache, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Southwest, Las Vegas, Nevada, United States|HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, United States|University Cancer Center, Las Vegas, Nevada, United States|Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Saint Mary's Regional Medical Center, Reno, Nevada, United States|Radiation Oncology Associates, Reno, Nevada, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Northwell Health/Center for Advanced Medicine, Lake Success, New York, United States|North Shore University Hospital, Manhasset, New York, United States|NYP/Weill Cornell Medical Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|University of Cincinnati/Barrett Cancer Center, Cincinnati, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|University Pointe, West Chester, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States|Saint Charles Health System, Bend, Oregon, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States|Bay Area Hospital, Coos Bay, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Oregon Health and Science University, Portland, Oregon, United States|Saint Charles Health System-Redmond, Redmond, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States|Christiana Care Health System-Concord Health Center, Chadds Ford, Pennsylvania, United States|Pocono Medical Center, East Stroudsburg, Pennsylvania, United States|Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States|Overlake Medical Center, Bellevue, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, United States|Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States|Providence Regional Cancer Partnership, Everett, Washington, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States|Kadlec Clinic Hematology and Oncology, Kennewick, Washington, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, United States|PeaceHealth Saint John Medical Center, Longview, Washington, United States|Valley Medical Center, Renton, Washington, United States|Pacific Gynecology Specialists, Seattle, Washington, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|Swedish Medical Center-Cherry Hill, Seattle, Washington, United States|PeaceHealth United General Medical Center, Sedro-Woolley, Washington, United States|Providence Regional Cancer System-Shelton, Shelton, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, United States|Providence Regional Cancer System-Yelm, Yelm, Washington, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States	https://ClinicalTrials.gov/show/NCT03739814
53	Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Adult B Acute Lymphoblastic Leukemia|Philadelphia Chromosome Positive	Biological: Blinatumomab|Drug: Ibrutinib	University of California Davis Comprehensive Cancer Center, Sacramento, California, United States	https://ClinicalTrials.gov/show/NCT02997761
54	Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia	Recruiting	No Results Available	B Cell Lymphoma|B-cell Acute Lymphoblastic Leukemia	Biological: Anti-CD19 CAR-T Cells Injection	Kunming Yan'an Hospital, Kunming, Yunnan, China	https://ClinicalTrials.gov/show/NCT04289220
55	CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia	Recruiting	No Results Available	B Cell Lymphoma|B-cell Acute Lymphoblastic Leukemia	Biological: Anti-CD19 CAR-T Cells Injection	Kunming Yan'an Hospital, Oncology Department, Kunming, Yunnan, China	https://ClinicalTrials.gov/show/NCT03854994
56	Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Recurrent B Acute Lymphoblastic Leukemia|Recurrent T Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia|Refractory T Acute Lymphoblastic Leukemia	Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dexamethasone|Drug: Methotrexate|Drug: Nelarabine|Drug: Pegaspargase|Drug: Prednisone|Biological: Rituximab|Drug: Venetoclax|Drug: Vincristine	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03808610
57	CAR-T Cell Therapy Targeting to CD19 for R/R ALL	Recruiting	No Results Available	Acute Lymphoblastic Leukemia With Failed Remission	Biological: CAR T-cell therapy	The Fisrt Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China	https://ClinicalTrials.gov/show/NCT03919240
58	Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)	Recruiting	No Results Available	Lymphoblastic Leukemia, Acute, Adult|Ph Negative ALL|Newly Diagnosed	Drug: Blinatumomab	Institute of Hematology and Blood Transfusion, Czech Republic, Prague, Czechia	https://ClinicalTrials.gov/show/NCT04554485
59	Assesment of JL1 Expression in Acute Leukemia	Not yet recruiting	No Results Available	Acute Lymphoblastic Leukemia	Biological: JL1 antigen		https://ClinicalTrials.gov/show/NCT04554381
60	CD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma	Not yet recruiting	No Results Available	Relapsed and/or Refractory Acute Lymphoblastic Leukemia|Relapsed and/or Refractory B-cell Non-Hodgkin's Lymphoma	Drug: CD79b CAR-T Cells	The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China	https://ClinicalTrials.gov/show/NCT04609241
61	Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT	Recruiting	No Results Available	Acute Lymphoblastic Leukemia, in Relapse	Biological: CARCIK-CD19	Ospedale PG23, Bergamo, BG, Italy|Fondazione MBBM, Monza, MB, Italy	https://ClinicalTrials.gov/show/NCT03389035
62	Venetoclax, Dasatinib, Prednisone, and Rituximab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia	Not yet recruiting	No Results Available	B Acute Lymphoblastic Leukemia|Recurrent B Acute Lymphoblastic Leukemia	Drug: Dasatinib|Drug: Methotrexate|Drug: Prednisone|Biological: Rituximab|Drug: Venetoclax	OHSU Knight Cancer Institute, Portland, Oregon, United States	https://ClinicalTrials.gov/show/NCT04872790
63	Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Recurrent B Acute Lymphoblastic Leukemia|Recurrent B Lymphoblastic Lymphoma|Refractory B Acute Lymphoblastic Leukemia|Refractory B Lymphoblastic Lymphoma	Drug: Etoposide|Drug: Doxorubicin|Drug: Vincristine|Drug: Prednisone|Drug: Cyclophosphamide|Biological: Inotuzumab Ozogamicin	Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT03991884
64	Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE	Recruiting	No Results Available	Acute Lymphoblastic Leukemia Ph Positive	Drug: Imatinib	Hospital Central de Asturias, Oviedo, Asturias, Spain|H. Son Llatzer, Palma de Mallorca, Baleares, Spain|Hospital Germans Trias i Pujol and all Hospital Pethema, Badalona, Barcelona, Spain|Hospital de Mataró, Mataró, Barcelona, Spain|Hospital Universitario de Canarias, Tenerife, Canarias, Spain|Hospital general de Castellón, Castello, Castellón, Spain|Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, La Coruña, Spain|Clínica Universitaria de Navarra, Pamplona, Navarra, Spain|Hospital de Navarra, Pamplona, Navarra, Spain|Hospital General de Albacete, Albacete, Spain|Hospital de Alcorcón, Alcorcón, Spain|Hospital General de Alicante., Alicante, Spain|Hospital de Cabueñes, Asturias, Spain|Hospital de Badalona Germans Trias i Pujol, Badalona, Spain|Hospital Clinic y Provincial de Barcelona, Barcelona, Spain|Hospital Clínico y Provincial de Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau., Barcelona, Spain|Hospital de la Santa Creu i Sant Pau., Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital de la santa Creu i Sant Pau, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Duran i Reynals - ICO L'Hospitalet, Barcelona, Spain|Basurtuko Ospitalea, Basurto, Spain|Complejo Hospitalario de Cáceres, Cáceres, Spain|Complejo Hospitalario Reina Sofía, Córdoba, Spain|Area Hospitalaria Juan Ramón Jimenez, Huelva, Spain|Hospital Juan Ramón Jiménez, Huelva, Spain|Hospital del SAS de Jerez de la Frontera, Jerez de la Frontera, Spain|Hospital general de Jerez de la Frontera, Jerez de la Frontera, Spain|Hospital Arnau de Vilanova, Lleida, Spain|Complexo Hospitalario Xeral-Calde, Lugo, Spain|Clínica La Concepción, Madrid, Spain|Clínica Puerta de Hierro, Madrid, Spain|Hospital 12 de Octubre. Madrid, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Clínico San Carlos de Madrid, Madrid, Spain|Hospital Clínico San Carlos de Madrid, Madrid, Spain|Hospital de Fuenlabrada, Madrid, Spain|Hospital de la Princesa, Madrid, Spain|Hospital de Madrid, S.A.- Norte Hospital General, Madrid, Spain|Hospital Gregorio Marañón, Madrid, Spain|Hospital Ramón y Cajal, Madrid, Spain|Hospital Universitario de la Princesa, Madrid, Spain|Hospital Universitario Princcipe de Asturias, Madrid, Spain|Althaia, Xarxa Asistencial de Manresa, Manresa, Spain|Hospital General Univeristario Morales Messeguer, Murcia, Spain|Hospital Sta. Maria del Rosell, Murcia, Spain|. Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain|. Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain|Hospital Carlos Haya, Málaga, Spain|Hospital Carlos Haya, Málaga, Spain|Hospital Carlos Haya, Málaga, Spain|Hospital de Mérida, Mérida, Spain|Hospital del Río Carrión, Palencia, Spain|Hospital de Gran Canaria Doctor Negrín, Palma De Gran Canaria, Spain|Clínica Universitaria de Navarra, Pamplona, Spain|Hospital de Montecelo, Pontevedra, Spain|Corporació Sanitaria Parc Taulí, Sabadell, Spain|Hospital Clínico de Salamanca, Salamanca, Spain|Hospital Clínico Universitario de Salamanca, Salamanca, Spain|Hospital Clínico Universitario, Salamanca, Spain|Hospital de Donostia, San Sebastián, Spain|Hoaspital Marqués de Valdecilla, Santander, Spain|Hospital General de Segovia, Segovia, Spain|Complejo Hospitalario Regional Virgen del Rocío, Sevilla, Spain|Hospital Joan XIII de, Tarragona, Spain|Hospital Joan XXIII, Tarragona, Spain|Hospital Clínico de Valencia., Valencia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Clínico Universitario, Valencia, Spain|Hospital Clínic, Valencia, Spain|Hospital Dr Pesset, Valencia, Spain|Hospital La Fe, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Hospital Clínico de Valladolid, Valladolid, Spain|Complejo Hospitalario Xeral-Cies, Vigo, Spain|Hospital do Meixoeiro, Vigo, Spain|Hospital Txagorritxu, Vitoria, Spain|Hospital Clínico Lozano Blesa, Zaragoza, Spain	https://ClinicalTrials.gov/show/NCT01491763
65	International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Lymphoblastic Leukemia, Adult|Acute Lymphoblastic Leukemia, Pediatric|Acute Lymphoblastic Leukemia, in Relapse|Acute Lymphoblastic Leukemia Recurrent	Drug: Selumetinib|Drug: Dexamethasone	Prinses Maxima Centrum Voor Kinderoncologie, Utrecht, Netherlands|Queen Elizabeth Hospital, Birmingham, United Kingdom|Birmingham Children's Hospital, Birmingham, United Kingdom|Bristol Haematology & Oncology Centre, Bristol, United Kingdom|The Noah's Ark Children's Hospital for Wales, University Hospital of Wales, Cardiff, United Kingdom|University Hospital of Wales Adult Unit, Cardiff, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom|Alder Hey Children's Hospital, Liverpool, United Kingdom|Department of Paediatric Oncology, Royal Marsden Hospital, Sutton, London Borough of Sutton, United Kingdom|Haemato-Oncology Adult Unit, Royal Marsden Hospital, Sutton, London Borough of Sutton, United Kingdom|University College Hospital Adult Unit, London, United Kingdom|University College Hospital Paediatric/Teenage & Young Adult Unit, London, United Kingdom|King's College Hospital, London, United Kingdom|Hammersmith Hospital, London, United Kingdom|Great Ormond Street Hospital, London, United Kingdom|The Christie Hospital, Manchester, United Kingdom|Great North Children's Hospital, Royal Victoria Infirmary, Newcastle, United Kingdom|Freeman Hospital, Newcastle, United Kingdom|Royal Hallamshire Hospital, Sheffield, United Kingdom	https://ClinicalTrials.gov/show/NCT03705507
66	Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia	Recruiting	No Results Available	CD19 Positive|Philadelphia Chromosome Positive|Recurrent Acute Lymphoblastic Leukemia|Refractory Acute Lymphoblastic Leukemia	Biological: Blinatumomab|Other: Laboratory Biomarker Analysis|Biological: Pembrolizumab	City of Hope Medical Center, Duarte, California, United States	https://ClinicalTrials.gov/show/NCT03512405
67	Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL	Recruiting	No Results Available	Relapsed B Acute Lymphoblastic Leukaemia|Refractory B Acute Lymphoblastic Leukaemia	Biological: CD19 CAR-T CELLS|Drug: Cyclophosphamide|Drug: Fludarabine	UKM Medical Centre, Bandar Tun Razak, Kuala Lumpur, Malaysia	https://ClinicalTrials.gov/show/NCT03937544
68	A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL	Not yet recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia	Biological: GC019F		https://ClinicalTrials.gov/show/NCT04595162
69	Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Device: Active tDCS|Device: Sham tDCS	St. Jude Children's Research Hospital, Memphis, Tennessee, United States	https://ClinicalTrials.gov/show/NCT04007601
70	Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation	Recruiting	No Results Available	Adult B Acute Lymphoblastic Leukemia	Drug: CD19 CAR-T|Drug: CD22 CAR-T|Drug: CD19+CD22 CAR-T|Drug: Fludarabine|Drug: Cyclophosphamide	No.2 Hospital of Hebei Medical University, Shijiazhuang, Hebei, China	https://ClinicalTrials.gov/show/NCT04626726
71	Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL	Not yet recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia	Drug: Blinatumomab	Moffitt Cancer Center, Tampa, Florida, United States|Novant Health Cancer Institute and Innovation Center, Winston-Salem, North Carolina, United States	https://ClinicalTrials.gov/show/NCT04448834
72	Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Younger Adults With Relapsed/Refractory B-cell ALL	Recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia	Drug: Inotuzumab ozogamicin|Drug: Prednisone Pill|Drug: Daunorubicin|Drug: Vincristine|Drug: Cytarabine|Drug: Methotrexate|Drug: Pegaspargase	University of Virginia, Charlottesville, Virginia, United States	https://ClinicalTrials.gov/show/NCT03962465
73	Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia	Recruiting	No Results Available	Recurrent B Acute Lymphoblastic Leukemia|Recurrent Mixed Phenotype Acute Leukemia|Refractory B Acute Lymphoblastic Leukemia|Refractory Mixed Phenotype Acute Leukemia	Biological: Blinatumomab|Biological: Ipilimumab|Biological: Nivolumab	Yale University, New Haven, Connecticut, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States	https://ClinicalTrials.gov/show/NCT02879695
74	Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Dual-target CAR-T Cells|B ALL|Relapse|Refractory B Acute Lymphoblastic Leukemia	Biological: Dual target CAR-T cell therapy	Shenzhen University General hospital, Shenzhen, Guangdong, China	https://ClinicalTrials.gov/show/NCT04723901
75	Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph+ B-ALL	Recruiting	No Results Available	B-Cell Acute Lymphoblastic Leukemia, Adult	Drug: CAR-T cells targeting CD19 and CD22	The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China	https://ClinicalTrials.gov/show/NCT04788472
76	Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALL	Recruiting	No Results Available	B-Cell Acute Lymphoblastic Leukemia, Adult	Drug: CAR-T cells targeting CD19 and CD22	The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China	https://ClinicalTrials.gov/show/NCT04740203
77	Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease	Recruiting	No Results Available	Adult Acute Lymphoblastic Leukemia in Complete Remission|B Acute Lymphoblastic Leukemia|Minimal Residual Disease|Philadelphia Chromosome Positive	Biological: Blinatumomab|Other: Laboratory Biomarker Analysis	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT02458014
78	Venetoclax and Vincristine Liposomal in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia|Lymphoblasts 5 Percent or More of Bone Marrow Nucleated Cells|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Refractory Acute Lymphoblastic Leukemia|T Acute Lymphoblastic Leukemia	Other: Laboratory Biomarker Analysis|Drug: Venetoclax|Drug: Vincristine Liposomal	Yale University, New Haven, Connecticut, United States|Northwestern University, Chicago, Illinois, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States	https://ClinicalTrials.gov/show/NCT03504644
79	ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Blasts 5 Percent or More of Bone Marrow Nucleated Cells|CD22 Positive|Philadelphia Chromosome Positive|Recurrent B Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia	Biological: ADCT-602	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03698552
80	A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Non-Hodgkin's Lymphoma	Drug: CAR-T cells|Procedure: Ommaya Reservoir	The First Affiliated Hospital，College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China	https://ClinicalTrials.gov/show/NCT04532203
81	Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL	Recruiting	No Results Available	Acute Lymphocytic Leukemia, Adult B-Cell|BCR-ABL1 Fusion Protein Expression	Drug: Flumatinib	Department of Hematology, Zhongda Hospital Southeast University, Institute of Hematology Southeast University, Nanjing, Jiangsu, China|Department of Hematology, Zhongda Hospital Southeast University, Institute of Hematology Southeast University, Nanjing, Jiangsu, China	https://ClinicalTrials.gov/show/NCT04375683
82	Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia	Recruiting	No Results Available	Burkitt Leukemia|High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|Recurrent Acute Lymphoblastic Leukemia|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Burkitt Leukemia|Recurrent Burkitt Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|Refractory Acute Lymphoblastic Leukemia|Refractory Burkitt Leukemia|Refractory Burkitt Lymphoma|Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|Refractory Lymphoblastic Lymphoma	Drug: Bortezomib|Drug: Clofarabine|Drug: Cyclophosphamide|Drug: Dexamethasone|Drug: Etoposide|Biological: Ofatumumab|Biological: Pegfilgrastim|Biological: Rituximab|Drug: Vincristine Sulfate Liposome	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03136146
83	A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Non-hodgkin Lymphoma,B Cell	Drug: Humanized CD19 CAR-T cells	The First Affiliated Hospital，College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China	https://ClinicalTrials.gov/show/NCT04532268
84	Human CD19 Targeted T Cells Injection Therapy for Relapsed and Refractory CD19-positive Leukemia	Recruiting	No Results Available	CD19-positive|Acute Lymphoblastic Leukemia	Drug: Human CD19 targeted T Cells Injection	Shanghai General Hospital, Shanghai, Shanghai, China	https://ClinicalTrials.gov/show/NCT03798509
85	Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for MRD Positive ALL	Recruiting	No Results Available	MRD-positive|Acute Lymphoblastic Leukemia	Biological: anti-CD19/CD22 CAR-T cells|Drug: Fludarabine|Drug: Cyclophosphamide	Shanghai General Hospital, Shanghai, Shanghai, China	https://ClinicalTrials.gov/show/NCT03919526
86	A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Non-Hodgkin Lymphoma of Soft Tissue	Drug: Murine CD19 CAR-T cells	The First Affiliated Hospital，College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China	https://ClinicalTrials.gov/show/NCT04532281
87	RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL	Recruiting	No Results Available	T Acute Lymphoblastic Leukemia|T-lymphoblastic Lymphoma	Drug: RD13-01 cell infusion	Hebei Yanda Ludaopei Hospital, Langfang, Hebei, China	https://ClinicalTrials.gov/show/NCT04620655
88	ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors	Recruiting	No Results Available	Lymphoblastic Lymphoma	Drug: Anti-human Thymoglobulin|Drug: Placebo	Shanghai First People's HOSPITAL, Shanghai, Shanghai, China|Shanghai First People's HOSPITAL, Shanghai, China	https://ClinicalTrials.gov/show/NCT02938741
89	Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Drug: Pediatric-type of chemotherapy|Procedure: allogeneic HSCT	Ico-Hugtip, Badalona, Barcelona, Spain|H Albacete, Albacete, Spain|H. General Univ. de Alicante, Alicante, Spain|H. General Univ. de Alicante, Alicante, Spain|Clínica Teknon, Barcelona, Spain|H del Mar, Barcelona, Spain|H. Clínic de Barcelona, Barcelona, Spain|H. del Mar, Barcelona, Spain|H. Sant Pau, Barcelona, Spain|H. Vall d'Hebron, Barcelona, Spain|H. Vall d'Hebron, Barcelona, Spain|ICO-Duran i Reynals, Bellvitge, Spain|H Basurto, Bilbao, Spain|Hu Basurto, Bilbao, Spain|H. Jerez, Cadiz, Spain|H. Puerta del Mar, Cadiz, Spain|H. General de Castellón, Castelló, Spain|H. San Pedro de Alcántara, Cáceres, Spain|H. Reina Sofía, Córdoba, Spain|H. Fuenlabrada, Fuenlabrada, Spain|H Galdakao, Galdakao, Spain|H. Univ. De Getafe, Getafe, Spain|ICO-Dr.Josep Trueta, Girona, Spain|H. Guadalajara, Guadalajara, Spain|H Juan Ramón Jiménez, Huelva, Spain|Complejo Hospitalario Ciudad de Jaén, Jaén, Spain|H. Jerez de la Frontera, Jerez De La Frontera, Spain|H. A Coruña, La Coruña, Spain|H. General Lanzarote, Lanzarote, Spain|H Dr. Negrín, Las Palmas De Gran Canaria, Spain|Hospital Insular de Gran Canaria, Las Palmas De Gran Canaria, Spain|Hu Gran Canarias Dr Negrin, Las Palmas De Gran Canaria, Spain|H. Arnau De Vilanova, Lleida, Spain|H. Lucus Augusti, Lugo, Spain|H. Lucus Augusti, Lugo, Spain|H. Lucus Augusti, Lugo, Spain|Fundación Jiménez Díaz, Madrid, Spain|H La Zarzuela, Madrid, Spain|H Puerta de Hierro, Madrid, Spain|H Puerta de Hierro, Madrid, Spain|H. 12 de Octubre, Madrid, Spain|H. 12 de Octubre, Madrid, Spain|H. 12 de Octubre, Madrid, Spain|H. 12 de Octubre, Madrid, Spain|H. 12 de Octubre, Madrid, Spain|H. Clínico de Madrid, Madrid, Spain|H. Clínico de Madrid, Madrid, Spain|H. Gregorio Marañón, Madrid, Spain|H. Gregorio Marañón, Madrid, Spain|H. Infanta Sofía, Madrid, Spain|H. Madrid-Norte Sanchinarro, Madrid, Spain|H. Ramón y Cajal, Madrid, Spain|H. Ramón y Cajal, Madrid, Spain|H. Univ La Paz, Madrid, Spain|Hu Infanta Leonor, Madrid, Spain|Hu La Princesa, Madrid, Spain|H. Morales Meseguer, Murcia, Spain|H. Virgen de la Arrixaca, Murcia, Spain|H. Virgen de la Arrixaca, Murcia, Spain|H. Virgen de la Arrixaca, Murcia, Spain|H. Carlos Haya, Málaga, Spain|H. Clínico Univ. Virgen de la Victoria, Málaga, Spain|H. Regional de Málaga, Málaga, Spain|Complejo Hosp. Univ. de Orense, Orense, Spain|Complejo Hosp. Univ. de Orense, Orense, Spain|Complejo Hosp. Univ. de Orense, Orense, Spain|Complejo Hosp. Univ. de Orense, Orense, Spain|H. Central de Asturias, Oviedo, Spain|H Río Carrión, Palencia, Spain|H. Son Espases, Palma De Mallorca, Spain|H. Son Llàtzer, Palma De Mallorca, Spain|Complejo Hospitalario Navarra, Pamplona, Spain|H. Clínico Univ. de Navarra, Pamplona, Spain|H. Virgen del Camino, Pamplona, Spain|Complejo Hospitalario Pontevedra - Hospital Montecelo, Pontevedra, Spain|H. Parc Taulí, Sabadell, Spain|H. Clínico Univ. de Salamanca, Salamanca, Spain|H. Clínico Univ. de Salamanca, Salamanca, Spain|H Donostia, San Sebastián, Spain|H Donostia, San Sebastián, Spain|H Donostia, San Sebastián, Spain|H Donostia, San Sebastián, Spain|H. Univ. de Canarias, Santa Cruz De Tenerife, Spain|H. Marqués de Valdecilla, Santander, Spain|H. Marqués de Valdecilla, Santander, Spain|Complejo Hosp. Univ. Santiago de Compostela, Santiago De Compostela, Spain|Complejo Hosp. Univ. Santiago de Compostela, Santiago De Compostela, Spain|H. General de Segovia, Segovia, Spain|H. Universitario de Valme, Sevilla, Spain|H. Virgen del Rocío, Sevilla, Spain|ICO-Joan XXIII, Tarragona, Spain|Mútua de Terrassa, Terrassa, Spain|H Torrejón, Torrejón De Ardoz, Spain|H. Verge de la Cinta, Tortosa, Spain|H. Arnau de Vilanova, Valencia, Spain|H. Clínico Univ. de Valencia, Valencia, Spain|H. Dr. Peset, Valencia, Spain|H. Dr. Peset, Valencia, Spain|H. General Univ. de Valencia, Valencia, Spain|H. la Fe, Valencia, Spain|H. Clínico Universitario de Valladolid, Valladolid, Spain|H. Río Hortega, Valladolid, Spain|H. Xeral-Cíes Vigo, Vigo, Spain|H. Xeral-Cíes Vigo, Vigo, Spain|H. Virgen de la Concha, Zamora, Spain|H. Lozano Blesa, Zaragoza, Spain|H. Miguel Servet, Zaragoza, Spain|Hospital Nuestra Señora de Sonsoles, Ávila, Spain	https://ClinicalTrials.gov/show/NCT04179929
90	Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Allogeneic Hematopoietic Stem Cell Transplantation Recipient|Blasts 5 Percent or More of Bone Marrow Nucleated Cells|Blasts 5 Percent or More of Peripheral Blood White Cells|CD22 Positive|Lymphoblasts 20 Percent or More of Bone Marrow Nucleated Cells|Lymphoblasts 20 Percent or More of Peripheral Blood White Cells|Recurrent B Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia	Biological: Inotuzumab Ozogamicin|Other: Quality-of-Life Assessment|Drug: Vincristine Sulfate Liposome	Roswell Park Cancer Institute, Buffalo, New York, United States	https://ClinicalTrials.gov/show/NCT03851081
91	CD19 hsCAR-T for Refractory/Relapsed CD19+ B-ALL Patients	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Biological: CD19 hsCAR-T	Beijing Children's Hospital Capital Meidcal University, Beijing, Beijing, China|Beijing Children's Hospital, Capital Medical University, Beijing, Beijing, China	https://ClinicalTrials.gov/show/NCT03902197
92	ABL001 + Dasatinib + Prednisone in BCR-ABL+ B-ALL or CML	Recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia|Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis|Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL	Drug: ABL001|Drug: Dasatinib|Drug: Prednisone	University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States	https://ClinicalTrials.gov/show/NCT03595917
93	Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses	Recruiting	No Results Available	Leukemia, Acute Lymphoblastic	Other: Acute Lymphobastic Leukemia (ALL) Treatment Options	University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, United States	https://ClinicalTrials.gov/show/NCT02580981
94	Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant	Recruiting	No Results Available	B-cell Adult Acute Lymphoblastic Leukemia|Stem Cell Leukemia|Minimal Residual Disease	Biological: blinatumomab	Vancouver General Hospital - Leukemia/Bone Marrow Transplant Program, Vancouver, British Columbia, Canada|BC Children's Hospital, Vancouver, British Columbia, Canada|QEII - Health Sciences Centre, Halifax, Nova Scotia, Canada	https://ClinicalTrials.gov/show/NCT04044560
95	Clinical Study of SenL-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Leukemia or T-cell Lymphoblastic Lymphoma	Recruiting	No Results Available	SenL-T7 CAR T Cells for CD7+ Leukemia or T-LBL	Biological: Senl-T7	Hebei yanda Ludaopei Hospital, Beijing, Hebei, China	https://ClinicalTrials.gov/show/NCT04916860
96	A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL	Recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia	Biological: GC022F	Hebei Yanda Ludaopei Hospital, Sanhe, Hebei, China	https://ClinicalTrials.gov/show/NCT04129099
97	Safety and Efficacy Study of CD22 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia	Recruiting	No Results Available	B-ALL	Biological: CD22 CAR-T	Hebei yanda Ludaopei Hospital, Heibei, Sanhe, China|BeiJing Ludaopei Hospital, Beijing, Yizhuang, China	https://ClinicalTrials.gov/show/NCT04546906
98	Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia	Recruiting	No Results Available	B-ALL	Biological: Senl-h19 CAR-T	Hebei yanda Ludaopei Hospital, Yanda, Hebei, China	https://ClinicalTrials.gov/show/NCT04792593
99	Cell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia Using CD7-Specific CAR-T Cells	Recruiting	No Results Available	T-All	Biological: CD7 CAR-T	Hebei yanda Ludaopei Hospital, Yanda, Hebei, China	https://ClinicalTrials.gov/show/NCT04572308
100	Study of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHL	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Non Hodgkin Lymphoma	Biological: Car-T Cell Therapy	Acıbadem Labcell Cellular Therapy Laboratories, Istanbul, Turkey	https://ClinicalTrials.gov/show/NCT04206943
101	Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse	Not yet recruiting	No Results Available	Philadelphia-Positive ALL|Acute Lymphoblastic Leukemia, in Relapse	Drug: Ponatinib		https://ClinicalTrials.gov/show/NCT04475731
102	Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults.	Recruiting	No Results Available	ALL, Adult	Drug: Blinatumomab	UZA, Antwerpen, Belgium|ZNA Stuivenberg, Antwerpen, Belgium|AZ st Jan, Brugge, Belgium|UZ Leuven, Leuven, Belgium|AZ Delta, Roeselare, Belgium|Meander MC, Amersfoort, Netherlands|Amsterdam Medical Centre (AMC), Amsterdam, Netherlands|VU medical Centre, Amsterdam, Netherlands|Hagaziekenhuis, locatie Leyweg, Den Haag, Netherlands|Medisch Spectrum Twente, Enschede, Netherlands|UMCG, Groningen, Netherlands|LUMC, Leiden, Netherlands|Antonius Ziekenhuis, Nieuwegein, Netherlands|Erasmus MC, Rotterdam, Netherlands|UMCU, Utrecht, Netherlands|Isala, Zwolle, Netherlands	https://ClinicalTrials.gov/show/NCT03541083
103	Calaspargase Pegol in Adults With ALL	Not yet recruiting	No Results Available	Acute Lymphoblastic Leukemia	Drug: Calaspargase pegol (S95015)	HonorHealth Cancer Transplant Institute, Scottsdale, Arizona, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|UC San Diego Health Moores Cancer Center, La Jolla, California, United States|Yale University, New Haven, Connecticut, United States|Robert H Lurie Cancer Center, Chicago, Illinois, United States|University of Chicago Medicine, Chicago, Illinois, United States|University of Maryland Greenbaum Cancer Center, Baltimore, Maryland, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|Dana Farber Cancer Institute, Weymouth, Massachusetts, United States|NYU Langone/Laura and Isaac Perlmutter Cancer Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Duke University, Durham, North Carolina, United States|Cleveland Clinic, Cleveland, Ohio, United States|Penn State Cancer Institute, Hershey, Pennsylvania, United States|University of Washington/Seattle Cancer Care Alliance, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT04817761
104	Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old)	Recruiting	No Results Available	T-cell Adult Acute Lymphoblastic Leukemia	Drug: nelarabine	Hematology, Paris, France	https://ClinicalTrials.gov/show/NCT02619630
105	A Treatment Study Protocol for Participants 1-45 Years With Acute Lymphoblastic Leukaemia	Recruiting	No Results Available	Leukemia, Acute Lymphoblastic	Drug: Omitted Doxorubicin|Drug: Omitted Vincristine+Dexamethasone pulses|Drug: Inotuzumab Ozogamicin+Standard Maintenance Therapy|Drug: Imatinib|Drug: 6-tioguanine+Standard Maintenance Therapy|Drug: Blinatumomab	L'hôpital Universitaire des enfants Reine Fabiola (Huderf), Brussels, Belgium|University Hospital Brussels, Brussels, Belgium|Cliniques Universitaires Saint-Luc (UCL), Brussels, Belgium|University Hospital Antwerp, Edegem, Belgium|University Hospital Ghent, Ghent, Belgium|University Hospital Leuven, Dept of Haematology, Leuven, Belgium|University Hospital Leuven, Dept of Paediatrics, Leuven, Belgium|CHC MontLégia, Boulevard Patience et Beaujonc 2, Liège, Belgium|CHR de la Citadelle, Liège, Belgium|Aalborg University Hospital, Dept of Paediatrics, Aalborg, Denmark|Aarhus University Hospital, Aarhus, Denmark|Aarhus University Hospital, Child and Adolescent Health, Aarhus, Denmark|Rigshospitalet, Dept of Haematology, Copenhagen, Denmark|Rigshospitalet, Dept of Paediatrics, Copenhagen, Denmark|Odense University Hospital, Dept of Paediatrics, Odense, Denmark|North Estonia Medical Centre, Dept of Haematology, Tallinn, Estonia|Tallinn Children´s Hospital, Dept of Paediatrics, Tallinn, Estonia|Tartu University Hospital, Dept of Paediatrics, Tartu, Estonia|Tartu University Hospital, Tartu, Estonia|Helsinki University Hospital, Dept of Haematology, Helsinki, Finland|Helsinki University Hospital, Dept of Paediatrics, Helsinki, Finland|Kuopio University Hospital, Dept of Haematology, Kuopio, Finland|Kuopio University Hospital, Dept of Paediatrics, Kuopio, Finland|Oulu University Hospital, Dept of Haematology, Dept of Medicine, Oulu, Finland|Oulu University Hospital, Dept of Paediatrics, Oulu, Finland|Tampere University Hospital, Dept of Haematology, Tampere, Finland|Tampere University Hospital, Dept of Paediatrics, Tampere, Finland|Turku University Hospital, Clinical Haematology and Stem Cell Transplantation Unit, Turku, Finland|Turku University Hospital, Dept of Paediatrics, Turku, Finland|Evangelisches Krankenhaus Bielefeld, Bielefeld, Germany|Universitätsklinikum Bonn, Bonn, Germany|Klinikum Bremen Mitte, Bremen, Germany|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|HELIOS Klinikum Krefeld, Krefeld, Germany|Universitätsmedizin Mainz, Mainz, Germany|Universitätsklinikum München, München, Germany|Landspitali University Hospital, Children's Hospital, Reykjavík, Iceland|Our Lady's Children's Hospital, Dublin, Ireland|Children's Hospital, Affiliate of Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania|Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands|Haukeland University Hospital, Dept of Haematology, Bergen, Norway|Haukeland University Hospital, Dept of Paediatrics, Bergen, Norway|Oslo University Hospital, Dept of Haematology, Oslo, Norway|Oslo University Hospital, Dept of paediatric haemato- and oncology, Oslo, Norway|Stavanger University Hospital, Dept of Haematology, Stavanger, Norway|University Hospital North Norway, Dept of Haematology, Tromsø, Norway|University Hospital of North Norway, Dept of Paediatrics, Tromsø, Norway|St. Olavs University Hospital, Dept of Paediatrics, Trondheim, Norway|St. Olavs University Hospital, Dept of Haematology, Trondheim, Norway|Centro Hospitalar e Universitário de Coimbra, EPE - Hospital Pediátrico de Coimbra, Coimbra, Portugal|Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE, Lisboa, Portugal|Instituto Português de Oncologia do Porto Francisco Gentil, EPE, Porto, Portugal|Sahlgrenska University Hospital, Section for Haematology and coagulation, Gothenburg, Sweden|Sahlgrenska University Hospital, Dept of Paediatric Haematology and Oncology, Gothenburg, Sweden|Linköping University Hospital, Dept of Haematology, Linköping, Sweden|Linköping University Hospital, Dept of Paediatrics, Linköping, Sweden|Skåne University Hospital, Dept of Haematology, Lund, Sweden|Skåne University Hospital, Dept of Paediatrics, Lund, Sweden|Karolinska University Hospital, Dept of Paediatric Oncology and Haematology, Stockholm, Sweden|Karolinska University Hospital, Patient area Haematology, Stockholm, Sweden|Norrland University Hospital, Dept of Haematology, Umeå, Sweden|Norrland University Hospital, Dept of Paediatrics, Umeå, Sweden|Uppsala University Hospital, Dept of Haematology, Uppsala, Sweden|Uppsala University Hospital, Dept of Paediatric Haematology and Oncology, Uppsala, Sweden|Örebro University Hospital, Section for Haematology, Örebro, Sweden|Aberdeen Royal Infirmary, Aberdeen, Aberdeen, United Kingdom|Royal Aberdeen Children's Hospital, Aberdeen, Aberdeen, United Kingdom|Royal Belfast Hospital for Sick Children, Belfast, Belfast, United Kingdom|Belfast City Hospital, Belfast, Belfast, United Kingdom|The Queen Elizabeth Hospital, Birmingham, Birmingham, United Kingdom|Birmingham Children's Hospital, Birmingham, Birmingham, United Kingdom|Bristol Royal Hospital for Children / Bristol Haematology and Oncology Centre, Bristol, United Kingdom|Addenbrooke's Hospital, Cambridge, Cambridge, United Kingdom|Noah's Ark Children's Hospital for Wales, Cardiff, Cardiff, United Kingdom|University Hospital of Wales, Cardiff, Cardiff, United Kingdom|Ninewells Hospital, Dundee, Dundee, United Kingdom|Western General Hospital, Edinburgh, Edinburgh, United Kingdom|Royal Hospital for Sick Children, Edinburgh, Edinburgh, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, Glasgow, United Kingdom|Royal Hospital for Children, Glasgow, Glasgow, United Kingdom|Leeds General Infirmary, Leeds, Leeds, United Kingdom|St. James's University Hospital, Leeds, Leeds, United Kingdom|Leicester Royal Infirmary, Leicester, Leicester, United Kingdom|Alder Hey Children's Hospital, Liverpool, Liverpool, United Kingdom|Royal Liverpool University Hospital, Liverpool, Liverpool, United Kingdom|University College London Hospital, London, London, United Kingdom|Great Ormond Street Hospital for Children, London, London, United Kingdom|Royal Manchester Children's Hospital, Manchester, Manchester, United Kingdom|Christie Hospital, Manchester, Manchester, United Kingdom|Royal Victoria Infirmary, Newcastle, Newcastle, United Kingdom|Freeman Hospital, Newcastle, Newcastle, United Kingdom|Nottingham City Hospital, Nottingham, Nottingham, United Kingdom|Queen's Medical Centre, Nottingham, Nottingham, United Kingdom|Churchill Hospital, Oxford, Oxford, United Kingdom|John Radcliffe Hospital, Oxford, Oxford, United Kingdom|Derriford Hospital, Plymouth, Plymouth, United Kingdom|Royal Hallamshire Hospital, Sheffield, Sheffield, United Kingdom|Sheffield Children's Hospital, Sheffield, Sheffield, United Kingdom|Southampton General Hospital, Southampton, Southampton, United Kingdom|Royal Stoke University Hospital, Stoke, Stoke, United Kingdom|Royal Marsden Hospital, Sutton, Sutton, United Kingdom	https://ClinicalTrials.gov/show/NCT04307576
106	Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia	Not yet recruiting	No Results Available	Leukemia, B-Cell	Biological: CD19-targeted CART cells		https://ClinicalTrials.gov/show/NCT03599375
107	Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Lymphoblastic Leukemia|BCR-ABL1 Fusion Protein Expression|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Philadelphia Chromosome Positive|Recurrent Acute Lymphoblastic Leukemia|Refractory Acute Lymphoblastic Leukemia|t(9;22)	Biological: Blinatumomab|Drug: Cytarabine|Drug: Methotrexate|Drug: Ponatinib	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03263572
108	Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia With BCR-ABL1|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Philadelphia Chromosome Positive|Recurrent Acute Lymphoblastic Leukemia|Refractory Acute Lymphoblastic Leukemia	Biological: Blinatumomab|Drug: Cyclophosphamide|Drug: Cytarabine|Biological: Filgrastim|Drug: Methotrexate|Biological: Pegfilgrastim|Drug: Ponatinib|Biological: Rituximab|Drug: Vincristine	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03147612
109	Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Lymphoblastic Leukemia|Adult Acute Lymphoblastic Leukemia in Complete Remission|B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Philadelphia Chromosome Positive|Untreated Adult Acute Lymphoblastic Leukemia	Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dexamethasone|Drug: Doxorubicin|Drug: Doxorubicin Hydrochloride|Other: Laboratory Biomarker Analysis|Drug: Methotrexate|Drug: Ponatinib|Drug: Ponatinib Hydrochloride|Drug: Prednisone|Biological: Rituximab|Drug: Vincristine|Drug: Vincristine Sulfate	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT01424982
110	Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|ALL, Childhood|ALL	Drug: Ruxolitinib|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Mercaptopurine|Drug: Vincristine|Drug: Pegaspargase|Drug: Rituximab|Drug: Methotrexate (Intrathecal Administration)|Drug: Methotrexate (Intravenous Administration)|Drug: Dexamethasone|Drug: Doxorubicin|Drug: Thioguanine|Drug: Methotrexate Oral Product	University of Chicago Medical Center, Chicago, Illinois, United States	https://ClinicalTrials.gov/show/NCT03571321
111	211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Acute Myeloid Leukemia|Hematopoietic and Lymphoid Cell Neoplasm|Chronic Myelomonocytic Leukemia|Myelodysplastic Syndrome With Excess Blasts|Recurrent Acute Myeloid Leukemia|Refractory Acute Lymphoblastic Leukemia|Recurrent Acute Lymphoblastic Leukemia|Recurrent Mixed Phenotype Acute Leukemia|Refractory Acute Myeloid Leukemia|Refractory Mixed Phenotype Acute Leukemia|Mixed Phenotype Acute Leukemia	Drug: Cyclosporine|Drug: Fludarabine Phosphate|Other: Laboratory Biomarker Analysis|Drug: Mycophenolate Mofetil|Procedure: Peripheral Blood Stem Cell Transplantation|Other: Pharmacological Study|Radiation: Pretargeted Radioimmunotherapy|Drug: Sirolimus|Radiation: Total-Body Irradiation	Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT03128034
112	TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Non Hodgkin Lymphoma|Acute Lymphoblastic Leukemia|Diffuse Large B Cell Lymphoma|Primary Mediastinal Large B Cell Lymphoma|Mantle Cell Lymphoma|Follicular Lymphoma	Drug: TC-110 T Cells|Drug: Fludarabine|Drug: Cyclophosphamide	Colorado Blood Cancer Institute, Denver, Colorado, United States|Sarah Cannon Research Institute, Nashville, Tennessee, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT04323657
113	huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma|Refractory Adult Acute Lymphoblastic Leukemia|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma|Recurrent Transformed Non-Hodgkin Lymphoma|Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements|Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements|Recurrent B Acute Lymphoblastic Leukemia|Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|Refractory B Acute Lymphoblastic Leukemia|Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements	Biological: Autologous Human Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ T-lymphocytes|Drug: Cyclophosphamide|Drug: Fludarabine|Other: Laboratory Biomarker Analysis|Procedure: Leukapheresis|Other: Pharmacological Study	Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT03103971
114	DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Hematopoietic and Lymphoid Cell Neoplasm|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Myelomonocytic Leukemia|Recurrent Myelodysplastic Syndrome|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Myelomonocytic Leukemia|Refractory Myelodysplastic Syndrome	Drug: DS-1594b|Drug: Azacitidine|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dexamethasone|Biological: Filgrastim|Drug: Leucovorin|Drug: Mesna|Drug: Methotrexate|Drug: Posaconazole|Drug: Prednisone|Biological: Rituximab|Drug: Venetoclax|Drug: Vincristine|Drug: Voriconazole	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT04752163
115	Dose-escalation Study of Safety of PBCAR0191 in Patients With r/r NHL and r/r B-cell ALL	Recruiting	No Results Available	Non-Hodgkin Lymphoma|B-cell Acute Lymphoblastic Leukemia	Genetic: PBCAR0191|Drug: Fludarabine|Drug: Cyclophosphamide	City of Hope, Duarte, California, United States|H. Lee Moffitt Cancer Center, Tampa, Florida, United States|Northside Hospital Cancer Institute, Atlanta, Georgia, United States|Indiana Blood and Marrow, Indianapolis, Indiana, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Barbara Ann Karmanos Cancer Institute (Wayne State University), Detroit, Michigan, United States|University of Minnesota, Minneapolis, Minnesota, United States|Weill Cornell Medical College - NY Presbyterian Hospital, New York, New York, United States|Columbia University Irving Medical Center/New York Presbyterian Hospital, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Lifespan Cancer Institute at Rhode Island Hospital, Providence, Rhode Island, United States|MD Anderson, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03666000
116	Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia	Recruiting	No Results Available	Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Philadelphia Chromosome Positive|Recurrent Acute Lymphoblastic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Acute Lymphoblastic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|t(9;22)	Drug: Dexamethasone|Drug: Ponatinib Hydrochloride|Biological: Rituximab|Drug: Venetoclax	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03576547
117	A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|B-cell Non Hodgkin Lymphoma|Pre B-Cell Acute Lymphoblastic Leukaemia	Drug: Blinatumomab|Drug: Dexamethasone	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States	https://ClinicalTrials.gov/show/NCT03114865
118	Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia	Recruiting	No Results Available	AIDS-Related Burkitt Lymphoma|Atypical Burkitt/Burkitt-Like Lymphoma|High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements|Recurrent Acute Lymphoblastic Leukemia|Recurrent Burkitt Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Burkitt Lymphoma	Drug: Cyclophosphamide|Drug: Doxorubicin Hydrochloride|Drug: Etoposide|Biological: Ofatumumab|Drug: Prednisone|Biological: Rituximab|Drug: Vincristine Sulfate	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT02199184
119	Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia	Drug: Allopurinol|Drug: Cytarabine|Drug: Daunorubicin Hydrochloride|Drug: Vincristine Sulfate|Drug: Dexamethasone|Drug: Pegylated L-Asparaginase|Drug: Methotrexate|Procedure: Bone Marrow Aspiration and Biopsy|Drug: Cyclophosphamide|Drug: Mercaptopurine|Biological: Rituximab|Drug: Doxorubicin|Drug: Thioguanine|Biological: Inotuzumab Ozogamicin|Other: Laboratory Biomarker Analysis	University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Anchorage Radiation Therapy Center, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Fairbanks Memorial Hospital, Fairbanks, Alaska, United States|Kingman Regional Medical Center, Kingman, Arizona, United States|Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States|Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States|PCR Oncology, Arroyo Grande, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Community Cancer Institute, Clovis, California, United States|University Oncology Associates, Clovis, California, United States|UC Irvine Health Cancer Center-Newport, Costa Mesa, California, United States|Kaiser Permanente Dublin, Dublin, California, United States|Kaiser Permanente-Fremont, Fremont, California, United States|Fresno Cancer Center, Fresno, California, United States|Kaiser Permanente-Fresno, Fresno, California, United States|Kaiser Permanente-Modesto, Modesto, California, United States|Kaiser Permanente Oakland-Broadway, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Stanford Cancer Institute Palo Alto, Palo Alto, California, United States|Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, United States|Kaiser Permanente-Redwood City, Redwood City, California, United States|Kaiser Permanente-Richmond, Richmond, California, United States|Rohnert Park Cancer Center, Rohnert Park, California, United States|Kaiser Permanente-Roseville, Roseville, California, United States|The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States|Kaiser Permanente Downtown Commons, Sacramento, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Kaiser Permanente-South Sacramento, Sacramento, California, United States|South Sacramento Cancer Center, Sacramento, California, United States|Kaiser Permanente - Sacramento, Sacramento, California, United States|Kaiser Permanente-San Francisco, San Francisco, California, United States|Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States|Kaiser Permanente San Leandro, San Leandro, California, United States|Kaiser Permanente-San Rafael, San Rafael, California, United States|Kaiser San Rafael-Gallinas, San Rafael, California, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States|Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States|Kaiser Permanente-South San Francisco, South San Francisco, California, United States|Kaiser Permanente-Stockton, Stockton, California, United States|Kaiser Permanente Medical Center-Vacaville, Vacaville, California, United States|Kaiser Permanente-Vallejo, Vallejo, California, United States|Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States|Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, United States|The Medical Center of Aurora, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Boulder Community Foothills Hospital, Boulder, Colorado, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, United States|Rocky Mountain Cancer Centers - Centennial, Centennial, Colorado, United States|Cancer Center of Colorado at Sloan's Lake, Denver, Colorado, United States|National Jewish Health-Main Campus, Denver, Colorado, United States|The Women's Imaging Center, Denver, Colorado, United States|Colorado Blood Cancer Institute, Denver, Colorado, United States|Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, United States|SCL Health Saint Joseph Hospital, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Rose, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Western Surgical Care, Denver, Colorado, United States|Mountain Blue Cancer Care Center - Swedish, Englewood, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|National Jewish Health-Western Hematology Oncology, Golden, Colorado, United States|Saint Mary's Hospital and Regional Medical Center, Grand Junction, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|Good Samaritan Medical Center, Lafayette, Colorado, United States|Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado, United States|Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado, United States|Sky Ridge Medical Center, Lone Tree, Colorado, United States|McKee Medical Center, Loveland, Colorado, United States|National Jewish Health-Northern Hematology Oncology, Thornton, Colorado, United States|SCL Health Lutheran Medical Center, Wheat Ridge, Colorado, United States|Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States|Smilow Cancer Center/Yale-New Haven Hospital, New Haven, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Holy Cross Hospital, Fort Lauderdale, Florida, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States|Miami Cancer Institute, Miami, Florida, United States|Orlando Health Cancer Institute, Orlando, Florida, United States|Memorial Hospital West, Pembroke Pines, Florida, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States|Hawaii Cancer Care - Savio, 'Aiea, Hawaii, United States|Pali Momi Medical Center, 'Aiea, Hawaii, United States|Queen's Cancer Center - Pearlridge, 'Aiea, Hawaii, United States|The Cancer Center of Hawaii-Pali Momi, 'Aiea, Hawaii, United States|Island Urology-Hilo, Hilo, Hawaii, United States|Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, United States|Island Urology, Honolulu, Hawaii, United States|Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, United States|Queen's Medical Center, Honolulu, Hawaii, United States|Straub Clinic and Hospital, Honolulu, Hawaii, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, United States|Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii, United States|Kuakini Medical Center, Honolulu, Hawaii, United States|Queen's Cancer Center - Kuakini, Honolulu, Hawaii, United States|The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, United States|Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States|Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States|Walter Knox Memorial Hospital, Emmett, Idaho, United States|Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, United States|Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, United States|Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, United States|Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States|Saint Anthony's Health, Alton, Illinois, United States|Loyola Center for Health at Burr Ridge, Burr Ridge, Illinois, United States|Northwestern University, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Illinois, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States|NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States|NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, United States|Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States|Rush Cancer Care in Lisle, Lisle, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park, Illinois, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States|UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States|Loyola Center for Cancer Care and Research, Orland Park, Illinois, United States|University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States|Blank Children's Hospital, Des Moines, Iowa, United States|Iowa Methodist Medical Center, Des Moines, Iowa, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, United States|Broadlawns Medical Center, Des Moines, Iowa, United States|Iowa Lutheran Hospital, Des Moines, Iowa, United States|Trinity Regional Medical Center, Fort Dodge, Iowa, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States|Methodist West Hospital, West Des Moines, Iowa, United States|Central Care Cancer Center - Garden City, Garden City, Kansas, United States|Central Care Cancer Center - Great Bend, Great Bend, Kansas, United States|University of Kansas Cancer Center, Kansas City, Kansas, United States|Lawrence Memorial Hospital, Lawrence, Kansas, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, United States|Ascension Via Christi Hospitals Wichita, Wichita, Kansas, United States|Cancer Center of Kansas - Wichita, Wichita, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Ochsner Health Center-Summa, Baton Rouge, Louisiana, United States|Medical Center of Baton Rouge, Baton Rouge, Louisiana, United States|Ochsner High Grove, Baton Rouge, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Bronson Battle Creek, Battle Creek, Michigan, United States|IHA Hematology Oncology Consultants-Brighton, Brighton, Michigan, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, United States|IHA Hematology Oncology Consultants-Canton, Canton, Michigan, United States|Saint Joseph Mercy Canton, Canton, Michigan, United States|Caro Cancer Center, Caro, Michigan, United States|IHA Hematology Oncology Consultants-Chelsea, Chelsea, Michigan, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, United States|Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, United States|Newland Medical Associates-Clarkston, Clarkston, Michigan, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States|Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan, United States|Genesee Hematology Oncology PC, Flint, Michigan, United States|Genesys Hurley Cancer Institute, Flint, Michigan, United States|Hurley Medical Center, Flint, Michigan, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan, United States|Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan, United States|Michigan Breast Specialists-Grosse Pointe Woods, Grosse Pointe Woods, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Sparrow Hospital, Lansing, Michigan, United States|Hope Cancer Clinic, Livonia, Michigan, United States|Saint Mary Mercy Hospital, Livonia, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan, United States|Michigan Breast Specialists-Macomb Township, Macomb, Michigan, United States|Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Lakeland Hospital Niles, Niles, Michigan, United States|Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, United States|21st Century Oncology-Pontiac, Pontiac, Michigan, United States|Hope Cancer Center, Pontiac, Michigan, United States|Newland Medical Associates-Pontiac, Pontiac, Michigan, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, United States|Great Lakes Cancer Management Specialists-Rochester Hills, Rochester Hills, Michigan, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, United States|Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, United States|Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, United States|Ascension Saint Joseph Hospital, Tawas City, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|Advanced Breast Care Center PLLC, Warren, Michigan, United States|Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan, United States|Macomb Hematology Oncology PC, Warren, Michigan, United States|Michigan Breast Specialists-Warren, Warren, Michigan, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, United States|Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|Huron Gastroenterology PC, Ypsilanti, Michigan, United States|IHA Hematology Oncology Consultants-Ann Arbor, Ypsilanti, Michigan, United States|Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, United States|Fairview Ridges Hospital, Burnsville, Minnesota, United States|Minnesota Oncology - Burnsville, Burnsville, Minnesota, United States|Cambridge Medical Center, Cambridge, Minnesota, United States|Mercy Hospital, Coon Rapids, Minnesota, United States|Essentia Health - Deer River Clinic, Deer River, Minnesota, United States|Essentia Health Saint Mary's - Detroit Lakes Clinic, Detroit Lakes, Minnesota, United States|Essentia Health Cancer Center, Duluth, Minnesota, United States|Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, United States|Miller-Dwan Hospital, Duluth, Minnesota, United States|Fairview Southdale Hospital, Edina, Minnesota, United States|Lake Region Healthcare Corporation-Cancer Care, Fergus Falls, Minnesota, United States|Essentia Health - Fosston, Fosston, Minnesota, United States|Unity Hospital, Fridley, Minnesota, United States|Essentia Health Hibbing Clinic, Hibbing, Minnesota, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Health Partners Inc, Minneapolis, Minnesota, United States|Monticello Cancer Center, Monticello, Minnesota, United States|New Ulm Medical Center, New Ulm, Minnesota, United States|Essentia Health - Park Rapids, Park Rapids, Minnesota, United States|Fairview Northland Medical Center, Princeton, Minnesota, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|United Hospital, Saint Paul, Minnesota, United States|Essentia Health Sandstone, Sandstone, Minnesota, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, United States|Lakeview Hospital, Stillwater, Minnesota, United States|Essentia Health Virginia Clinic, Virginia, Minnesota, United States|Ridgeview Medical Center, Waconia, Minnesota, United States|Rice Memorial Hospital, Willmar, Minnesota, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States|Freeman Health System, Joplin, Missouri, United States|Mercy Hospital Joplin, Joplin, Missouri, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Saint Louis Cancer and Breast Institute-South City, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercy Hospital South, Saint Louis, Missouri, United States|Siteman Cancer Center-South County, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri, United States|Mercy Hospital Springfield, Springfield, Missouri, United States|CoxHealth South Hospital, Springfield, Missouri, United States|Mercy Hospital Washington, Washington, Missouri, United States|Community Hospital of Anaconda, Anaconda, Montana, United States|Billings Clinic Cancer Center, Billings, Montana, United States|Saint Vincent Healthcare, Billings, Montana, United States|Saint Vincent Frontier Cancer Center, Billings, Montana, United States|Bozeman Deaconess Hospital, Bozeman, Montana, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States|Great Falls Clinic, Great Falls, Montana, United States|Kalispell Regional Medical Center, Kalispell, Montana, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States|Community Medical Hospital, Missoula, Montana, United States|Nebraska Medicine-Village Pointe, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Carson Tahoe Regional Medical Center, Carson City, Nevada, United States|Cancer and Blood Specialists-Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, United States|OptumCare Cancer Care at Seven Hills, Henderson, Nevada, United States|21st Century Oncology-Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, United States|Las Vegas Urology - Green Valley, Henderson, Nevada, United States|Las Vegas Urology - Pebble, Henderson, Nevada, United States|Urology Specialists of Nevada - Green Valley, Henderson, Nevada, United States|Las Vegas Urology - Pecos, Las Vegas, Nevada, United States|Desert West Surgery, Las Vegas, Nevada, United States|OptumCare Cancer Care at Charleston, Las Vegas, Nevada, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Hope Cancer Care of Nevada, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Central, Las Vegas, Nevada, United States|21st Century Oncology, Las Vegas, Nevada, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States|Las Vegas Prostate Cancer Center, Las Vegas, Nevada, United States|Las Vegas Urology - Sunset, Las Vegas, Nevada, United States|Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, United States|21st Century Oncology-Vegas Tenaya, Las Vegas, Nevada, United States|Ann M Wierman MD LTD, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, United States|Las Vegas Urology - Cathedral Rock, Las Vegas, Nevada, United States|Las Vegas Urology - Smoke Ranch, Las Vegas, Nevada, United States|OptumCare Cancer Care at MountainView, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Northwest, Las Vegas, Nevada, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, United States|21st Century Oncology-Fort Apache, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States|Urology Specialists of Nevada - Southwest, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, United States|University Cancer Center, Las Vegas, Nevada, United States|Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Saint Mary's Regional Medical Center, Reno, Nevada, United States|Radiation Oncology Associates, Reno, Nevada, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Northwell Health/Center for Advanced Medicine, Lake Success, New York, United States|North Shore University Hospital, Manhasset, New York, United States|Long Island Jewish Medical Center, New Hyde Park, New York, United States|Mount Sinai Hospital, New York, New York, United States|NYP/Weill Cornell Medical Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota, United States|Essentia Health - Jamestown Clinic, Jamestown, North Dakota, United States|University of Cincinnati/Barrett Cancer Center, Cincinnati, Ohio, United States|Case Western Reserve University, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States|University Pointe, West Chester, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States|Saint Alphonsus Medical Center-Baker City, Baker City, Oregon, United States|Saint Charles Health System, Bend, Oregon, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, United States|Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States|Bay Area Hospital, Coos Bay, Oregon, United States|Providence Newberg Medical Center, Newberg, Oregon, United States|Saint Alphonsus Medical Center-Ontario, Ontario, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence Saint Vincent Medical Center, Portland, Oregon, United States|Oregon Health and Science University, Portland, Oregon, United States|Saint Charles Health System-Redmond, Redmond, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States|Pocono Medical Center, East Stroudsburg, Pennsylvania, United States|Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Miriam Hospital, Providence, Rhode Island, United States|Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina, United States|Prisma Health Cancer Institute - Laurens, Clinton, South Carolina, United States|Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States|Saint Francis Hospital, Greenville, South Carolina, United States|BI-LO Charities Children's Cancer Center, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina, United States|Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, United States|Saint Francis Cancer Center, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, United States|Houston Methodist Hospital, Houston, Texas, United States|Covenant Medical Center-Lakeside, Lubbock, Texas, United States|American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork, Utah, United States|Sandra L Maxwell Cancer Center, Cedar City, Utah, United States|Logan Regional Hospital, Logan, Utah, United States|Intermountain Medical Center, Murray, Utah, United States|McKay-Dee Hospital Center, Ogden, Utah, United States|Utah Valley Regional Medical Center, Provo, Utah, United States|Riverton Hospital, Riverton, Utah, United States|Dixie Medical Center Regional Cancer Center, Saint George, Utah, United States|Utah Cancer Specialists-Salt Lake City, Salt Lake City, Utah, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States|LDS Hospital, Salt Lake City, Utah, United States|Inova Schar Cancer Institute, Fairfax, Virginia, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, United States|Overlake Medical Center, Bellevue, Washington, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, United States|Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States|Providence Regional Cancer Partnership, Everett, Washington, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, United States|Kadlec Clinic Hematology and Oncology, Kennewick, Washington, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, United States|PeaceHealth Saint John Medical Center, Longview, Washington, United States|Jefferson Healthcare, Port Townsend, Washington, United States|Valley Medical Center, Renton, Washington, United States|Pacific Gynecology Specialists, Seattle, Washington, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, United States|Kaiser Permanente Washington, Seattle, Washington, United States|Swedish Medical Center-First Hill, Seattle, Washington, United States|Swedish Medical Center-Cherry Hill, Seattle, Washington, United States|PeaceHealth United General Medical Center, Sedro-Woolley, Washington, United States|Providence Regional Cancer System-Shelton, Shelton, Washington, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, United States|Providence Regional Cancer System-Yelm, Yelm, Washington, United States|Duluth Clinic Ashland, Ashland, Wisconsin, United States|Northwest Wisconsin Cancer Center, Ashland, Wisconsin, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States|Cheyenne Regional Medical Center-West, Cheyenne, Wyoming, United States|Billings Clinic-Cody, Cody, Wyoming, United States|Welch Cancer Center, Sheridan, Wyoming, United States|Tom Baker Cancer Centre, Calgary, Alberta, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|QEII Health Sciences Centre/Nova Scotia Health Authority, Halifax, Nova Scotia, Canada|Ottawa Hospital and Cancer Center-General Campus, Ottawa, Ontario, Canada|Jewish General Hospital, Montreal, Quebec, Canada	https://ClinicalTrials.gov/show/NCT03150693
120	Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Leukemia|Mucositis|Oral Complications	Biological: palifermin|Biological: rituximab|Drug: cyclophosphamide|Drug: cytarabine|Drug: daunorubicin hydrochloride|Drug: etoposide|Drug: fludarabine phosphate|Drug: imatinib mesylate|Drug: melphalan|Drug: mercaptopurine|Drug: methotrexate|Drug: nelarabine|Drug: pegaspargase|Drug: vincristine sulfate|Procedure: allogeneic hematopoietic stem cell transplantation|Radiation: total-body irradiation	UCL Cancer Institute, London, England, United Kingdom	https://ClinicalTrials.gov/show/NCT01085617
121	Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL	Recruiting	No Results Available	Acute Lymphoblastic Leukemia, Adult|Ph+ ALL|Newly Diagnosed	Drug: Ponatinib 15 MG Oral Tablet	University Hospital Brno, Internal hematology and oncology clinic, Brno, Czechia|University Hospital Hradec Kralove, The 4th Department of Internal Medicine - Hematology, Hradec Králové, Czechia|University Hospital Olomouc, Hematooncology Clinic, Olomouc, Czechia|University Hospital Ostrava, Hematooncology Clinic, Ostrava, Czechia|University Hospital Plzen, Hematology and Oncology Department, Plzeň-Lochotín, Czechia|University Hospital Kralovske Vinohrady, Internal Hematology Clinic, Praha, Czechia|Institute of Hematology and Blood Transfusion, Praha, Czechia	https://ClinicalTrials.gov/show/NCT04554459
122	Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia	Recruiting	No Results Available	ALL, Recurrent, Adult	Drug: Blinatumomab	University Hospital of Frankfurt (Main), Frankfurt (Main), Hessen, Germany|Charité - Campus Benjamin Franklin, Berlin, Germany|Uniklinik Dresden, Dresden, Germany|Uniklinik Düsseldorf, Düsseldorf, Germany|Univeristätsklinikum Essen, Essen, Germany|Universitätsklinikum Freiburg, Freiburg, Germany|Universitätsmedizin Göttingen, Göttingen, Germany|Uniklinik Hamburg Eppendorf, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Uniklinik Heidelberg, Heidelberg, Germany|UKSH-Kiel, Kiel, Germany|Universitätsklinik Leipzig, Leipzig, Germany|Klinikum Mannheim, Mannheim, Germany|Universitätsklinkum Gießen und Marburg, Marburg, Germany|Klinikum Großhadern, München, Germany|Uniklinik Münster, Münster, Germany|Klinikum Nürnberg Nord, Nürnberg, Germany|Uniklinik Regensburg, Regensburg, Germany|Robert - Bosch - Krankenhaus, Stuttgart, Germany|Universitätsklinik Tübingen, Tübingen, Germany|Universitätsklinkum Ulm, Ulm, Germany|Uniklinik Würzburg, Würzburg, Germany	https://ClinicalTrials.gov/show/NCT03109093
123	Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)	Recruiting	No Results Available	Relapsed Non Hodgkin Lymphoma|Relapsed Adult ALL|Relapsed Pediatric ALL	Biological: autologous CD19-directed chimeric antigen receptor (CAR) T-cells	Foothills Medical Centre, Calgary, Alberta, Canada|Tom Baker Cancer Centre, Calgary, Alberta, Canada|Alberta Children's Hospital, Calgary, Alberta, Canada|Cross Cancer Institute, Edmonton, Alberta, Canada|Stollery Children's Hospital, Edmonton, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada	https://ClinicalTrials.gov/show/NCT03938987
124	Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Drug: Inotuzumab ozogamicin|Drug: Methotrexate|Drug: Hydrocortisone|Drug: Cytarabine|Drug: Diphenhydramine|Drug: Acetaminophen|Drug: Methylprednisolone	St. Jude Children's Research Hospital, Memphis, Tennessee, United States	https://ClinicalTrials.gov/show/NCT03913559
125	Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma	Recruiting	No Results Available	Hypertension|Osteonecrosis|Osteonecrosis Due to Drug	Drug: Intensive Antihypertensive Therapy|Drug: Conventional Antihypertensive Therapy|Other: Symptom Survey|Other: Semi-structured interview	St. Jude Children's Research Hospital, Memphis, Tennessee, United States	https://ClinicalTrials.gov/show/NCT04401267
126	Phase I Study of pCAR-19B in the Treatment of Adult CD19-positive Relapsed/Refractory B-ALL	Recruiting	No Results Available	Acute Lymphoblastic Leukemia, in Relapse|Refractory Acute Lymphoblastic Leukemia	Biological: pCAR-19B cells	Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China	https://ClinicalTrials.gov/show/NCT04888442
127	A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL	Recruiting	No Results Available	Chronic Myelogenous Leukemia|Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia	Drug: ABL001|Drug: ABL001 + Nilotinib|Drug: ABL001+imatinib|Drug: ABL001+dasatinib	Dana Farber Cancer Institute Hematology / Oncology, Boston, Massachusetts, United States|University of Michigan Comprehensive Cancer Center SC, Ann Arbor, Michigan, United States|Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering, New York, New York, United States|Oregon Health and Science University SC-6, Portland, Oregon, United States|University of Texas/MD Anderson Cancer Center UT MD Anderson, Houston, Texas, United States|Huntsman Cancer Institute SC, Salt Lake City, Utah, United States|Novartis Investigative Site, Adelaide, South Australia, Australia|Novartis Investigative Site, Paris Cedex 10, Cedex 10, France|Novartis Investigative Site, Bordeaux, France|Novartis Investigative Site, Berlin, Germany|Novartis Investigative Site, Frankfurt, Germany|Novartis Investigative Site, Jena, Germany|Novartis Investigative Site, Roma, RM, Italy|Novartis Investigative Site, Kobe-shi, Hyogo, Japan|Novartis Investigative Site, Seoul, Seocho Gu, Korea, Republic of|Novartis Investigative Site, Amsterdam, Netherlands|Novartis Investigative Site, Singapore, Singapore|Novartis Investigative Site, Madrid, Spain	https://ClinicalTrials.gov/show/NCT02081378
128	Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage	Not yet recruiting	No Results Available	Acute Leukemia of Ambiguous Lineage	Drug: vincristine|Drug: daunorubicin|Drug: cyclophosphamide|Drug: L-Asparaginase|Drug: prednisone|Drug: mercaptopurine|Drug: methotrexate|Drug: dexamethasone|Drug: Tyrosine kinase inhibitor	HBDH, Tianjin, Tianjin, China	https://ClinicalTrials.gov/show/NCT04440267
129	Humanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|B Cell Lymphoma	Genetic: Second generation humanized CAR-T cells	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China	https://ClinicalTrials.gov/show/NCT04008251
130	Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents	Recruiting	No Results Available	Acute Lymphoblastic Leukemia, Pediatric	Drug: Pegaspargase|Drug: Erwinia asparaginase|Drug: Cyclophosphamide|Drug: CYTARABINE|Drug: DASATINIB|Drug: DEXAMETHASONE|Drug: Dexrazoxane|Drug: Doxorubicin|Drug: ETOPOSIDE|Drug: HYDROCORTISONE|Drug: LEUCOVORIN CALCIUM|Drug: MERCAPTOPURINE|Drug: METHOTREXATE|Drug: NELARABINE|Drug: Vincristine	Boston Children's Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian, New York, New York, United States|Hasbro Children's Hospital / Rhode Island Hospital, Providence, Rhode Island, United States|Hospital Sainte Justine, University of Montreal, Montreal, Quebec, Canada|Centre Hospitalier U. de Quebec, Quebec City, Quebec, Canada	https://ClinicalTrials.gov/show/NCT03020030
131	A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults	Recruiting	No Results Available	Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia	Drug: Nilotinib|Drug: Methotrexate|Drug: Aracytine (Ara C)|Drug: Granulocyte Colony-Stimulating Factor (G-CSF)|Drug: Depomedrol|Drug: Dexamethasone|Drug: Vincristine|Drug: Imatinib|Drug: 6 Mercaptopurine (6MP)	Hopital Saint Louis, Paris, France	https://ClinicalTrials.gov/show/NCT02611492
132	CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|B Cell Lymphoma	Genetic: Second generation CAR-T cells	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China	https://ClinicalTrials.gov/show/NCT02965092
133	Anti-CD22 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy for Relapsed Refractory B-cell Malignancies	Recruiting	No Results Available	B Cell Lymphoma|Acute Lymphoblastic Leukemia	Genetic: Third generation CAR-T cells	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China	https://ClinicalTrials.gov/show/NCT04007978
134	CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)	Not yet recruiting	No Results Available	Non-hodgkin Lymphoma|Acute Lymphoblastic Leukemia	Biological: CD19.CAR-multiVST for Group A|Biological: CD19.CAR-multiVST for Group B	Houston Methodist Hosptial, Houston, Texas, United States|Texas Children's Hospital, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03768310
135	In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies	Recruiting	No Results Available	Acute Lymphocytic Leukemia|Lymphoma	Biological: Biological/Genetically Modified T cells|Drug: Cyclophosphamide-based chemotherapy	Memorial Sloan Kettering Cancer Center, New York, New York, United States	https://ClinicalTrials.gov/show/NCT01430390
136	Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Leukemia, Acute Lymphoblastic	Dietary Supplement: Eskimo-3 Pure Fish Oil|Dietary Supplement: Rapeseed Oil	Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Aarhus, Denmark|Rigshospitalet, Copenhagen, Denmark|Odense University Hospital, Odense, Denmark	https://ClinicalTrials.gov/show/NCT04209244
137	CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)	Not yet recruiting	No Results Available	Relapsed B Cell Acute Lymphoblastic Leukemia (ALL)|Refractory B Cell Acute Lymphoblastic Leukemia (ALL)	Biological: CD19 CAR engineered autologous T-cells|Drug: Cyclophosphamide|Drug: Fludarabine|Drug: Mesna	Gene therapy research center, Shariati hospital, Tehran university of medical sciences, Iran, Tehran, Iran, Islamic Republic of|Research Institute for Oncology- Hematology and Cell Therapy (RIOHCT), Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of	https://ClinicalTrials.gov/show/NCT04653493
138	Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia	Recruiting	No Results Available	Acute Lymphoblastic Leukaemia	Drug: VP16|Radiation: TBI|Drug: Thiotepa|Drug: Treosulfan|Drug: Fludarabine|Drug: Busulfan|Drug: ATG Thymoglobulin|Drug: Cyclophosphamide|Drug: Grafalon	Hospital de Pediatria "Juan P. Garrahan" Combate de Los Pozos N°1800 CABA, Buenos Aires, Argentina|Hospital Sor Maria Ludovica, Department Hematology Stem Cell Transplant Unit, La Plata, Argentina|Children's Cancer Centre The Royal Children's Hospital, Melbourne, Australia|Princess Margaret Hospital for Children, Perth, Australia|Sydney Children's Hospital, Randwick, Australia|Lady Cilento Children's Hospital, South Brisbane, Australia|The Children's Hospital at Westmead Oncology Unit, Sydney, Australia|Universitätsklinik für Kinder- und Jugendheilkunde, Abt. f. Hämato-Onkologie, Graz, Austria|Universitätsklinik für Kinder- und Jugendheilkunde, Innsbruck, Austria|St. Anna Children's Hospital, Vienna, Austria, Vienna, Austria|Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus|Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Brussels, Belgium|Cliniques Universitaires Saint-Luc (UCL) Hématologie et oncologie pédiatrique, Brussels, Belgium|University Hospital Gent Pediatrische hemato-oncologie, Gent, Belgium|University Hospitals Leuven Kinderhemato-oncologie, Leuven, Belgium|Centre Hospitalier Universitaire de Liège Domaine Universitaire du Sart Tilman, Liège, Belgium|Alberta Children's Hospital Division of Pediatric Oncology, Calgary, Canada|Montreal Children's Hospital, Montral, Canada|CHU Sainte-Justine Hematology-Oncology Division, Montreal, Canada|Hospital for Sick Children University of Toronto Division of Haematology/Oncology, Toronto, Canada|BC Children's Hospital, Vancouver, Canada|CancerCare Manitoba/University of Manitoba, Winnipeg, Canada|Hospital Dr Luis Calvo Mackenna, Santiago, Chile|Department of Pediatrics, UHC Zagreb, Zagreb, Croatia|Department of Pediatric Hematology and Oncology Teaching Hospital Motol, 2nd Medical School, Charles University, Prague, Czechia|Paediatric Stem Cell Transplant and Immune Deficiency, Dept. for children and adolescents 4072, Rigshospitalet, Copenhagen, Denmark|Division of Hematology-Oncology and Stem Cell Transplantation, Hospital for Children and Adolescents, Univ. of Helsinki, Helsinki, Finland|CHU Bordeaux, Bordeaux, France|CHU Clermont-Ferrand, Clermont-Ferrand, France|CHU Grenoble - Clinique Universitaire de Pédiatrie, Hôpital Couple Enfant, Grenoble, France|CHRU Lille, Service d'Hématologie Pédiatrique, Lille, France|IHOP / Lyon, Service Hématologie et d'Oncologie pédiatrique, Lyon, France|Hopital la Timone Adulte, Marseille, France|Hopital Arnaud de Villeneuve, Montpellier, France|CHU Nancy - Hopital d'Enfants, Nancy, France|CHU Nantes, Service d'onco hémato pédiatrie, Nantes, France|Hôpital Robert Debré, Paris, France|CHU de Rennes, Serive d'Onco-Pédiatrie, Rennes, France|CHU de Rouen, Hopital des Enfants, Service d' Immuno-Hématologie Oncologie Pédiatrique, Rouen, France|CHU Strasbourg, Service d'hématologie et d'oncologie pédiatrique, Strasbourg, France|Uniklinik RWTH Aachen, Kinder- und Jugendmedizin, Aachen, Germany|Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany|Universitätsklinikum Bonn, Abteilung für Pädiatrische Hämatologie und Onkologie, Bonn, Germany|Universitätsklinikum Düsseldorf, Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immunologie, Düsseldorf, Germany|Universitätsklinikum Erlangen, Kinder- und Jugendklinik, Erlangen, Germany|Universitätsklinikum Essen, Klinik für Kinderheilkunde III, Essen, Germany|Klinikum der Johann Wolfgang Goethe-Universität, Klinik für Kinder- und Jugendmedizin (KKJM), Frankfurt am Main, Germany|Universitätsklinikum Freiburg, Zentrum für Kinder- und Jugendmedizin, Freiburg, Germany|Universitätsklinikum Gießen, Zentrum für Kinder- und Jugendmedizin, Gießen, Germany|Universitätsmedizin Greifswald, Klinik und Poliklinik für Kinder- und Jugendmedizin, Greifswald, Germany|Universitätsklinikum Halle (Saale), Universitätsklinik und Poliklinik für Kinder- und Jugendmedizin, Halle, Germany|Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Pädiatrische Hämatologie und Onkologie, Hamburg, Germany|Medizinische Hochschule Hannover, Zentrum Kinderheilkunde und Jugendmedizin, Hannover, Germany|Universitätsklinikum Heidelberg, Zentrum für Kinder- und Jugendmedizin, Heidelberg, Germany|Universitätsklinikum Jena, Sektion für Stammzelltransplantation, Jena, Germany|UKSH - Universitätsklinikum Schleswig-Holstein, Klinik für Allgemeine Pädiatrie, Kiel, Germany|Universitätsmedizin Leipzig, Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie, Leipzig, Germany|Klinikum der Universität München, Dr. von Haunersches Kinderspital, München, Germany|Städt. Krankenhaus München Schwabing, Universitätskinderklinik der TU München, München, Germany|Universitätsklinikum Münster, Klinik für Kinder- und Jugendmedizin, Münster, Germany|Universitätsklinikum Regensburg, Klinik und Poliklinik für Kinder- und Jugendmedizin, Regensburg, Germany|Universitätsklinik für Kinder- und Jugendmedizin Tübingen, Tübingen, Germany|Universitätsklinikum Ulm, Klinik für Kinder- und Jugendmedizin, Ulm, Germany|Universitäts-Kinderklinik Würzburg, Würzburg, Germany|Saint Sophia Children's Hospital BMT Unit, Athens, Greece|Hospital of Southern Pest, National Insitute of Hematology and Infectious DiseaseHospital of Southern Pest, National Insitute of Hematology and Infectious Disease Pediatric Bone Marrow Transplantation Unit at Central, Budapest, Hungary|Rambam Medical Center, Haifa, Israel|Schneider Children's Medical Center of Israel, Petach-Tikva, Israel|Dana Children's Hospital, Tel Aviv, Israel|Azienda Ospedaliero-Universitaria Policlinico S. Orsola-Malpighi di Bologna, Bologna, Italy|Ospedale Mayer di Firenze SODc Tumori Pediatrici e TMO, Florence, Italy|Istituto Gaslini Genova Oncoematologia Pediatrica-, Genoa, Italy|A.O. San Gerardo di Monza Clinica Pediatrica, Monza, Italy|A.O.R.N. Santobono Pausilipon, Dipartimento di Oncoematologia, Napoli, Italy|Azienda Ospedaliera di Padova Oncoematologia Pediatrica, Padova, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|Azienda Ospedaliero Universitaria Pisana U.O. di Oncoematologia Pediatrica A.O., Pisa, Italy|Ospedale Pediatrico Bambino Gesù, Sapienza, University of Rome, Rome, Italy|Ospedale Infantile Regina Margherita SC Oncoematologia e Centro Trapianti, Torino, Italy|University of Malaya, Department of Paediatrics, Kuala Lumpur, Malaysia|Instituto Nacional de Peditria, Ciudad de México, Mexico|Leiden University Medical Center Department of Pediatrics/BMT unit, Leiden, Netherlands|Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands|Starship Children's Hospital, Auckland, New Zealand|Oslo University Hospital Rikshospitalet, Oslo, Norway|University Hospital No.1, Collegium Medicum UMK, department of Paediatrics, Oncology, Hematology and Paediatric Transplantology, Bydgoszcz, Poland|University Children's Hospital in Krakow, Department of Transplantation, Kraków, Poland|Children's University Hospital, Dept. Pediatric Hematology, Oncology, and Transplantology, Lublin, Poland|Poznan University of Medical Sciences, Department of Pediatric Onology, Hematology & HSCT, Poznań, Poland|Cape of Hope, Wroclaw Medical University, Wrocław, Poland|IInsitutul Clinic Fundeni, Sectia de Transplant Medular, Bukarest, Romania|University of Medicine and Pharmacy V. BABES, Emergency Children's Hospital LOUIS TURCANU, III. Clinic of Pediatrics , Department of Onco-hematology and Bone Marrow Transplantation, Timişoara, Romania|King Abdullah specialists children hospital, Riyadh, Saudi Arabia|University Children's Hospital, Bratislava, Slovakia|University childrens' hospital, UMCL, Ljubljana, Slovenia|Hospital Santa Creu i Sant Pau, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Virgen de la Arrixaca, El Palmar, Spain|Hospital Materno Infantil de Málaga, Málaga, Spain|Hospital Universitario Central de Asturias, Oviedo, Spain|Queen Silvia Children's Hospital, Department of Pediatric Oncology (Avdelnig 321-322), Göteborg, Sweden|Skane University Hospital, Dept. of Pediatrics, Section for Hematology and Oncology, Lund, Sweden|Karolinska University Hospital, Department of Pediatrics, Stockholm, Sweden|University Children's Hospital, Dept. of Women's & Children's Health Section for Pediatrics, Uppsala, Sweden|Universitäts-Kinderspital beider Basel (UKBB), Basel, Switzerland|HUG Hôpitaux Universitaire de Genève, Geneva, Switzerland|Universitäts-Kinderspital Zurich, Zurich, Switzerland|Ankara University School of Medicine Pediatric Stem Cell Transplantation Unit, Ankara, Turkey|Gazi University School of Medicine Pediatric Stem Cell Transplantation Unit, Ankara, Turkey|Gülhane Training and Research Hospital, Ankara, Turkey|Akdeniz University School of Medicine Pediatric Stem Cell Transplantation Unit, Antalya, Turkey|Bahcesehir University School of Medicine Pediatric Stem Cell Transplantation Unit, Antalya, Turkey|Acibadem University Atakent Hospital Pediatric Stem Cell Transplantation Unit, Istanbul, Turkey|Bahcelievler Medicalpark Hospital Pediatric Stem Cell Transplantation Unit, Istanbul, Turkey|Bahcesehir University School of Medicine Pediatric Stem Cell Transplantation Unit, Istanbul, Turkey|Medipol Mega Üniversite Hastanesi, Istanbul, Turkey|Dokuzeylul University School of Medicine Pediatric Stem Cell Transplantation Unit, Izmir, Turkey|Ege University School of Medicine Pediatric Stem Cell Transplantation Unit, Izmir, Turkey|Erciyes University School of Medicine Pediatric Stem Cell Transplantation Unit, Kayseri, Turkey	https://ClinicalTrials.gov/show/NCT01949129
139	ETOILE : A Feasibility Study in Pediatric Patient Education	Recruiting	No Results Available	Leukemia, Lymphoblastic	Behavioral: ETOILE therapeutic education	Robert Debre Hospital, Paris, France	https://ClinicalTrials.gov/show/NCT04399863
140	Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma	Recruiting	No Results Available	B-ALL|DLBCL|B ALL|Dlbcl-Ci|DLBCL Unclassifiable|DLBCL, Nos Genetic Subtypes|DLBCL Activated B-Cell Type|DLBCL Germinal Center B-Cell Type|Diffuse Large B-cell Lymphoma|HGBL|HGBL, Nos	Drug: 131-I Apamistamab|Biological: CAR T-cell	Memorial Sloan Kettering Cancer Center, New York, New York, United States	https://ClinicalTrials.gov/show/NCT04512716
141	Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2019 Pilot	Recruiting	No Results Available	Childhood Acute Lymphoblastic Leukemia	Drug: Blinatumomab	Dmitry Rogachev National Medical Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation|National Medical Research Center of Oncology named after N.N. Blokhin, Moscow, Russian Federation|Russian Children's Clinic Hospital; Pirogov Russian National Research Medical University, Moscow, Russian Federation|Almazov National Medical Research Centre, Saint Petersburg, Russian Federation	https://ClinicalTrials.gov/show/NCT04723342
142	The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China	Not yet recruiting	No Results Available	Acute Lymphoblastic Leukemia, Pediatric	Drug: 6-mercaptopurine|Procedure: Standard treatment|Procedure: Individualized treatment	State Key Laboratory of Experimental Haematology, Department of Paediatric Haematology, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tanjin, Tianjin, China	https://ClinicalTrials.gov/show/NCT04228393
143	Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL	Not yet recruiting	No Results Available	Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Mixed Phenotype Acute Leukemia	Drug: MRX-2843		https://ClinicalTrials.gov/show/NCT04872478
144	Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Immune System Diseases|Immunoproliferative Disorders	Biological: iC9-CAR19 cells|Drug: Rimiducid|Drug: Cyclophosphamide|Drug: Fludarabine	Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States	https://ClinicalTrials.gov/show/NCT03016377
145	TT52CAR19 Therapy for B-cell Acute Lymphoblastic Leukaemia (B-ALL)	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia	Drug: PBLTT52CAR19	Great Ormond Street Hospital, London, United Kingdom	https://ClinicalTrials.gov/show/NCT04557436
146	Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years)	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Drug: Dexamethasona, Idarubicine, ARA-C, Methotrexate	Hospital Germans Trias i Pujol and all Hospital Pethema, Badalona, Barcelona, Spain	https://ClinicalTrials.gov/show/NCT01366898
147	A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Drug: pegaspargase 1250 IU/m2 x 2|Drug: pegaspargase 2500 IU/m2 x 1	CHU, Amiens, France|CHU, Angers, France|CHRU, Besançon, France|CHU, Bordeaux, France|CHU, Brest, France|CHU, Caen, France|CHU, Clermont-Ferrand, France|CHU, Dijon, France|CHU, Grenoble, France|CHU, Lille, France|CHU, Limoges, France|Chu-Ihope, Lyon, France|CHU, Marseille, France|CHU, Montpellier, France|CHU, Nancy, France|CHU, Nantes, France|CHU, Nice, France|CHU Saint Louis, Paris, France|CHU Armand Trousseau, Paris, France|CHU Robert Debré, Paris, France|CHU, Poitiers, France|CHU, Reims, France|CHU, Rennes, France|CHU, Rouen, France|CHU, Saint Etienne, France|CHU, Strasbourg, France|CHU, Toulouse, France|CHu, Tours, France	https://ClinicalTrials.gov/show/NCT02716233
148	CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children	Recruiting	No Results Available	Acute Lymphoblastic Leukemia, in Relapse	Drug: Bortezomib Injection|Drug: rituximab injection	Hong Kong Children's Hospital, Hong Kong, Hong Kong	https://ClinicalTrials.gov/show/NCT04224571
149	CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Childhood Acute Lymphoblastic Leukemia	Drug: CD19 CAR-T|Drug: CD22 CAR-T|Drug: CD 19+22|Drug: Fludarabine|Drug: Cyclophosphamide	No.2 Hospital of Hebei Medical University, Shijiazhuang, Hebei, China	https://ClinicalTrials.gov/show/NCT04626765
150	Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL	Not yet recruiting	No Results Available	Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)|ALL, Adult|Philadelphia-Positive ALL	Drug: Ponatinib + Blinatumomab|Drug: Chemotherapy + Imatinib		https://ClinicalTrials.gov/show/NCT04722848
151	A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Non-hodgkin Lymphoma	Drug: CTA30X	The First Affiliated Hospital，College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China	https://ClinicalTrials.gov/show/NCT04689204
152	Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Lymphoblastic Lymphoma	Drug: Prednisone|Drug: Vincristine|Drug: Daunorubicin|Drug: Pegaspargase|Drug: Erwinase®|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Mercaptopurine|Drug: Dasatinib|Drug: Methotrexate|Drug: Blinatumomab|Drug: Ruxolitinib|Drug: Bortezomib|Drug: Dexamethasone|Drug: Doxorubicin|Drug: Etoposide|Drug: Clofarabine|Drug: Vorinostat|Drug: Idarubicin|Drug: Nelarabine|Drug: Thioguanine	Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States|Rady Children's Hospital San Diego, San Diego, California, United States|Children's Hospital of Michigan, Detroit, Michigan, United States|St. Jude Affiliate Clinic - Novant Health Hemby Children's Hospital, Charlotte, North Carolina, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, United States|Cook Children's Medical Center, Fort Worth, Texas, United States	https://ClinicalTrials.gov/show/NCT03117751
153	Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic Leukemia	Recruiting	No Results Available	Acute Lymphocytic Leukemia， B-Cell	Biological: CD19-CD22 CAR-T cells	Hematology Department of ShanXi Cancer Hospital, Taiyuan, Shanxi, China	https://ClinicalTrials.gov/show/NCT04714593
154	Treatment of Acute Lymphoblastic Leukemia Ph '(BCR / ABL) Positive Patients Aged > 55 Years	Recruiting	No Results Available	Acute Lymphoblastic Leukemia Ph Positive	Drug: Dexamethasone|Drug: Methotrexate|Drug: Vincristine	Hospital Germans Trias i Pujol and all Hospital Pethema, Badalona, Barcelona, Spain	https://ClinicalTrials.gov/show/NCT01376427
155	A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Non-hodgkin Lymphoma	Drug: CTA101	The First Hospital of Zhejiang Medical Colleage Zhejiang University, Hangzhou, Zhejiang, China	https://ClinicalTrials.gov/show/NCT04227015
156	A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Non-Hodgkin's Lymphoma	Biological: CT-RD06	The First Hospital of Zhejiang Medical Colleage Zhejiang University, Hangzhou, Zhejiang, China	https://ClinicalTrials.gov/show/NCT04226989
157	CLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Non-Hodgkin's Lymphoma	Biological: CLIC-1901	Vancouver General Hospital, Vancouver, British Columbia, Canada|The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada	https://ClinicalTrials.gov/show/NCT03765177
158	Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab	Recruiting	No Results Available	B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell Transplantation|B-Cell Acute Lymphoblastic Leukemia|Acute Lymphoblastic Leukemia|Acute Lymphoblastic Leukemia in Remission|Acute Lymphoblastic Leukemia, Adult	Drug: Blinatumomab in combination with donor lymphocyte infusion	Klinikum der Universität München, Munich, Germany	https://ClinicalTrials.gov/show/NCT03982992
159	International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma	Recruiting	No Results Available	Lymphoblastic Lymphoma, Childhood	Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dexamethasone|Drug: Daunorubicin|Drug: Doxorubicin|Drug: Ifosfamide|Drug: 6-Mercaptopurine|Drug: Methotrexate|Drug: PEG asparaginase|Drug: Prednisone|Drug: Prednisolone|Drug: Thioguanine|Drug: Vincristine|Drug: Vindesine	Univ.Klinik für Kinder- und Jugendheilkunde Graz, Klin. Abteilung für pädiatrische Hämato-Onkologie, Graz, Austria|Univ.Klinik für Kinder- und Jugendheilkunde Innsbruck, Universitätsklinik für Pädiatrie I, Innsbruck, Austria|Kepler Universitätsklinikum, Med Campus IV / Onkologie, Linz, Austria|LKH Salzburg, Universitätsklinik für Kinder- und Jugendheilkunde, Kinderonkologie, Salzburg, Austria|St. Anna Kinderspital, Wien, Austria|Hôpital Universitaire des Enfants Reine Fabiola (ULB), Pédiatrie hémato-oncologie, Brussels, Belgium|University Hospital Brussels, Pediatrische oncologie, Brussel, Belgium|Cliniques Universitaires Saint-Luc (UCL), Hématologie et oncologie pédiatrique, Brussel, Belgium|UZ Antwerpen Kinderhemato-oncologie, Edegem, Belgium|University Hospital Gent Pediatrische hemato-oncologie, Gent, Belgium|University Hospitals Leuven, Kinderhemato-oncologie, Leuven, Belgium|CHR Citadelle Hémato - oncologie pédiatrique, Liège, Belgium|CHR Citadelle Hémato - oncologie pédiatrique, Montegnée, Belgium|Hong Kong Children's Hospital, Hong Kong, China|Dept. of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University Cernopolni, Brno, Czechia|Dept. of Pediatric Hematology and Oncology. University Hospital Motol and 2nd Medical School, Charles University, Praha, Czechia|University Hospital Aalborg, Nord, Department of Pediatrics, Aalborg, Denmark|Aarhus University Hospital, Department of Pediatrics, Aarhus, Denmark|Børneonkologisk afsnit 5054, BørneUngeKlinikken, Juliane Marie Centret, Rigshospitalet, Kobenhavn, Denmark|H.C. Andersens Children Hospital, Odense University Hospital, Odense, Denmark|Helsinki University Hospital, Department of Pediatric Hematology and Oncology, Helsinki, Finland|Kuopio University Hospital, Department of Pediatric Hematology and Oncology, Kuopio, Finland|University Hospital of Oulu, Paediatric Haematology and Oncology, Oulu, Finland|Tampere University Hospital, Paediatric Haematology and Oncology, Tampere, Finland|Turku University Hospital, Paediatric and Adolescent Haematology and Oncology, Turku, Finland|Service d'oncolologie, Hématologie pédiatrique. CHU Amiens, Avenue René Laënnec - SALOUEL, Amiens, France|Pôle Femme Mère Enfant ; Unité d'Hématologie/Oncologie pédiatrique, CHU Angers, Angers, France|Hématologie Oncologie pédiatrique, CHRU Besançon, Besançon, France|Hôpital de Enfants, Unité Onco-Hématologie Pédiatrique, Groupe Hospitalier Pellegrin, Bordeaux, France|Département de Pédiatrie et Génétique Médicale CHRU Morvan, Brest, France|Unité d'hémato-immuno-oncologie pédiatrique. Centre Hospitalier Universitaire niveau 1 - bâtiment FEH, Caen, France|Unité Onco- Hématologie Pédiatrique CHU Estaing 1 place Lucie-Aubrac, Clermont-Ferrand, France|Service Immuno-Hématologie Oncologie Pédiatrique, Dijon, France|Service onco hématologie pédiatrique CHU de Grenoble site Nord - Hôpital Couple enfant, Grenoble, France|Unité d'hématologie pédiatrique CHRU de Lille - Hôpital Jeanne de Flandre, Lille, France|Service d'Hématologie - Oncologie pédiatrique CHU Limoges - Hôpital de la mère et de l'enfant, Limoges, France|Service d'immuno-hématologie pédiatrique et de transplantation de moelle osseuse, CHU de Lyon HCL - GH Est-Institut d'hématologie et d'oncologie pédiatrique IHOP, Lyon, France|Service de Pédiatrie et hématologie pédiatrique, CHU de Marseille - Hôpital de la Timone, Marseille, France|UAM Hématologie et Oncologie Pédiatrique, CHU de Montpellier - Hôpital Arnaud de Villeneuve, Montpellier, France|Service d'hématologie et oncologie pédiatriques, Hôpital enfant-adolescent, CHU NANTES, Nantes, France|Service d'hémato-oncologie pédiatrique CHU NICE - Hôpital l'Archet 2, Nice, France|service d'oncologie pédiatrique, institut Curie, Paris, France|Service Hémato-immuno- oncologie- CHU PARIS Armand Trousseau, Paris, France|Service d' hémato-immunologie CHU Paris - Hôpital Robert Debré, Paris, France|Service Oncologie-Hématologie pédiatrique CHU de Poitiers, Poitiers, France|Service d'Hémato-Oncologie Pédiatrique- American Hospital, Reims, France|Pôle pédiatrie Hémato-cancérologie pédiatrique- CHU RENNES - Hôpital sud, Rennes, France|Service d'Hemato-Oncologie Pediatrique CHU Rouen, Rouen, France|service d'oncologie pédiatrique, hopital Félix Guyon, Saint-Denis, France|Pôle mère enfant-Unité Hématologie - Oncologie pédiatrique - CHU Hôpital NORD, Saint-Priest-en-Jarez, France|Service d'Onco-Hematologie Pediatrique CHU STRASBOURG -Hôpital de Hautepierre, Strasbourg, France|Service Pédiatrie - Hématologie Immunologie Oncologie - CHU Toulouse, Toulouse, France|Service d'hémato-oncologie pédiatrique- CHU de Nancy - Hôpital de Brabois Enfant, Vandœuvre-lès-Nancy, France|Dépt de Pédiatrie Gustave Roussy, Villejuif, France|Universitätsklinikum Aachen .Klinik für Kinder - und Jugendmedizin Hämatologie / Onkologie, Aachen, Germany|Klinikum Augsburg ,Schwäbisches Kinderkrebszentrum. I. Klinik für Kinder und Jugendliche Hämatologie / Onkologie, Augsburg, Germany|HELIOS Klinikum Berlin-Buch, Kinderklinik, Pädiatrische Hämatologie und Onkologie, Berlin, Germany|Charité Campus Virchow-Klinikum, Zentrum für Kinder- und Jugendmedizin- Abt. Hämatologie / Onkologie, Berlin, Germany|Evangelisches Krankenhaus Bielefeld GmbH, Klinik für Kinder- und Jugendmedizin, Hämatologie und Onkologie, Bielefeld, Germany|Zentrum für Kinderheilkunde der Universität Bonn, Abt. Päd. Hämatologie / Onkologie, Bonn, Germany|Städtisches Klinikum Braunschweig gGmbH, Klinik für Kinder- und Jugendmedizin, Station K5 / Päd. Hämato- und Onkologie, Braunschweig, Germany|Klinikum Bremen-Mitte gGmbH, Prof.-Hess-Kinderklinik,Pädiatrische Onkologie und Hämatologie, Bremen, Germany|Klinikum Chemnitz gGmbH, Klinik für Kinder- und Jugendmedizin, Päd. Hämatologie und Onkologie, Chemnitz, Germany|Carl-Thiem-Klinikum, Kinderklinik, Station 5e, Cottbus, Germany|Vestische Kinderklinik, Universität Witten / Herdecke, Datteln, Germany|Klinikum Dortmund gGmbH, Klinik für Kinder- und Jugendmedizin, Station K1, Abt. Päd. Onkologie / Hämatologie, Dortmund, Germany|Universitätsklinik Carl Gustav Carus der TU Dresden, Klinik für Kinder- und Jugendmedizin, Dresden, Germany|Universitätsklinikum Düsseldorf, Zentrum für Kinder- und Jugendmedizin, Klinik für Päd. Hämatologie und Onkologie, Düsseldorf, Germany|HELIOS Klinikum Erfurt GmbH, Klinik für Kinder- und Jugendmedizin, Päd. Onkologie / Hämatologie, Erfurt, Germany|Universitätsklinikum Erlangen, Klinik für Kinder- und Jugendmedizin, Pädiatrische Onkologie / Hämatologie, Erlangen, Germany|Universitätsklinikum Essen, Zentrum für Kinder- und Jugendmedizin, Hämatologie / Onkologie, Essen, Germany|Universitätsklinikum Frankfurt, Klinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie und Onkologie, Frankfurt, Germany|Universitätsklinikum Freiburg, Zentrum für Kinder- und Jugendmedizin, Klinik IV: Päd. Hämatologie und Onkologie, Freiburg, Germany|Universitätsklinikum Gießen und Marburg, Standort Gießen, Zentrum für Kinderhämatologie und -onkologie, Gießen, Germany|Universitätsklinikum Greifswald KdöR, Klinik und Poliklinik für Kinder- und Jugendmedizin, Abt. Pädiatrische Onkologie und Hämatologie, Greifswald, Germany|Georg-August-Universität Universitäts-Kinderklinik, Pädiatrie I, Göttingen, Germany|Universitätsklinikum Halle (Saale), Klinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie / Onkologie, Halle, Germany|Universitätsklinikum Hamburg Eppendorf, Zentrum für Kinder- und Jugendmedizin, Abt. Pädiatrische Hämatologie und Onkologie, Hamburg, Germany|Medizinische Hochschule Hannover, Kinderheilkunde, Päd. Hämatologie / Onkologie, Hannover, Germany|Universitäts-Kinderklinik Heidelberg, Abt. Hämatologie / Onkologie, Heidelberg, Germany|Gemeinschaftskrankenhaus Herdecke, Kinder- und Jugendmedizin, Päd. Hämatologie / Onkologie, Herdecke, Germany|Universitätskliniken für Kinder- und Jugendmedizin, Päd. Hämatologie und Onkologie, Geb. 9, Homburg, Germany|Universitätsklinikum Jena, Klinik für Kinder- und Jugendmedizin, Jena, Germany|Städtisches Klinikum Karlsruhe gGmbH, Kinderklinik, Station S 24, Karlsruhe, Germany|Klinikum Kassel Gesundheit Nordhessen Holding AG, Klinik für pädiatrische Hämatologie und Onkologie, Kassel, Germany|Universitätsklinikum Schleswig Holstein Campus Kiel, Klinik für Allgemeine Pädiatrie, Päd. Onkologie / Hämatologie, Kiel, Germany|Gemeinschaftsklinikum Mittelrhein Kemperhof, Klinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie und Onkologie, Koblenz, Germany|HELIOS Klinikum Krefeld, Zentrum für Kinder- und Jugendmedizin, Päd. Hämatologie/Onkologie, Krefeld, Germany|Klinikum der Universität zu Köln, Klinik für Kinder- und Jugendmedizin, Abt. Kinderonkologie und -hämatologie, Köln, Germany|Universitätsklinikum Leipzig, Klinik für Kinder und Jugendliche, Abt. Päd. Hämatologie / Onkologie, Leipzig, Germany|Universitätsklinikum Schleswig Holstein Campus Lübeck, Klinik für Kinder- und Jugendmedizin, Hämatologie und Onkologie, Lübeck, Germany|Universitätsklinikum Magdeburg A. ö. R., Kinderklinik, Päd. Hämatologie / Onkologie, Magdeburg, Germany|Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Zentrum für Kinder- und Jugendmedizin, Pädiatrische Hämatologie / Onkologie, Mainz, Germany|Klinikum Mannheim gGmbH, Universitäts-Kinderklinik, Päd. Onkologie /Hämatologie, Manheim, Germany|Johannes Wesling Klinikum Minden, Klinik für Kinder- und Jugendmedizin, Päd. Hämatologie / Onkologie, Station E 22, Minden, Germany|Klinikum der LMU, Dr. von Haunersches Kinderspital, Pädiatrische Hämatologie / Onkologie, München, Germany|Klinikum Schwabing, Kinderklinik der TU Päd. Hämatologie / Onkologie, Station 24d, München, Germany|Universitätsklinikum Münster, Klinik für Kinder- und Jugendmedizin, Abt. Pädiatrische Hämatologie und Onkologie, Münster, Germany|Diakonie Neuendettelsau, Kliniken Hallerwiese / Cnopf'sche Kinderklinik, Pädiatrische Hämatologie /Onkologie, Nürnberg, Germany|Klinikum Oldenburg AöR, Zentrum für Kinder- und Jugendmedizin, Abt. Hämatologie / Onkologie, Oldenburg, Germany|Universitätsklinikum Regensburg, Klinik für Kinder- und Jugendmedizin, Abt. Päd. Hämatologie, Onkologie, SZT, Regensburg, Germany|Universitätsklinikum Rostock, Kinder- und Jugendklinik, Päd. Hämatologie und Onkologie, Rostock, Germany|Asklepios Klinik St. Augustin GmbH, Kinder- und Jugendmedizin, Kinder-Hämatologie und Onkologie, Sankt Augustin, Germany|HELIOS Kliniken Schwerin GmbH, Klinik für Kinder- und Jugendmedizin, Station A1, Schwerin, Germany|Klinikum Stuttgart, Olgahospital Zentrum für Kinder- und Jugendmedizin Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), Stuttgart, Germany|Klinikum Mutterhaus der Borromäerinnen gGmbH, Pädiatrische Abteilung, Trier, Germany|Universitätsklinik Tübingen, Klinik für Kinderheilkunde und Jugendmedizin, Päd. Hämatologie / Onkologie, Tübingen, Germany|Universitätsklinikum Ulm, Klinik für Kinder- und Jugendmedizin, Päd. Hämatologie und Onkologie, Ulm, Germany|Universitätskinderklinik Würzburg, Päd. Onkologie und Hämatologie, Würzburg, Germany|2nd Dep. of Pediatrics, Semmelweis Univ, Budapest, Hungary|Heim Pal Children Hospital, Budapest, Hungary|Dep. of Pediatrics, Univ. of Debrecen, Debrecen, Hungary|Children's Treating Center, Miskolc, Miskolc, Hungary|Dep. of Pediatrics, University of Pecs, Pécs, Hungary|Dep. of Pediatrics, Univ. of Szeged, Szeged, Hungary|Our Lady's Children's Hospital Crumlin, Dublin, Ireland|Children's Hospital at Soroka Medical Center, Be'er Sheva, Israel|Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa, Israel|Children's Hospital at Hadassah, Ein Kerem Medical Center, Jerusalem, Israel|Schneider Children's hospital, Rabin Medical Center, Petah tikva, Israel|Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel|Dana Children's Hospital, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel|Clinica Pediatrica, Centro Regionale Oncoematologia Pediatrica- Ospedale dei Bambini "G. Salesi", Ancona, Italy|Dipartimento Biomedicina Età Evolutiva- U.O. Pediatrica I Policlinico, Bari, Italy|Dipartimento Pediatrico degli OO.RR. di Bergamo, Bergamo, Italy|Dipartimento di Scienze Pediatriche Mediche Chirurgiche Ospedale Sant'Orsola Malpighi, Bologna, Italy|Clinica Pediatrica Ospedale Civile, Brescia, Italy|Istituto di Clinica Pediatrica- Ospedale Regionale Microcitemie, Cagliari, Italy|Divisione Ematologia - Oncologia Pediatrica, Clinica Pediatrica, Catania, Italy|U. O. di Pediatria- Azienda Ospedaliera Annunziata, Cosenza, Italy|Dipartimento di Medicina Clinica e Sperimentale Sezione di Pediatria - Università di Ferrara, Ferrara, Italy|Unità Autonoma di Oncoematologia Pediatrica, Dipartimento Pediatria - Azienda "A.Meyer", Firenze, Italy|Dipartimento di Ematologia e Oncologia Pediatrica Istituto " G. Gaslini", Genova, Italy|Divisione di Oncologia Pediatrica Ist. Nazionale Studio e Cura Tumori, Milano, Italy|U.O. di Ematologia, Oncologia e Trapianto-Azienda Policlinico di Modena, Modena, Italy|Clinica Pediatrica Ospedale S. Gerardo Via Donizetti, Monza, Italy|S.C. Ematologia Oncologica- Ospedale "Pausilipon", Napoli, Italy|Clinica di Oncoematologia Pediatrica- Azienda Ospedaliera-Università di Padova, Padova, Italy|Oncoematologia Pediatrica- Ospedale dei Bambini G. di Cristina, Palermo, Italy|U.O. di Pediatria e Oncoematologia Pediatrica. Az. Osp. di Parma, Parma, Italy|Oncoematologia Pediatrica IRCCS, Policlinico San Matteo Piazzale Golgi, Pavia, Italy|Dipartimento di Ematologia -Ospedale Civile, Pescara, Italy|U.O. Pediatria Ospedale Infermi- Azienda USL Rimini, Rimini, Italy|Sezione Ematologia- Dipart. Biotecnico Cellulare ed Ematologia- Università "La Sapienza", Roma, Italy|Divisione di Ematologia Pediatrica- Ospedale "Bambino Gesù". Istituto di Ricerca Scientifica, Roma, Italy|Divisione di Pediatria- Ospedale "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy|Oncologia Pediatrica,- Ospedale "R. Silvestrini", San Sisto, Italy|Dip. Scienze Pediatriche e dell'Adolescenza Ospedale Infantile Regina Margherita, Torino, Italy|U.O. Emato-Oncologia Pediatrica- Università degli studi di Trieste-Ospedale Infantile Burlo Garofolo, Trieste, Italy|U.O. Oncoematologia Pediatrica- Policlinico "G.B. Rossi", Verona, Italy|Princess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands|Haukeland University Hospital in Bergen, Bergen, Norway|University Hospital Northern Norway, Tromsø, Norway|St Olavs Hospital in Trondheim, Trondheim, Norway|Department of Pediatric Oncology and Hematology, Medical University of Bialystok, Białystok, Poland|Department of Pediatric Hematology and Oncology, Nicolaus Copernicus University, Bydgoszcz, Poland|Department of Pediatric Hematology and Oncology, Center of Pediatrics and Oncology in Chorzów, Chorzów, Poland|Department of Pediatrics, Hematology, Oncology and Endocrinology, Medical University of Gdansk, Gdańsk, Poland|Department of Pediatric Oncology and Hematology, Center of Pediatrics in Kielce, Kielce, Poland|Department of Pediatric Oncology/Hematology, Institute of Pediatrics, Medical College Jagiellonian University, Kraków, Poland|Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland|Department of Pediatric Oncology and Hematology, Provincial Specialist Children's Hospital, Olsztyn, Poland|Department of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, Poznań, Poland|Department of Paediatric Oncology and Haematology, University of Rzeszów, Department of Pediatrics, Rzeszów, Poland|Department of Pediatrics, Children Hematology nad Oncology, Pomeranian Medical University, Szczecin, Poland|Department of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Warsaw, Poland|Department of Pediatric Oncology, Children's Memorial Health Institute, Warsaw, Poland|Department of Bone Marrow Transplantation, Children Oncology and Hematology, Wroclaw Medical University, Wrocław, Poland|Department of Pediatric Hematology and Oncology, Silesian Medical University in Katowice, Zabrze, Poland|Department of Pediatrics, Oncology, Hematology and Diabetology, Institute of Pediatrics, Medical University of Lodz, Łódź, Poland|Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal|Instituto Português de Oncologia - Francisco Gentil - Libosa, Lisboa, Portugal|Instituto Português de Oncologia - Francisco Gentil - Porto, Porto, Portugal|Oncological center of regional Children's Hospital, Ekaterinburg, Russian Federation|National Center for Pediatric Hematology, Oncology and Immunology Moscow, Moscow, Russian Federation|Department of pediatric oncology and hematology, Children´s Faculty Hospital, Banská Bystrica, Slovakia|Department of pediatric hematology and oncology, National Institute of Children's Diseases, Bratislava, Slovakia|Department of pediatric hematology and oncology, Children´s University Hospital, Košice, Slovakia|Hospital General Universitario de Alicante, Alicante, Spain|Hospital Universitario Torrecárdenas, Almería, Spain|Hospital Materno-Infantil de Badajoz, Badajoz, Spain|Hospital Universitario Cruces, Baracaldo, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario Donostia, Donostia, Spain|Hospital Sant Joan de Déu, Esplugues De Llobregat, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas De Gran Canaria, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Infantil Universitario Niño Jesús, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain|Hospital Regional Universitario de Málaga, Málaga, Spain|Hospital Universitario Central de Asturias, Oviedo, Spain|Hospital Universitari Son Espases, Palma De Mallorca, Spain|Hospital Virgen del Camino, Pamplona, Spain|Complejo Hospitalario Universitario de Vigo, Pontevedra, Spain|Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz De Tenerife, Spain|Hospital Universitario Marqués de Valdecilla, Santander, Spain|Hospital Clínico Universitario de Santiago, Santiago De Compostela, Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Hospital Virgen de la Salud, Toledo, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Universitari i Politècnic La Fe, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain|Barncancercentrum, Drottning Silvias Barn och Ungdomssjukhus, Sahlgrenska Universitetssjukhuset, Göteborg, Sweden|Barnonkologiska enheten, Barn och Ungdomsmedicinska kliniken, Universitetssjukhuset i Linköping, Linköping, Sweden|Barnonkologi, Skåne Universitetssjukhus, Lund, Sweden|Barncanceravdelningen Astrid Lindgrens Barnsjukhus, Nya Karolinska Universitetssjukhuset, Stockholm, Sweden|Barnonkologiska avdelningen, Barn 3, Norrlands Universitetssjukhus, Umeå, Sweden|Barnavdelningen för blod- och tumörsjukdomar 95A, Akademiska sjukhuset, Uppsala, Sweden|Kantonsspital Aarau, Aarau, Switzerland|Universitäts-Kinderspital beider Basel (UKBB), Basel, Switzerland|Ospedale San Giovanni, Bellinzona, Switzerland|Inselspital Bern, University of Bern, Bern, Switzerland|HUG Hôpitaux Universitaires de Genève, Geneva, Switzerland|CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland|Luzerner Kantonspital - Kinderspital Luzern, Luzern, Switzerland|Ostschweizer Kinderspital, Sankt Gallen, Switzerland|Universitäts-Kinderspital Zürich, Zürich, Switzerland	https://ClinicalTrials.gov/show/NCT04043494
160	Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies	Recruiting	No Results Available	Non Hodgkin Lymphoma|Acute Lymphoblastic Leukemia|Chronic Lymphocytic Leukemia	Biological: Fully human anti CD19 CAR-T Cell Dose|Drug: Fludarabine|Drug: Cyclophosphamide	University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States	https://ClinicalTrials.gov/show/NCT04732845
161	Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia, in Relapse|Acute Lymphoblastic Leukemia, Refractory	Drug: Cyclophosphamide|Drug: Fludarabine|Drug: Mesna|Device: CliniMACS|Biological: CD19- specific CAR engineered autologous T-cells (SJCAR19 product)	St. Jude Children's Research Hospital, Memphis, Tennessee, United States	https://ClinicalTrials.gov/show/NCT03573700
162	Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia (ALL)	Drug: Carfilzomib|Drug: Dexamethasone|Drug: Mitoxantrone|Drug: PEG-asparaginase|Drug: Vincristine|Drug: Intrathecal (IT) Methotrexate|Drug: Intrathecal Triple Therapy (Intrathecal Cytarabine, Hydrocortisone, and Methotrexate)|Drug: 6-Mercaptopurine|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Daunorubicin	Research Site, Los Angeles, California, United States|Research Site, Aurora, Colorado, United States|Research Site, Washington, District of Columbia, United States|Research Site, Miami, Florida, United States|Research Site, Saint Petersburg, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Chicago, Illinois, United States|Research Site, Baltimore, Maryland, United States|Research Site, Ann Arbor, Michigan, United States|Research Site, Minneapolis, Minnesota, United States|Research Site, New York, New York, United States|Research Site, Charlotte, North Carolina, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Columbus, Ohio, United States|Research Site, Memphis, Tennessee, United States|Research Site, Dallas, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Salt Lake City, Utah, United States|Research Site, Milwaukee, Wisconsin, United States|Research Site, Randwick, New South Wales, Australia|Research Site, South Brisbane, Queensland, Australia|Research Site, Parkville, Victoria, Australia|Research Site, Wien, Austria|Research Site, Toronto, Ontario, Canada|Research Site, Montreal, Quebec, Canada|Research Site, Kobenhavn O, Denmark|Research Site, Bordeaux Cedex, France|Research Site, Lille, France|Research Site, Paris, France|Research Site, Paris, France|Research Site, Toulouse Cedex 9, France|Research Site, Vandoeuvre les Nancy, France|Research Site, Tel Hashomer, Israel|Research Site, Monza (MB), Italy|Research Site, Roma, Italy|Research Site, Rotterdam, Netherlands|Research Site, Madrid, Spain|Research Site, Zuerich, Switzerland|Research Site, Birmingham, United Kingdom|Research Site, London, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Newcastle upon Tyne, United Kingdom|Research Site, Sutton, United Kingdom	https://ClinicalTrials.gov/show/NCT02303821
163	Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)	Recruiting	No Results Available	Non-Hodgkin Lymphoma|Chronic Lymphocytic Leukemia|Acute Lymphocytic Leukemia	Biological: CD19 CAR T Cells|Drug: Fludarabine|Drug: Cyclophosphamide	Houston Methodist Hospital, Houston, Texas, United States|Texas Children's Hospital, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT01853631
164	CD19-specific CAR-T Cells in CLL/SLL and DLBCL	Recruiting	No Results Available	Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Diffuse Large B-cell Lymphoma; Acute Lymphoblastic Leukemia	Drug: YTB323 and ibrutinib|Drug: YTB323 single agent	University of Chicago Medical Center Hematology and Oncology, Chicago, Illinois, United States|University of Kansas Cancer Center SC - CTL019C2201, Westwood, Kansas, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Sarah Cannon Research Institute Drug Ship - 4, Nashville, Tennessee, United States|Medical College of Wisconsin, Inc., Milwaukee, Wisconsin, United States|Novartis Investigative Site, Melbourne, Victoria, Australia|Novartis Investigative Site, Wien, Austria|Novartis Investigative Site, Marseille, France|Novartis Investigative Site, Paris Cedex 10, France|Novartis Investigative Site, Pierre Benite Cedex, France|Novartis Investigative Site, Milano, MI, Italy|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Barcelona, Spain	https://ClinicalTrials.gov/show/NCT03960840
165	Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia|Leukemia Relapse	Biological: Collection of blood samples	University Hospital of Amiens, Amiens, France|University Hospital of Angers, Angers, France|University Hospital of Besancon, Besançon, France|University Hospital of Bordeaux, Bordeaux, France|University Hospital of Caen, Caen, France|Civil Hospices of Lyon, Lyon, France|University Hospital of Marseille, Marseille, France|University Hospital of Nancy, Nancy, France|University Hospital of Nantes, Nantes, France|University Hospital of Nice, Nice, France|University Hospital of Trousseau (Paris), Paris, France|University Hospital of Robert Debre (Paris), Paris, France|University Hospital of Reims, Reims, France|University Hospital of Rennes, Rennes, France|University Hospital of Saint Etienne, Saint-Étienne, France|University Hospital of Strasbourg, Strasbourg, France|University Hospital of Toulouse, Toulouse, France|University Hospital of Tours, Tours, France	https://ClinicalTrials.gov/show/NCT02618109
166	Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies	Not yet recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia|B-cell Lymphoma	Biological: anti-CD19 UCAR-T cells|Drug: Fludarabine|Drug: Cytoxan|Drug: Melphalan	Department of Hematology, Xinqiao Hospital, ChongQing, Chongqing, China	https://ClinicalTrials.gov/show/NCT04264039
167	A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	Recruiting	No Results Available	Precursor Cell Lymphoblastic Leukemia-Lymphoma	Drug: Daratumumab|Drug: Vincristine|Drug: Prednisone|Drug: Doxorubicin|Biological: Peg-asparaginase|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: 6-mercaptopurine|Drug: Methotrexate	University of Alabama at Birmingham, Birmingham, Alabama, United States|Phoenix Children's Hospital, Phoenix, Arizona, United States|UCSF Benioff Children's Hospital Oakland, Oakland, California, United States|Children's Hospital Orange County, Orange, California, United States|Stanford University, Palo Alto, California, United States|University of California San Francisco, San Francisco, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Children'S Healthcare Of Atlanta/Emory Univ. Dept. Of Pediatrics, Atlanta, Georgia, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Johns Hopkins University, Baltimore, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States|Washington Univeristy School of Medicine/ Pediatrics, Saint Louis, Missouri, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|New York University Langone Medical Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Dell Children's Medical Center of Central Texas/Children's Blood and Cancer Center, Austin, Texas, United States|UT Southwestern Medical Center, Dallas, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|University of Utah Primary Children's Medical Center, Salt Lake City, Utah, United States|Medical College Of Wisconsin, Milwaukee, Wisconsin, United States|Universitair Ziekenhuis Gent - UZ GENT, Gent, Belgium|CHU de Bordeaux, Hopital des Enfants, Bordeaux, France|IHOPE - Hospices civils de Lyon, Lyon, France|Hôpital trousseau- APHP, Paris, France|Hôpital Robert Debré, Paris, France|Hôpital D'Enfants, Vandoeuvre les Nancy, France|Charite-Universitätsmedizin Berlin - Berlin, Berlin, Germany|Universitatsklinikum Essen, Essen, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitätsklinikum Münster, Münster, Germany|Schneider Children's Medical Center, Petach Tiquva, Israel|Istituto Giannina Gaslini, Genova, Italy|Fondazione MBBM, ASST Monza, Monza, Italy|Ospedale Pediatrico Bambin Gesù, Roma, Italy|AOU Città della Salute e della Scienza di Torino, Presidio Ospedale Infantile Regina Margherita, Torino, Italy|Princess Maxima Center, Utrecht, Netherlands|Hosp. Univ. Vall D'Hebron, Barcelona, Spain|Hosp. Sant Joan de Deu, Esplugues de Llobregat, Spain|Hosp. Infantil Univ. Niño Jesus, Madrid, Spain|Hosp. Univ. La Paz, Madrid, Spain|Hosp. Univ. I Politecni La Fe, Valencia, Spain|Karolinska University Hospital, Stockholm, Sweden|Bristol Royal Hospital for Children, Bristol, United Kingdom|Royal Hospital for Sick Children, Glasgow, United Kingdom|Leeds Children's Hospital, Leeds, United Kingdom|University College London Hospitals, London, United Kingdom|Great Ormond Street Hospital, London, United Kingdom|Royal Manchester Children's Hospital, Manchester, United Kingdom|Royal Marsden Hospital, Surrey, United Kingdom	https://ClinicalTrials.gov/show/NCT03384654
168	Anti-CD5 CAR T Cells for Relapsed/Refractory T Cell Malignancies	Recruiting	No Results Available	T-cell Acute Lymphoblastic Leukemia|T-cell Non-Hodgkin Lymphoma	Drug: anti-CD5 CAR T cells	Peking University Shenzhen Hospital, Shenzhen, Guangdong, China	https://ClinicalTrials.gov/show/NCT04594135
169	Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous Leukemia	Recruiting	No Results Available	AML|Advanced MDS|ALL|Advanced CML|Advanced MPNs	Drug: OTS167IV	University of Chicago, Chicago, Illinois, United States|Weill Cornell Medicine, New York, New York, United States	https://ClinicalTrials.gov/show/NCT02795520
170	Safety and Efficacy Evaluation of CD19-UCART	Recruiting	No Results Available	Acute Lymphoblastic Leukemia (ALL)|Non Hodgkin Lymphoma (NHL)	Biological: CD19-UCART	First Affliated Hospital of Zhengzhou University, Zhengzhou, Henan, China|First Affliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China	https://ClinicalTrials.gov/show/NCT03229876
171	T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies	Recruiting	No Results Available	Acute Lymphoblastic Leukemia, B-precursor|Non-Hodgkin Lymphoma, B-cell	Biological: CD19 CAR T cells	Chaim Sheba Medical Center, Ramat Gan, Israel	https://ClinicalTrials.gov/show/NCT02772198
172	Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Child	Drug: high dose methotrexate|Drug: Intrathecal triple chemotherapy	Seoul National University, College of Medicine, Seoul, Korea, Republic of	https://ClinicalTrials.gov/show/NCT02339350
173	Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission	Recruiting	No Results Available	Acute Myeloid Leukemia|Acute Lymphoid Leukemia	Drug: Busulfan|Drug: Cyclophosphamide|Drug: CXCR4 Antagonist|Procedure: Hematopoietic Stem Cell Transplantation	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Distrito Federal, Mexico	https://ClinicalTrials.gov/show/NCT02605460
174	Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells	Not yet recruiting	No Results Available	T-cell Acute Lymphoblastic Leukemia|T-cell Acute Lymphoblastic Lymphoma|T-non-Hodgkin Lymphoma	Genetic: CD7.CAR/28zeta CAR T cells|Drug: Fludarabine|Drug: Cytoxan	Houston Methodist Hospital, Houston, Texas, United States|Texas Children's Hospital, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03690011
175	Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Acute Lymphoblastic Leukemia	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative|Pre-B Acute Lymphoblastic Leukemia	Biological: Blinatumomab|Drug: Cyclophosphamide|Drug: Cytarabine|Biological: Inotuzumab Ozogamicin|Other: Laboratory Biomarker Analysis|Drug: Mercaptopurine|Drug: Methotrexate|Drug: Prednisone|Biological: Rituximab|Drug: Vincristine	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT01371630
176	Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants	Recruiting	No Results Available	Philadelphia Chromosome Positive Acute Lymphocytic Leukemia|Tyrosine Kinase Inhibitor|Minimal Residual Disease|Allogeneic Hematopoietic Stem Cell Transplantation	Drug: Tyrosine kinase inhibitor (TKIs)	Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China	https://ClinicalTrials.gov/show/NCT03624530
177	Goal Management Training for Adult Survivors of Childhood Acute Lymphoblastic Leukemia With Neurocognitive Sequelae	Recruiting	No Results Available	Leukemia, Acute Lymphoblastic	Behavioral: Goal Management Training (GMT)|Behavioral: Brain Health Workshop (BHW)	Oslo University Hospital - Rikshospitalet, Oslo, Norway|St. Olavs Hospital, Trondheim, Norway|Department of Psychology, Norwegian University of Science and Technology (NTNU), Trondheim, Norway	https://ClinicalTrials.gov/show/NCT04541056
178	First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome	Recruiting	No Results Available	Leukaemia	Drug: SAR440234	Investigational Site Number 8400001, Houston, Texas, United States|Investigational Site Number 2500004, Marseille, France|Investigational Site Number 2500001, Paris Cedex 10, France|Investigational Site Number 2500003, Villejuif Cedex, France	https://ClinicalTrials.gov/show/NCT03594955
179	PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma	Recruiting	No Results Available	ALL, Childhood|Lymphoblastic Lymphoma, Childhood|Lymphoblastic Leukemia, Acute, Childhood	Drug: Ixazomib|Drug: Vincristine|Drug: Dexamethasone|Drug: Asparaginase|Drug: Doxorubicin	Children's Hospital Los Angeles, Los Angeles, California, United States|Children's Hospital Orange County, Orange, California, United States|University of Miami, Miami, Florida, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota, United States|Columbia University Medical Center, New York, New York, United States|Levine Cancer Institute, Charlotte, North Carolina, United States|University Hospitals Seidman Cancer Center, Cleveland, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Doernbecher Children's Hospital, Portland, Oregon, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, United States|University of Texas, Southwestern, Dallas, Texas, United States|Cook Children's Medical Center, Fort Worth, Texas, United States|Texas Children's Hospital/Baylor University, Houston, Texas, United States|The Children's Hospital at Westmead, Westmead, New South Wales, Australia	https://ClinicalTrials.gov/show/NCT03817320
180	Ponatinib With Chemotherapy in Pediatric Participants With Relapsed, Resistant, or Intolerant Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) or Have the T315I Mutation	Recruiting	No Results Available	Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)|Ph+ Mixed Phenotype Acute Leukemia (MPAL)	Drug: Ponatinib|Drug: Ponatinib AAF|Drug: Chemotherapy Agents	Phoenix Childrens Hospital, Phoenix, Arizona, United States|Arkansas Children's Hospital, Little Rock, Arkansas, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Rady Childrens Hospital San Diego - PIN, San Diego, California, United States|UCSF Medical Comprehensive Cancer, San Francisco, California, United States|Alfred I Dupont Hospital For Children, Wilmington, Delaware, United States|Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States|Riley Hospital For Children, Indianapolis, Indiana, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Children's Mercy Hospital and Clinica, Kansas City, Missouri, United States|Cincinnati Children's Hospital Medical Center - PIN, Cincinnati, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|St Jude Children's Research Hospital, Memphis, Tennessee, United States|Childrens Medical Center Research Institute at UT Southwestern, Dallas, Texas, United States|Hospital Universitario Austral, Pilar, Buenos Aires, Argentina|Hospital Italiano de Buenos Aires, Buenos Aires, Argentina|Queensland Childrens Hospital, South Brisbane, Queensland, Australia|Royal Children's Hospital Melbourne - PIN, Parkville, Victoria, Australia|Perth Childrens Hospital, Nedlands, Western Australia, Australia|Fundacao Pio XII Hospital de Cancer de Barretos, Barretos, Sao Paulo, Brazil|Hospital Das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP, Ribeirao Preto, Brazil|Graacc Grupo de Apoio Ao Adolescente E A Crianca Com Cancer, Sao Paulo, Brazil|Hospital Santa Marcelina, Sao Paulo, Brazil|British Columbia Children's Hospital, Vancouver, Canada|Fakultni nemocnice Brno, Brno, Czechia|Fakultni nemocnice v Motole, Praha, Czechia|Hopital Sud, Rennes, Ille-et-Vilaine, France|Assistance Publique Hopitaux de Marseille, Marseille, France|Hopital Robert Debre, Paris, France|Hopital Des Enfants, Toulouse, France|Universitatsklinikum Giesen und Marburg GmbH, Giesen, Hessen, Germany|Christian-Albrechts-Universitat zu Kiel, Kiel, Schleswig-Holstein, Germany|Charite - Universitatsmedizin Berlin, Berlin, Germany|Universitaetsklinik Erlangen Kinder- und Jugendklinik, Erlangen, Germany|IRCCS Ospedale Pediatrico Bambino Gesu - INCIPIT - PIN, Roma, Lazio, Italy|Fndazione MBBM (MONZA E BRIANZA PER IL BAMBINO E LA SUA MAMMA) - c/o Centro Maria Letizia Verga, Monza, Lombardia, Italy|Ospedale Infantile Regina Margherita - INCIPIT - PIN, Torino, Piemonte, Italy|Seoul National University Hospital, Seoul, Korea, Republic of|Severance Hospital Yonsei University Health System, Seoul, Korea, Republic of|Asan Medical Center - PPDS, Seoul, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Korea, Republic of|Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico|Instituto Nacional de Pediatria, Ciudad De Mexico, Mexico|Nuevo Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, Mexico|Princess Maxima Center for Pediatric Oncology - PIN, Utrecht, Netherlands|Hospital Universitario Vall d'Hebron - PPDS, Barcelona, Spain|Hospital Infantil Universitario Nino Jesus - PIN, Madrid, Spain|Royal Marsden Hospital - Surrey, Sutton, Surrey, United Kingdom|Birmingham Childrens Hospital, Birmingham, United Kingdom|Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom|Royal Hospital for Children (Glasgow) - PPDS - PIN, Glasgow, United Kingdom	https://ClinicalTrials.gov/show/NCT04501614
181	Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia	Procedure: Biospecimen Collection|Procedure: Dual-Energy Computed Tomography|Drug: Fluorothymidine F-18|Other: Laboratory Biomarker Analysis|Procedure: Magnetic Resonance Imaging|Procedure: Positron Emission Tomography	City of Hope Medical Center, Duarte, California, United States	https://ClinicalTrials.gov/show/NCT03422731
182	A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma|Down Syndrome	Drug: Asparaginase Erwinia chrysanthemi|Biological: Blinatumomab|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dexamethasone|Drug: Doxorubicin Hydrochloride|Drug: Leucovorin Calcium|Drug: Mercaptopurine|Drug: Mercaptopurine Oral Suspension|Drug: Methotrexate|Drug: Pegaspargase|Drug: Prednisolone|Drug: Prednisone|Radiation: Radiation Therapy|Drug: Thioguanine|Drug: Vincristine Sulfate	Children's Hospital of Alabama, Birmingham, Alabama, United States|USA Health Strada Patient Care Center, Mobile, Alabama, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Banner Children's at Desert, Mesa, Arizona, United States|Phoenix Childrens Hospital, Phoenix, Arizona, United States|Banner University Medical Center - Tucson, Tucson, Arizona, United States|Arkansas Children's Hospital, Little Rock, Arkansas, United States|Kaiser Permanente Downey Medical Center, Downey, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Miller Children's and Women's Hospital Long Beach, Long Beach, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Mattel Children's Hospital UCLA, Los Angeles, California, United States|Valley Children's Hospital, Madera, California, United States|UCSF Benioff Children's Hospital Oakland, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Children's Hospital of Orange County, Orange, California, United States|Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Rady Children's Hospital - San Diego, San Diego, California, United States|Naval Medical Center -San Diego, San Diego, California, United States|UCSF Medical Center-Mission Bay, San Francisco, California, United States|Santa Barbara Cottage Hospital, Santa Barbara, California, United States|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, Colorado, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Alfred I duPont Hospital for Children, Wilmington, Delaware, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Children's National Medical Center, Washington, District of Columbia, United States|Broward Health Medical Center, Fort Lauderdale, Florida, United States|Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States|Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, United States|Palms West Radiation Therapy, Loxahatchee Groves, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|Nicklaus Children's Hospital, Miami, Florida, United States|Miami Cancer Institute, Miami, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Arnold Palmer Hospital for Children, Orlando, Florida, United States|Nemours Children's Hospital, Orlando, Florida, United States|Sacred Heart Hospital, Pensacola, Florida, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida, United States|Saint Mary's Hospital, West Palm Beach, Florida, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States|Augusta University Medical Center, Augusta, Georgia, United States|Medical Center of Central Georgia, Macon, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Tripler Army Medical Center, Honolulu, Hawaii, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, United States|University of Illinois, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Advocate Children's Hospital-Oak Lawn, Oak Lawn, Illinois, United States|Advocate Children's Hospital-Park Ridge, Park Ridge, Illinois, United States|Saint Jude Midwest Affiliate, Peoria, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Saint Vincent Hospital and Health Care Center, Indianapolis, Indiana, United States|Blank Children's Hospital, Des Moines, Iowa, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Norton Children's Hospital, Louisville, Kentucky, United States|Children's Hospital New Orleans, New Orleans, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Eastern Maine Medical Center, Bangor, Maine, United States|Maine Children's Cancer Program, Scarborough, Maine, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Tufts Children's Hospital, Boston, Massachusetts, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|UMass Memorial Medical Center - University Campus, Worcester, Massachusetts, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Michigan State University Clinical Center, East Lansing, Michigan, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|Beaumont Children's Hospital-Royal Oak, Royal Oak, Michigan, United States|Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Columbia Regional, Columbia, Missouri, United States|Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States|Cardinal Glennon Children's Medical Center, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Children's Hospital and Medical Center of Omaha, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Morristown Medical Center, Morristown, New Jersey, United States|Saint Peter's University Hospital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|Saint Joseph's Regional Medical Center, Paterson, New Jersey, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Presbyterian Hospital, Albuquerque, New Mexico, United States|Albany Medical Center, Albany, New York, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|Maimonides Medical Center, Brooklyn, New York, United States|NYU Winthrop Hospital, Mineola, New York, United States|The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|Mount Sinai Hospital, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|NYP/Weill Cornell Medical Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|New York Medical College, Valhalla, New York, United States|Mission Hospital, Asheville, North Carolina, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States|Novant Health Presbyterian Medical Center, Charlotte, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Children's Hospital Medical Center of Akron, Akron, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Rainbow Babies and Childrens Hospital, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Dayton Children's Hospital, Dayton, Ohio, United States|ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Natalie Warren Bryant Cancer Center at Saint Francis, Tulsa, Oklahoma, United States|Legacy Emanuel Children's Hospital, Portland, Oregon, United States|Oregon Health and Science University, Portland, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Penn State Children's Hospital, Hershey, Pennsylvania, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|BI-LO Charities Children's Cancer Center, Greenville, South Carolina, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|T C Thompson Children's Hospital, Chattanooga, Tennessee, United States|East Tennessee Childrens Hospital, Knoxville, Tennessee, United States|The Children's Hospital at TriStar Centennial, Nashville, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|Texas Tech University Health Sciences Center-Amarillo, Amarillo, Texas, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, United States|Driscoll Children's Hospital, Corpus Christi, Texas, United States|Medical City Dallas Hospital, Dallas, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|El Paso Children's Hospital, El Paso, Texas, United States|Cook Children's Medical Center, Fort Worth, Texas, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|Covenant Children's Hospital, Lubbock, Texas, United States|UMC Cancer Center / UMC Health System, Lubbock, Texas, United States|Vannie Cook Children's Clinic, McAllen, Texas, United States|Children's Hospital of San Antonio, San Antonio, Texas, United States|Methodist Children's Hospital of South Texas, San Antonio, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Scott and White Memorial Hospital, Temple, Texas, United States|Primary Children's Hospital, Salt Lake City, Utah, United States|University of Vermont and State Agricultural College, Burlington, Vermont, United States|University of Virginia Cancer Center, Charlottesville, Virginia, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, United States|Naval Medical Center - Portsmouth, Portsmouth, Virginia, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|Carilion Children's, Roanoke, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, United States|Mary Bridge Children's Hospital and Health Center, Tacoma, Washington, United States|Madigan Army Medical Center, Tacoma, Washington, United States|West Virginia University Charleston Division, Charleston, West Virginia, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States|John Hunter Children's Hospital, Hunter Regional Mail Centre, New South Wales, Australia|Queensland Children's Hospital, South Brisbane, Queensland, Australia|Women's and Children's Hospital-Adelaide, North Adelaide, South Australia, Australia|Monash Medical Center-Clayton Campus, Clayton, Victoria, Australia|Perth Children's Hospital, Perth, Western Australia, Australia|Alberta Children's Hospital, Calgary, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|British Columbia Children's Hospital, Vancouver, British Columbia, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|Janeway Child Health Centre, Saint John's, Newfoundland and Labrador, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario, Canada|Kingston Health Sciences Centre, Kingston, Ontario, Canada|Children's Hospital, London, Ontario, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|Hospital for Sick Children, Toronto, Ontario, Canada|The Montreal Children's Hospital of the MUHC, Montreal, Quebec, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada|Starship Children's Hospital, Grafton, Auckland, New Zealand|Christchurch Hospital, Christchurch, New Zealand|HIMA San Pablo Oncologic Hospital, Caguas, Puerto Rico|University Pediatric Hospital, San Juan, Puerto Rico	https://ClinicalTrials.gov/show/NCT03914625
183	CD19 CAR and PD-1 Knockout Engineered T Cells for CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma	Not yet recruiting	No Results Available	Acute Lymphoblastic Leukemia|Burkitt Lymphoma	Biological: CD19 CAR and PD-1 knock out engineered T-cells|Biological: CD19 CAR T-cells		https://ClinicalTrials.gov/show/NCT03298828
184	Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen	Recruiting	No Results Available	T-cell Acute Lymphoblastic Lymphoma|T-non-Hodgkin Lymphoma|T-cell Acute Lymphoblastic Leukemia	Genetic: Autologous CD5.CAR/28zeta CAR T cells|Drug: Fludarabine|Drug: Cytoxan|Genetic: Allogeneic CD5.CAR/28zeta CAR T cells	Houston Methodist Hospital, Houston, Texas, United States|Texas Children's Hospital, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03081910
185	LBL-2016 for Children or Adolescents in China	Recruiting	No Results Available	Lymphoblastic Lymphoma	Drug: Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine|Drug: 6-mercaptopurine,Methotrexate|Drug: Dexamethasone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Doxorubicin, 6-mercaptopurine|Drug: Dexamethasone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Methotrexate|Drug: Dexamethasone, Vindesine, Methotrexate, Ifosfamide, Daunorubicin, Pegylated-asparaginase|Drug: Dexamethasone, Cytarabine, Etoposide, Pegylated-asparaginase|Drug: Methotrexate, 6-mercaptopurine	West China Second University Hospital, Chengdu, China|Shanghai Children's Medical Center, Shanghai, China	https://ClinicalTrials.gov/show/NCT02845882
186	The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation	Recruiting	No Results Available	Chronic Myeloid Leukemia|Acute Lymphoblastic Leukemia	Drug: Ponatinib	Anhui Provincial Hospital, Hefei, Anhui, China|The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China|Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China|Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China|Xiangya Hospital Central South University, Changsha, Hunan, China|The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China|Shengjing Hospital of China Medical University, Shenyang, Liaoning, China|Qilu Hospital of Shandong University, Jinan, Shandong, China|Second hospital of Shanxi Medical University, Taiyuan, Shanxi, China|Shenzhen Second People's Hospital, Shenzhen, Shenzhen, China|West China Hospital, Sichuan University, Chengdu, Sichuan, China|The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, Zhejiang, China|1st affiliated hospital, Peking University, Beijing, China|Hematology Hospital, Chinese Academy of Medical Sciences, Tianjin, China	https://ClinicalTrials.gov/show/NCT04233346
187	Aflac LL1602 ENCERT	Recruiting	No Results Available	Lymphoblastic Leukemia|Lymphoblastic Lymphoma	Drug: Everolimus|Drug: Nelarabine|Drug: Cyclophosphamide|Drug: Etoposide	Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Cincinnati Children's Hospital, Cincinnati, Ohio, United States|Texas Children's Hospital, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03328104
188	A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)	Recruiting	No Results Available	Precursor Cell Lymphoblastic Leukemia-Lymphoma|Lymphoma, Non-Hodgkin	Drug: JCAR017|Drug: Lymphodepleting|Drug: Fludarabine|Drug: Cyclophosphamide	Memorial Sloan Kettering Cancer Center, New York, New York, United States|The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Seattle Children's Hospital, Seattle, Washington, United States|UZ Gent, Gent, Belgium|Institute for Pediatric Hematology - Oncology, Leon Berard Cancer Center, Lyon, France|Hopital d'Enfants de la Timone, Marseille Cedex 01, France|Hopital Robert Debre, Paris, France|Charite Campus Virchow, Berlin, Germany|Klinikum der Johann Wolfgang Goethe-Universitaet Frankfurt, Frankfurt am Main, Germany|Fondazione MBBM, Monza, Italy|Ospedale Bambin Gesu, Roma, Italy|Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands|Hospital San Joan de Deu Barcelona, Esplugues de Llobregat, Spain|Hospital Infantil Universitario Nino Jesus, Madrid, Spain	https://ClinicalTrials.gov/show/NCT03743246
189	Study of Out of Specification for Tisagenlecleucel	Recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia|Diffuse Large B-cell Lymphoma	Biological: Tisagenlecleucel	Novartis Investigative Site, Hamilton, Ontario, Canada|Novartis Investigative Site, Toronto, Ontario, Canada|Novartis Investigative Site, Toronto, Ontario, Canada|Novartis Investigative Site, Nagoya, Aichi, Japan|Novartis Investigative Site, Fukuoka city, Fukuoka, Japan|Novartis Investigative Site, Sapporo city, Hokkaido, Japan|Novartis Investigative Site, Kobe-city, Hyogo, Japan|Novartis Investigative Site, Nishinomiya, Hyogo, Japan|Novartis Investigative Site, Tsukuba city, Ibaraki, Japan|Novartis Investigative Site, Sendai city, Miyagi, Japan|Novartis Investigative Site, Matsumoto-city, Nagano, Japan|Novartis Investigative Site, Okayama-city, Okayama, Japan|Novartis Investigative Site, Osaka Sayama, Osaka, Japan|Novartis Investigative Site, Suita city, Osaka, Japan|Novartis Investigative Site, Hamamatsu-city, Shizuoka, Japan|Novartis Investigative Site, Bunkyo ku, Tokyo, Japan|Novartis Investigative Site, Bunkyo ku, Tokyo, Japan|Novartis Investigative Site, Bunkyo-ku, Tokyo, Japan|Novartis Investigative Site, Chuo ku, Tokyo, Japan|Novartis Investigative Site, Setagaya-ku, Tokyo, Japan|Novartis Investigative Site, Shinjuku-ku, Tokyo, Japan|Novartis Investigative Site, Kyoto, Japan|Novartis Investigative Site, Osaka, Japan|Novartis Investigative Site, Saitama, Japan	https://ClinicalTrials.gov/show/NCT04094311
190	Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL	Recruiting	No Results Available	Leukemia, Myeloid, Chronic|Myeloid Leukemia|Chronic Myeloid Leukemia|Philadelphia Positive Acute Lymphoblastic Leukemia	Drug: Ascentage Pharma HQP1351 bioavailable inhibitor	Highlands Oncology, Rogers, Arkansas, United States|City of Hope, Duarte, California, United States|Winship Cancer Institute, Emory University, Atlanta, Georgia, United States|Cleveland Clinic, Cleveland, Ohio, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT04260022
191	Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia|Mixed Phenotype Acute Leukemia|T Acute Lymphoblastic Leukemia	Procedure: Allogeneic Hematopoietic Stem Cell Transplantation|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Daunorubicin Hydrochloride|Drug: Dexamethasone|Drug: Dexrazoxane Hydrochloride|Drug: Doxorubicin|Drug: Etoposide|Biological: Filgrastim|Drug: Ifosfamide|Drug: Imatinib Mesylate|Other: Laboratory Biomarker Analysis|Drug: Leucovorin Calcium|Drug: Mercaptopurine|Drug: Methotrexate|Drug: Methylprednisolone|Drug: Pegaspargase|Drug: Prednisolone|Other: Questionnaire Administration|Drug: Therapeutic Hydrocortisone|Drug: Thioguanine|Drug: Vincristine Sulfate	Children's Hospital of Alabama, Birmingham, Alabama, United States|USA Health Strada Patient Care Center, Mobile, Alabama, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Banner Children's at Desert, Mesa, Arizona, United States|Phoenix Childrens Hospital, Phoenix, Arizona, United States|Arkansas Children's Hospital, Little Rock, Arkansas, United States|Kaiser Permanente Downey Medical Center, Downey, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Miller Children's and Women's Hospital Long Beach, Long Beach, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Valley Children's Hospital, Madera, California, United States|UCSF Benioff Children's Hospital Oakland, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Children's Hospital of Orange County, Orange, California, United States|Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Rady Children's Hospital - San Diego, San Diego, California, United States|UCSF Medical Center-Mission Bay, San Francisco, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, Colorado, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Alfred I duPont Hospital for Children, Wilmington, Delaware, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Children's National Medical Center, Washington, District of Columbia, United States|Broward Health Medical Center, Fort Lauderdale, Florida, United States|Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States|Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, United States|Palms West Radiation Therapy, Loxahatchee Groves, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|Nicklaus Children's Hospital, Miami, Florida, United States|Miami Cancer Institute, Miami, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Arnold Palmer Hospital for Children, Orlando, Florida, United States|Nemours Children's Hospital, Orlando, Florida, United States|Sacred Heart Hospital, Pensacola, Florida, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida, United States|Saint Mary's Hospital, West Palm Beach, Florida, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States|Medical Center of Central Georgia, Macon, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, United States|University of Illinois, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Advocate Children's Hospital-Oak Lawn, Oak Lawn, Illinois, United States|Advocate Children's Hospital-Park Ridge, Park Ridge, Illinois, United States|Saint Jude Midwest Affiliate, Peoria, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Saint Vincent Hospital and Health Care Center, Indianapolis, Indiana, United States|Blank Children's Hospital, Des Moines, Iowa, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Norton Children's Hospital, Louisville, Kentucky, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Eastern Maine Medical Center, Bangor, Maine, United States|Maine Children's Cancer Program, Scarborough, Maine, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Tufts Children's Hospital, Boston, Massachusetts, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Michigan State University Clinical Center, East Lansing, Michigan, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|Beaumont Children's Hospital-Royal Oak, Royal Oak, Michigan, United States|Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Columbia Regional, Columbia, Missouri, United States|Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Children's Hospital and Medical Center of Omaha, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Morristown Medical Center, Morristown, New Jersey, United States|Saint Peter's University Hospital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|Saint Joseph's Regional Medical Center, Paterson, New Jersey, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Albany Medical Center, Albany, New York, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|Maimonides Medical Center, Brooklyn, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|NYU Winthrop Hospital, Mineola, New York, United States|The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|Mount Sinai Hospital, New York, New York, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|Mission Hospital, Asheville, North Carolina, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States|Novant Health Presbyterian Medical Center, Charlotte, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Children's Hospital Medical Center of Akron, Akron, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Rainbow Babies and Childrens Hospital, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Dayton Children's Hospital, Dayton, Ohio, United States|ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Oregon Health and Science University, Portland, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Penn State Children's Hospital, Hershey, Pennsylvania, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|BI-LO Charities Children's Cancer Center, Greenville, South Carolina, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|T C Thompson Children's Hospital, Chattanooga, Tennessee, United States|East Tennessee Childrens Hospital, Knoxville, Tennessee, United States|The Children's Hospital at TriStar Centennial, Nashville, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|Texas Tech University Health Sciences Center-Amarillo, Amarillo, Texas, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, United States|Driscoll Children's Hospital, Corpus Christi, Texas, United States|Medical City Dallas Hospital, Dallas, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|El Paso Children's Hospital, El Paso, Texas, United States|Cook Children's Medical Center, Fort Worth, Texas, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|Covenant Children's Hospital, Lubbock, Texas, United States|UMC Cancer Center / UMC Health System, Lubbock, Texas, United States|Children's Hospital of San Antonio, San Antonio, Texas, United States|Methodist Children's Hospital of South Texas, San Antonio, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Scott and White Memorial Hospital, Temple, Texas, United States|Primary Children's Hospital, Salt Lake City, Utah, United States|University of Vermont and State Agricultural College, Burlington, Vermont, United States|University of Virginia Cancer Center, Charlottesville, Virginia, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, United States|Naval Medical Center - Portsmouth, Portsmouth, Virginia, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|Carilion Children's, Roanoke, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, United States|Mary Bridge Children's Hospital and Health Center, Tacoma, Washington, United States|Madigan Army Medical Center, Tacoma, Washington, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States|John Hunter Children's Hospital, Hunter Regional Mail Centre, New South Wales, Australia|Sydney Children's Hospital, Randwick, New South Wales, Australia|The Children's Hospital at Westmead, Westmead, New South Wales, Australia|Queensland Children's Hospital, South Brisbane, Queensland, Australia|Princess Margaret Hospital for Children, Perth, Western Australia, Australia|Perth Children's Hospital, Perth, Western Australia, Australia|St. Anna Children's Hospital, Vienna, Austria|Hospitals Leuven, Leuven, Flemish Brabant, Belgium|Alberta Children's Hospital, Calgary, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario, Canada|Kingston Health Sciences Centre, Kingston, Ontario, Canada|Children's Hospital, London, Ontario, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|Hospital for Sick Children, Toronto, Ontario, Canada|The Montreal Children's Hospital of the MUHC, Montreal, Quebec, Canada|Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada|Centre Hospitalier Universitaire de Quebec, Quebec, Canada|Hospital Roberto del Rio-Universidad de Chile, Santiago, Chile|University Hospital Motol, Praha, Czechia|Tampere University Hospital, Tampere, Finland|CHU Hopital Sud, Rennes, France|University Medical Center chleswig- Campus Kiel, Kiel, Schleswig-Holstein, Germany|Universitätsklinik Eppendorf, Hamburg, Germany|Hong Kong Children's Hospital, Kowloon Bay, Kowloon, Hong Kong|Schneider Children's Medical Center of Israel, Petah-Tikva, Central District, Israel|Clinica Pediatrica Università Milano-Bicocca Ospedale S. Gerardo/Fondazione MBBM, Monza, Italy|Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands|Starship Children's Hospital, Grafton, Auckland, New Zealand|Christchurch Hospital, Christchurch, New Zealand|HIMA San Pablo Oncologic Hospital, Caguas, Puerto Rico|San Jorge Children's Hospital, San Juan, Puerto Rico|University Pediatric Hospital, San Juan, Puerto Rico|King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia|Skane University Hospital, Lund, Scania, Sweden|University Children's Hospital, Zurich, Switzerland	https://ClinicalTrials.gov/show/NCT03007147
192	Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL	Not yet recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia	Biological: Tisagenlecleucel		https://ClinicalTrials.gov/show/NCT04156659
193	Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell Transplantation	Recruiting	No Results Available	CD19-chimeric Antigen Receptor T Cells|Relapsed and/or Refractory Acute Lymphoblastic Leukemia|the Haploidentical Hematopoietic Stem Cell Transplantation	Procedure: the new model of haplo-HSCT for r/r B-ALL	First affiliated hospital of Harbin medical university, Harbin, Heilongjiang, China	https://ClinicalTrials.gov/show/NCT03423706
194	Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL	Recruiting	No Results Available	Refractory Acute Lymphoblastic Leukemia|Relapsed Acute Lymphoblastic Leukemia	Drug: Pevonedistat|Drug: Vincristine|Drug: Dexamethasone|Drug: PEG-asparaginase|Drug: Doxorubicin|Drug: Cytarabine|Drug: Methotrexate|Drug: Hydrocortisone	University of Florida, Gainesville, Florida, United States|University of Miami, Miami, Florida, United States	https://ClinicalTrials.gov/show/NCT03349281
195	Study in Adult Ph-positive ALL	Not yet recruiting	No Results Available	Acute Lymphoblastic Leukemia, Adult	Drug: Ponatinib|Drug: Blinatumomab|Drug: Imatinib		https://ClinicalTrials.gov/show/NCT04688983
196	Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL	Recruiting	No Results Available	Acute Lymphoblastic Leukemia ALL	Drug: Ribociclib|Drug: Dexamethasone|Drug: Everolimus	Children's Hospital Colorado, Aurora, Colorado, United States|Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Texas Children's Hospital, Houston, Texas, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States	https://ClinicalTrials.gov/show/NCT03740334
197	Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL.	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Drug: Busulfan	Seoul National University Hospital, Seoul, Daehangno, Jongno-gu, Korea, Republic of	https://ClinicalTrials.gov/show/NCT02047578
198	Blinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL	Recruiting	No Results Available	B-Cell Acute Lymphoblastic Leukaemia|ALL, Adult|B-ALL	Drug: Blinatumomab|Other: Haplo-Mismatched Cell Therapy (HMCT)	Cedars-Sinai Medical Center, Los Angeles, California, United States	https://ClinicalTrials.gov/show/NCT03751709
199	Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients	Recruiting	No Results Available	B-Cell Acute Lymphoblastic Leukemia	Biological: CTL019	Phoenix Children's Hospital, Phoenix, Arizona, United States|City of Hope National Medical Center, Duarte, California, United States|Childrens Hospital Los Angeles SC CTL019, Los Angeles, California, United States|Mattel Childrens Hospital UCLA, Los Angeles, California, United States|Rady Children s Hospital CTBM100C2401, San Diego, California, United States|UCSF Medical Center, San Francisco, California, United States|Stanford Universtiy Medical Center, Stanford, California, United States|Childrens Hospital Colorado, Aurora, Colorado, United States|Children s National Hospital, Washington, District of Columbia, United States|Johns Hopkins All childrens, Saint Petersburg, Florida, United States|Children's Healthcare of Atlanta Emory University IRB, Atlanta, Georgia, United States|Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|James Whitcomb Riley Hospital for Children, Indianapolis, Indiana, United States|Johns Hopkins Oncology Center Cancer Research Building, Baltimore, Maryland, United States|Children s Mercy Hospital, Kansas City, Missouri, United States|Washington University CTBM100C2412, Saint Louis, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio, United States|Univ Hospital - Cleveland/Rainbow Babies and Children's Hosp Pediatric Nephrology, Cleveland, Ohio, United States|Nationwide Childrens Hospital suite T6B, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|The Childrens Hospital of Philadelphia Div Gastroint., Hepat. & Nutr., Philadelphia, Pennsylvania, United States|Medical University of South Carolina Medical Univ of SC, Charleston, South Carolina, United States|Monroe Carell Jr Childrens Hospital at Vanderbilt, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Texas Children's Cancer and Hematology Center, Houston, Texas, United States|Methodist Children's Hospital, San Antonio, Texas, United States|University of Utah Clinical Trials Office, Salt Lake City, Utah, United States|University of Wisconsin Hospital and Clinics Pharmacy/Drug Shipping Address, Madison, Wisconsin, United States|Novartis Investigative Site, Gent, Belgium|Novartis Investigative Site, Calgary, Alberta, Canada|Novartis Investigative Site, Toronto, Ontario, Canada|Novartis Investigative Site, Montreal, Quebec, Canada|Novartis Investigative Site, Copenhagen, Denmark|Novartis Investigative Site, Helsinki, Finland|Novartis Investigative Site, Paris Cedex 19, France|Novartis Investigative Site, Frankfurt, Germany|Novartis Investigative Site, Muenchen, Germany|Novartis Investigative Site, Roma, ITA, Italy|Novartis Investigative Site, Monza, MB, Italy|Prinses Maxima Centrum voor Kinderoncologie, Utrecht, CS, Netherlands|Novartis Investigative Site, Oslo, Norway|Novartis Investigative Site, Esplugues de Llobregat, Barcelona, Spain|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, London, United Kingdom	https://ClinicalTrials.gov/show/NCT03876769
200	ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016	Recruiting	No Results Available	Down Syndrome|Acute Lymphoblastic Leukemia|Childhood Cancer	Drug: Daunorubicin|Drug: Prednisolone|Drug: Vincristine|Drug: Epirubicin|Drug: E-coli L-asparaginase|Drug: 6-Mercaptopurine|Drug: Methotrexate|Drug: Hydrocortisone|Drug: Cytarabine|Drug: Cyclophosphamide	Prince of Wales Hospital, Shatin, New Territories, Hong Kong|Kagoshima University Hospital, Kagoshima, Japan|University of Malaya Medical Centre, Kuala Lumpur, Malaysia|Subang Jaya Medical Centre, Subang Jaya, Malaysia|National University Hospital, Singapore, Singapore|KK Women's and Children's Hospital, Singapore, Singapore|National Taiwan University Children's Hospital, Taipei, Taiwan|Mackay Memorial Hospital, Taipei, Taiwan|Chang Gung Memorial Hopsital, Linkou, Taoyuan, Taiwan|Siriraj Hospital Mahidol University, Bangkok, Thailand	https://ClinicalTrials.gov/show/NCT03286634
201	Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Recurrent B Acute Lymphoblastic Leukemia|Recurrent B Lymphoblastic Lymphoma|Refractory B Acute Lymphoblastic Leukemia|Refractory B Lymphoblastic Lymphoma	Drug: Cyclophosphamide|Drug: Cytarabine|Biological: Inotuzumab Ozogamicin|Drug: Leucovorin Calcium|Drug: Mercaptopurine|Drug: Methotrexate|Drug: Pegaspargase|Drug: Vincristine	Children's Hospital of Alabama, Birmingham, Alabama, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Banner Children's at Desert, Mesa, Arizona, United States|Phoenix Childrens Hospital, Phoenix, Arizona, United States|Banner University Medical Center - Tucson, Tucson, Arizona, United States|Arkansas Children's Hospital, Little Rock, Arkansas, United States|Kaiser Permanente Downey Medical Center, Downey, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Valley Children's Hospital, Madera, California, United States|UCSF Benioff Children's Hospital Oakland, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Children's Hospital of Orange County, Orange, California, United States|Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Rady Children's Hospital - San Diego, San Diego, California, United States|UCSF Medical Center-Mission Bay, San Francisco, California, United States|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, Colorado, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Alfred I duPont Hospital for Children, Wilmington, Delaware, United States|Children's National Medical Center, Washington, District of Columbia, United States|Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States|Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, United States|Nicklaus Children's Hospital, Miami, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States|Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida, United States|Saint Mary's Hospital, West Palm Beach, Florida, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Saint Jude Midwest Affiliate, Peoria, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Saint Vincent Hospital and Health Care Center, Indianapolis, Indiana, United States|Blank Children's Hospital, Des Moines, Iowa, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Norton Children's Hospital, Louisville, Kentucky, United States|Children's Hospital New Orleans, New Orleans, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Eastern Maine Medical Center, Bangor, Maine, United States|Maine Children's Cancer Program, Scarborough, Maine, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Tufts Children's Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|UMass Memorial Medical Center - University Campus, Worcester, Massachusetts, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States|Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Columbia Regional, Columbia, Missouri, United States|Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States|Cardinal Glennon Children's Medical Center, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Children's Hospital and Medical Center of Omaha, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Morristown Medical Center, Morristown, New Jersey, United States|Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|Albany Medical Center, Albany, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|NYU Winthrop Hospital, Mineola, New York, United States|The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|Mount Sinai Hospital, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|New York Medical College, Valhalla, New York, United States|Mission Hospital, Asheville, North Carolina, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Children's Hospital Medical Center of Akron, Akron, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Dayton Children's Hospital, Dayton, Ohio, United States|ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Legacy Emanuel Children's Hospital, Portland, Oregon, United States|Oregon Health and Science University, Portland, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Penn State Children's Hospital, Hershey, Pennsylvania, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|BI-LO Charities Children's Cancer Center, Greenville, South Carolina, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|East Tennessee Childrens Hospital, Knoxville, Tennessee, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, United States|The Children's Hospital at TriStar Centennial, Nashville, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, United States|Driscoll Children's Hospital, Corpus Christi, Texas, United States|Medical City Dallas Hospital, Dallas, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|El Paso Children's Hospital, El Paso, Texas, United States|Cook Children's Medical Center, Fort Worth, Texas, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States|UMC Cancer Center / UMC Health System, Lubbock, Texas, United States|Children's Hospital of San Antonio, San Antonio, Texas, United States|Methodist Children's Hospital of South Texas, San Antonio, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Primary Children's Hospital, Salt Lake City, Utah, United States|University of Vermont and State Agricultural College, Burlington, Vermont, United States|University of Virginia Cancer Center, Charlottesville, Virginia, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States|HIMA San Pablo Oncologic Hospital, Caguas, Puerto Rico	https://ClinicalTrials.gov/show/NCT02981628
202	A Study of Anti-CD7 CAR-T Cells in Pediatric and Young Adult Patients With Relapse and Refractory T-ALL/ T-LBL	Not yet recruiting	No Results Available	T-cell Acute Lymphoblastic Leukemia|T-lymphoblastic Lymphoma	Biological: Target CD7 CAR-T cells	920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming, Yunnan, China	https://ClinicalTrials.gov/show/NCT04860817
203	CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies	Recruiting	No Results Available	Multiple Myeloma in Relapse|Multiple Myeloma, Refractory|Acute Lymphoblastic Leukemia, in Relapse|Acute Lymphocytic Leukaemia Refractory|Non-Hodgkin's Lymphoma, Relapsed|Non-Hodgkin's Lymphoma Refractory	Drug: CD19/BCMA Targeted CAR T-cells and dasatinib|Drug: CD19/BCMA Targeted CAR T-cells	The First Hospital of Zhejiang Medical Colleage Zhejiang University, Hangzhou, Zhejiang, China	https://ClinicalTrials.gov/show/NCT04603872
204	The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL	Recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia	Diagnostic Test: NGS-MRD|Drug: Myeloablative allogeneic HCT with a non-TBI conditioning regimen	Children's of Alabama/University of Alabama in Birmingham(UAB), Birmingham, Alabama, United States|Phoenix Children's Hospital, Phoenix, Arizona, United States|City of Hope, Duarte, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|UCLA Mattel Children's Hospital, Los Angeles, California, United States|UCSF Benioff Children's Hospital Oakland, Oakland, California, United States|UCSF, San Francisco, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Yale University School of Medicine, New Haven, Connecticut, United States|Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington, Delaware, United States|University of Florida, Gainesville, Florida, United States|Nicklaus Children's Hospital, Miami, Florida, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Riley Hospital for Children - Indiana University, Indianapolis, Indiana, United States|Floating Hospital for Children at Tufts Medical Center, Boston, Massachusetts, United States|Dana Faber Cancer Institute/ Boston Children's Hospital, Boston, Massachusetts, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States|Children's Mercy Hospital, Kansas City, Missouri, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Atrium Health - Levine Cancer Center, Charlotte, North Carolina, United States|The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States|Methodist Healthcare System, San Antonio, Texas, United States	https://ClinicalTrials.gov/show/NCT03509961
205	Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Chronic Lymphoblastic Leukemia|B-cell Lymphoma	Drug: Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells	Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China|Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China	https://ClinicalTrials.gov/show/NCT04796688
206	PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Drug: vINCRISTINE|Drug: Dexamethasone|Drug: Methotrexate|Drug: Cytosine arabinoside	H. Son Llatzer, Palma de Mallorca, Baleares, Spain|Consorci Sanitari de Terrassa, Terrassa, Barcelona, Spain|Clínica Universitaria de Navarra, Pamplona, Navarra, Spain|Complejo Hospitalario Universitario de Albacete, Albacete, Spain|Fundación Hospital Alcorcón, Alcorcón, Spain|Hospital de Alcorcón, Alcorcón, Spain|Hoapital General, Alicante, Spain|Hospital General de Alicante, Alicante, Spain|Hospital General de Alicante, Alicante, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Clinic y Provincial de Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau., Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Valle Hebrón, Barcelona, Spain|Institut Català d'oncología, Barcelona, Spain|Basurtuko Ospitalea, Basurto, Spain|Hospital de Cruces, Bilbao, Spain|Complejo Hospitalario de Cáceres, Cáceres, Spain|Complejo Hospitalario Reina Sofía, Córdoba, Spain|Area Hospitalaria Juan Ramón Jimenez, Huelva, Spain|Hospital Médico Quirúrgico Ciudad de Jaén, Jaen, Spain|H. de Jerez, Jerez de la Frontera, Spain|Hospital Juan Canalejo, La Coruña, Spain|Complejo Hospitalario León, Leon, Spain|Hospital Arnau de Vilanova, Lleida, Spain|Complexo Hospitalario Xeral-Calde, Lugo, Spain|Clínica La Concepción, Madrid, Spain|Clínica Puerta de Hierro, Madrid, Spain|Clínica Rúber, Madrid, Spain|Fundación Jiménez Díaz, Madrid, Spain|Hospital 12 de Octubre. Madrid, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Clínico San Carlos de Madrid, Madrid, Spain|Hospital de Fuenlabrada, Madrid, Spain|Hospital de la Princesa, Madrid, Spain|Hospital de Madrid, S.A.- Norte Hospital General, Madrid, Spain|Hospital La Paz, Madrid, Spain|Althaia, Xarxa Asistencial de Manresa, Manresa, Spain|Fundación Hospital Sant Joan de Déu de Martorell, Martorell, Spain|Hospital General Morales Meseguer, Murcia, Spain|Hospital Morales Messeguer. Murcia, Murcia, Spain|Hospital Sta. Maria del Rosell, Murcia, Spain|. Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain|Complejo Hospital Costa del Sol, Málaga, Spain|H. Carlos Haya, Málaga, Spain|Hospital Carlos Haya, Málaga, Spain|Hospital Central de Asturias, Oviedo, Spain|Hospital del Río Carrión, Palencia, Spain|Complejo Asistencial Son Dureta, Palma de Mallorca, Spain|Complejo Hospitalario de Pontevedra_Hospital Montecelo, Pontevedra, Spain|Complejo Hospitalario de Pontevedra_Hospital Provincial, Pontevedra, Spain|Corporació Sanitaria Parc Taulí, Sabadell, Spain|Hospital Clinico Universitario, Salamanca, Spain|Hospital Clínico de Salamanca, Salamanca, Spain|Hospital Clínico Universitario de Salamanca, Salamanca, Spain|Hospital Clínico Universitario de Salamanca, Salamanca, Spain|Clínica Sant Camil, Sant Pere de Ribes, Spain|Hoaspital Marqués de Valdecilla, Santander, Spain|Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain|Hospital General de Segovia, Segovia, Spain|Complejo Hospitalario Regional Virgen del Rocío, Sevilla, Spain|Hospital Joan XXIII, Tarragona, Spain|Fundación Instituto Valenciano de Oncología, Valencia, Spain|Hoapital La Fe, Valencia, Spain|Hospital Clínico de Valencia., Valencia, Spain|Hospital Clínico de Valencia, Valencia, Spain|Hospital Clínic, Valencia, Spain|Hospital Dr Pesset, Valencia, Spain|Hospital General, Valencia, Spain|Hospital La Fe, Valencia, Spain|Hospital Clínico de Valladolid, Valladolid, Spain|Complejo Hospitalario Universitario de Vigo, Vigo, Spain|Comarcal de Vinaros, Vinaros, Spain|Hospital Clinico Lozano Blesa, Zaragoza, Spain|Hospital Lozano Blesa. Zaragoza, Zaragoza, Spain	https://ClinicalTrials.gov/show/NCT01358201
207	Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Relapsed Non Hodgkin Lymphoma|Refractory Non-Hodgkin Lymphoma	Biological: Brexucabtagene Autoleucel (KTE-X19)|Drug: Fludarabine|Drug: Cyclophosphamide	City of Hope, Duarte, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Children's Hospital of Orange County, Orange, California, United States|UCSF Benioff Children's Hospital, San Francisco, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|University of Miami Hospital & Clinics, Miami, Florida, United States|Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Johns Hopkins University, Baltimore, Maryland, United States|Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Columbia University Irving Medical Center/Morgan Stanley Children's Hospital-NYP, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Monroe-Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States|Texas Children's Hospital, Houston, Texas, United States|The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States|University of Virginia Health System, Pediatric Hematology/Oncology Clinic, Charlottesville, Virginia, United States|Medical College of Wisconsin (Administrative Offices), Milwaukee, Wisconsin, United States|The Hospital for Sick Children, Toronto, Canada|Unité d'Oncologie et Hématologie Pédiatriques, Bordeaux, France|Institut d'Hematologie et Oncologie Pediatrique, Lyon, France|Hopital d'Enfants la Timone, Marseille, France|Hopital Robert Debre - Sevice d'Hemato-immunologic, Paris Cedex 10, France|University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany|Prinses Maxima Centrum, Utrecht, Netherlands	https://ClinicalTrials.gov/show/NCT02625480
208	Study of Sequential CAR-T Cell Treating Leukemia Children	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Lymphoblastic Leukemia, in Relapse|Refractory Acute Lymphoid Leukemia	Biological: chimeric antigen receptor T cell	Beijing Boren Hospital, Beijing, Beijing, China	https://ClinicalTrials.gov/show/NCT04340154
209	Study of Anti-CD22 CAR-T Cells Treating Leukemia Children	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Lymphoblastic Leukemia, in Relapse|Refractory Acute Lymphoblastic Leukemia	Biological: Autologous humanized anti-CD22 chimeric antigen receptor T cells	Beijing Boren Hospital, Beijing, Beijing, China	https://ClinicalTrials.gov/show/NCT04340167
210	Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALL	Recruiting	No Results Available	Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP)	Drug: Inotuzumab ozogamicin (INO)	CH Amiens sud, Amiens, France|CHU Angers, Angers, France|CHU Besançon, Besançon, France|Hopital Avicenne, Bobigny, France|Hopital Duchenne, Boulogne-sur-Mer, France|CHU Caen, Caen, France|CH metropole Savois_ chambery, Chambéry, France|HIA Percy, Clamart, France|CHU Clermond Ferrand, Clermont-Ferrand, France|Hopital Mondor, Créteil, France|Hopital Dijon, Dijon, France|CHU Grenoble, Grenoble, France|CH Versailles, Le Chesnay, France|CHU Limoges, Limoges, France|Centre Leon Berard, Lyon, France|IPC, Marseille, France|CH Meaux, Meaux, France|CH Montpellier, Montpellier, France|CHU Nantes, Nantes, France|Centre Lacassagne, Nice, France|CHU Nice, Nice, France|CHR Orléans, Orléans, France|Hopital Necker, Paris, France|Hopital St Antoine, Paris, France|Hopital St Louis, Paris, France|CHU Haut Leveque, Pessac, France|CH Lyon Sud, Pierre-Bénite, France|CH Reims, Reims, France|CH Roubaix, Roubaix, France|Centre H Becquerel Rouen, Rouen, France|Institut de cancerologie, Saint-Priest-en-Jarez, France|CHU Strasbourg, Strasbourg, France|IUCT Oncopole, Toulouse, France|CH Valenciennes, Valenciennes, France|CHRU Nancy, Vandœuvre-lès-Nancy, France	https://ClinicalTrials.gov/show/NCT03249870
211	Window Trial to Evaluate Molecular Response to PI3K Inhibition With Copanlisib in r/r Adult B-cell ALL	Not yet recruiting	No Results Available	Leukemia, Acute Lymphocytic	Drug: Copanlisib	Duke Cancer Center, Durham, North Carolina, United States	https://ClinicalTrials.gov/show/NCT04803123
212	CD19-targeting CAR T Cells in Relapsed or Refractory CD19 Positive B-cell Malignancies	Recruiting	No Results Available	B-cell Malignancy|B-cell Lymphoma|B-Cell Acute Lymphoblastic Leukaemia	Biological: CD19 CAR T	Shanghai Tong Ren hospital, Shanghai, China	https://ClinicalTrials.gov/show/NCT03559439
213	GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL	Recruiting	No Results Available	B-precursor Acute Lymphoblastic Leukemia|ALL|GNR-084	Biological: GNR-084, 0.01 ng/kg|Biological: GNR-084, 0.1 ng/kg|Biological: GNR-084, 1 ng/kg|Biological: GNR-084, 4 ng/kg|Biological: GNR-084, 20 ng/kg|Biological: GNR-084, 60 ng/kg	Federal State Budget Funded Institution National Medical Research Center of Hematology, Ministry of Health of the Russian Federation (MoH of Russia), Moscow, Russian Federation|Almazov National Medical Research Centre, Saint Petersburg, Russian Federation|Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russian Federation	https://ClinicalTrials.gov/show/NCT04601584
214	Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children	Recruiting	No Results Available	Acute Lymphoblastic Leukemia, Pediatric|Acute Lymphoblastic Leukemia, in Relapse|Refractory Acute Lymphoblastic Leukemia	Biological: Murine autologous anti-CD19 chimeric antigen receptor T cells	Beijing Boren Hospital, Beijing, Beijing, China	https://ClinicalTrials.gov/show/NCT04325841
215	Blinatumomab Bridging Therapy	Recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia|Relapsed B-cell Acute Lymphoblastic Leukemia	Drug: Blinatumomab	Medical College of Wisconsin, Milwaukee, Wisconsin, United States	https://ClinicalTrials.gov/show/NCT04556084
216	Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL	Recruiting	No Results Available	T Acute Lymphoblastic Leukemia|Early T Acute Lymphoblastic Leukemia|T-lymphoblastic Lymphoma|Etp All	Other: bone marrow and/or peripheral blood samples withdrawal	Aulss 3 Serenissima, Ospedale Dell'Angelo - Mestre - Uo Ematologia, Mestre, Italy|Ematologia ed Immunologia Clinica, Perugia, Italy	https://ClinicalTrials.gov/show/NCT04582487
217	A Study of JNJ-75276617 in Participants With Acute Leukemia	Recruiting	No Results Available	Acute Leukemias|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia	Drug: JNJ-75276617	City of Hope, Duarte, California, United States|University of California Irvine Medical Center, Orange, California, United States|University of California San Francisco, San Francisco, California, United States|University of Chicago Medical Center, Chicago, Illinois, United States|Norton Cancer Institute, Louisville, Kentucky, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|NYU Langone Medical Center, New York, New York, United States|MD Anderson, Houston, Texas, United States|University of Virginia, Charlottesville, Virginia, United States|Medical College of WI at Froedtert, Milwaukee, Wisconsin, United States|Gold Coast University Hospital, Southport, Australia|Institut Paoli Calmettes, Marseille, France|CHU de Nantes hôtel-Dieu, Nantes Cedex 1, France|Centre Hospitalier Universitaire (CHU) de Bordeaux Hopital HautLeveque Centre Francois Magendie, Pessac, France|Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France|CHU Bretonneau, Tours cedex, France|Hosp. Univ. Vall D Hebron, Barcelona, Spain|Hosp. Clinic I Provincial de Barcelona, Barcelona, Spain|Hosp. Univ. Fund. Jimenez Diaz, Madrid, Spain|Clinica Univ. de Navarra, Pamplona, Spain|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|The Christie Nhs Foundation Trust, Manchester, United Kingdom|Oxford University Hospitals NHS Trust, Oxfordshire, United Kingdom	https://ClinicalTrials.gov/show/NCT04811560
218	Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|B-cell Lymphoma|Chronic Lymphocytic Leukemia	Drug: hCD19.IL15.CAR-iNKT	The Affiliated hospital of Xuzhou medical University, Xuzhou, Jiangsu, China	https://ClinicalTrials.gov/show/NCT04814004
219	Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab	Recruiting	No Results Available	Myelodysplastic Syndromes|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia	Drug: Pembrolizumab	University of Michigan Cancer Center, Ann Arbor, Michigan, United States	https://ClinicalTrials.gov/show/NCT03286114
220	Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT	Not yet recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|B-Cell ALL, Childhood	Device: Alpha/Beta T-cell and B-cell depleted HCT|Drug: Blinatumomab		https://ClinicalTrials.gov/show/NCT04746209
221	A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)	Recruiting	No Results Available	Down Syndrome|Recurrent B Acute Lymphoblastic Leukemia	Radiation: 3-Dimensional Conformal Radiation Therapy|Biological: Blinatumomab|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dexamethasone|Drug: Etoposide|Drug: Hydrocortisone Sodium Succinate|Drug: Leucovorin Calcium|Drug: Mercaptopurine|Drug: Methotrexate|Biological: Nivolumab|Drug: Pegaspargase|Drug: Thioguanine|Drug: Vincristine Sulfate	Children's Hospital of Alabama, Birmingham, Alabama, United States|USA Health Strada Patient Care Center, Mobile, Alabama, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Kingman Regional Medical Center, Kingman, Arizona, United States|Banner University Medical Center - Tucson, Tucson, Arizona, United States|Arkansas Children's Hospital, Little Rock, Arkansas, United States|Kaiser Permanente-Anaheim, Anaheim, California, United States|PCR Oncology, Arroyo Grande, California, United States|Kaiser Permanente-Bellflower, Bellflower, California, United States|Kaiser Permanente Downey Medical Center, Downey, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Kaiser Permanente-Fontana, Fontana, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Mattel Children's Hospital UCLA, Los Angeles, California, United States|Valley Children's Hospital, Madera, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Children's Hospital of Orange County, Orange, California, United States|Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|Kaiser Permanente-San Diego Zion, San Diego, California, United States|UCSF Medical Center-Mission Bay, San Francisco, California, United States|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, Colorado, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Alfred I duPont Hospital for Children, Wilmington, Delaware, United States|Children's National Medical Center, Washington, District of Columbia, United States|Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States|Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, United States|Arnold Palmer Hospital for Children, Orlando, Florida, United States|Nemours Children's Hospital, Orlando, Florida, United States|Sacred Heart Hospital, Pensacola, Florida, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States|Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida, United States|Saint Mary's Hospital, West Palm Beach, Florida, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Saint Jude Midwest Affiliate, Peoria, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Blank Children's Hospital, Des Moines, Iowa, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Maine Children's Cancer Program, Scarborough, Maine, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Tufts Children's Hospital, Boston, Massachusetts, United States|Bronson Battle Creek, Battle Creek, Michigan, United States|Michigan State University Clinical Center, East Lansing, Michigan, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|West Michigan Cancer Center, Kalamazoo, Michigan, United States|Borgess Medical Center, Kalamazoo, Michigan, United States|Mercy Health Mercy Campus, Muskegon, Michigan, United States|Lakeland Hospital Niles, Niles, Michigan, United States|Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, United States|Munson Medical Center, Traverse City, Michigan, United States|Metro Health Hospital, Wyoming, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States|Cardinal Glennon Children's Medical Center, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Children's Hospital and Medical Center of Omaha, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Carson Tahoe Regional Medical Center, Carson City, Nevada, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, United States|OptumCare Cancer Care at Seven Hills, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, United States|OptumCare Cancer Care at Charleston, Las Vegas, Nevada, United States|Hope Cancer Care of Nevada, Las Vegas, Nevada, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States|Ann M Wierman MD LTD, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, United States|OptumCare Cancer Care at MountainView, Las Vegas, Nevada, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, United States|Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Saint Mary's Regional Medical Center, Reno, Nevada, United States|Cancer Care Specialists - Reno, Reno, Nevada, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Morristown Medical Center, Morristown, New Jersey, United States|Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|Saint Joseph's Regional Medical Center, Paterson, New Jersey, United States|Albany Medical Center, Albany, New York, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|Maimonides Medical Center, Brooklyn, New York, United States|NYU Winthrop Hospital, Mineola, New York, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Children's Hospital Medical Center of Akron, Akron, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Rainbow Babies and Childrens Hospital, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Dayton Children's Hospital, Dayton, Ohio, United States|ProMedica Flower Hospital, Sylvania, Ohio, United States|ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Oregon Health and Science University, Portland, Oregon, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|BI-LO Charities Children's Cancer Center, Greenville, South Carolina, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|East Tennessee Childrens Hospital, Knoxville, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, United States|Driscoll Children's Hospital, Corpus Christi, Texas, United States|Medical City Dallas Hospital, Dallas, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|El Paso Children's Hospital, El Paso, Texas, United States|Cook Children's Medical Center, Fort Worth, Texas, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States|Children's Hospital of San Antonio, San Antonio, Texas, United States|Methodist Children's Hospital of South Texas, San Antonio, Texas, United States|Primary Children's Hospital, Salt Lake City, Utah, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, United States|Overlake Medical Center, Bellevue, Washington, United States|Valley Medical Center, Renton, Washington, United States|Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, United States|Mary Bridge Children's Hospital and Health Center, Tacoma, Washington, United States|Madigan Army Medical Center, Tacoma, Washington, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States|John Hunter Children's Hospital, Hunter Regional Mail Centre, New South Wales, Australia|Perth Children's Hospital, Perth, Western Australia, Australia|IWK Health Centre, Halifax, Nova Scotia, Canada|University Pediatric Hospital, San Juan, Puerto Rico	https://ClinicalTrials.gov/show/NCT04546399
222	Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic Leukemia	Not yet recruiting	No Results Available	Acute Leukemia	Diagnostic Test: MRI		https://ClinicalTrials.gov/show/NCT04767165
223	Bright Ideas - CIN Feasibility Study	Not yet recruiting	No Results Available	Acute Lymphoblastic Leukemia (ALL)	Behavioral: Bright Ideas - CIN Training		https://ClinicalTrials.gov/show/NCT04929899
224	Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia	Not yet recruiting	No Results Available	Acute Lymphoblastic Leukemia	Behavioral: AYA ADAPTS (ADherence Assessments and Personalized Timely Support).		https://ClinicalTrials.gov/show/NCT03932903
225	A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia	Recruiting	No Results Available	Leukemia	Drug: Ruxolitinib|Drug: Asparaginase Erwinia Chrysanthemi|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Dexamethasone|Drug: Doxorubicin|Drug: Leucovorin Calcium|Drug: Mercaptopurine|Drug: Methotrexate|Drug: Pegaspargase|Drug: Prednisone|Drug: Thioguanine|Drug: Vincristine Sulfate	Uab Dept of Pediatrics, Birmingham, Alabama, United States|Phoenix Children'S Hospital, Phoenix, Arizona, United States|Arkansas Childrens Hospital, Little Rock, Arkansas, United States|Kaiser Permanente, Fontana, California, United States|Loma Linda University Cancer Center, Loma Linda, California, United States|Miller Childrens Hospital Pharmacy, Long Beach, California, United States|Kaiser Foundation Health Plan, Los Angeles, California, United States|Valley Childrens Hospital, Madera, California, United States|Choc Children Hospital, Orange, California, United States|Lucille Packard Childrens Hospital, Palo Alto, California, United States|Kaiser Permanente, San Diego, California, United States|Rady Children'S Hospital - San Diego, San Diego, California, United States|Ucsf Medical Center Benioff, San Francisco, California, United States|Kaiser Permanente Downey, Santa Fe Springs, California, United States|Children'S Hospital Colorado, Aurora, Colorado, United States|Connecticut Children'S Medical Ctr, Hartford, Connecticut, United States|Yale New Haven Hospital, New Haven, Connecticut, United States|Alfred I Dupont Hospital For, Wilmington, Delaware, United States|Childrens Hospital of Southwest Florida, Fort Myers, Florida, United States|University of Florida Health Shands Hospital, Gainesville, Florida, United States|Joe Dimaggio Children Hospital, Hollywood, Florida, United States|Nemours Childrens Clinic, Jacksonville, Florida, United States|Florida Hospital Orlando, Orlando, Florida, United States|Arndol Palmer Hospital For Children, Orlando, Florida, United States|Nemours Childrens Clinic, Pensacola, Florida, United States|All Childrens Hospital, Saint Petersburg, Florida, United States|Healthpoint Medical Group-Hematology, Tampa, Florida, United States|St Marys Medical Center, West Palm Beach, Florida, United States|Egleston Children'S Health, Atlanta, Georgia, United States|Hawaii Pacific Health Research Insititution, Honolulu, Hawaii, United States|Ann & Robert H. Lurie Children'S Hospita, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Riley Hospital For Children At Iu Health, Indianapolis, Indiana, United States|St Vincent Hospital, Indianapolis, Indiana, United States|Blank Childrens Hospital, Des Moines, Iowa, United States|University of Iowa, Iowa City, Iowa, United States|University of Kentucky Department of Neurology, Lexington, Kentucky, United States|Norton Cancer Institute, Louisville, Kentucky, United States|Ochsner Clinic, New Orleans, Louisiana, United States|Maine Center For Cancer Medicine, Scarborough, Maine, United States|Sinai Hospital Cancer Institute, Baltimore, Maryland, United States|Johns Hopkins Medicine - the Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan Cancer Center, Ann Arbor, Michigan, United States|Grand Rapids Clinical Oncology Program, Grand Rapids, Michigan, United States|Sparrow Cancer Center Grand Rounds, Lansing, Michigan, United States|Children'S Hlth Care Mnpls, Minneapolis, Minnesota, United States|University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|The Children'S Mercy Hospital Outpatient, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Children'S Hospital & Medical Center, Omaha, Nebraska, United States|Children'S Center For Cancer & Blood Dis, Las Vegas, Nevada, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Regional Cancer Care Associates Llc (Rcca)- Morristown/Summit Medical Group, Morristown, New Jersey, United States|Rutgers Cancer Institute of Nj, New Brunswick, New Jersey, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|St. Joseph'S Medical Center, Paterson, New Jersey, United States|University of New Mexico Hospital, Albuquerque, New Mexico, United States|Albany Medical College, Albany, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Steven & Alexandra Cohen Children'S Medi, New Hyde Park, New York, United States|Columbia University Medical Center, New York, New York, United States|Weill Medical College of Cornell University, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Suny Upstate Medical University, Syracuse, New York, United States|New York Medical College, Valhalla, New York, United States|Lineberger Comprehensive Cancer Center At University of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States|Carolina Neurological Clinic, Charlotte, North Carolina, United States|Wake Forest University, Winston-Salem, North Carolina, United States|Akron Children'S Hospital, Akron, Ohio, United States|Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States|Rainbow Babies & Children Hosp, Cleveland, Ohio, United States|Cleveland Clinic Cancer Ctr R40, Cleveland, Ohio, United States|Nationwide Children'S Hospital, Columbus, Ohio, United States|Dayton Clinical Oncology Program, Dayton, Ohio, United States|Toledo Hospital, Toledo, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Emanuel Hosp & Health Center, Portland, Oregon, United States|Oregon Health & Science University, Portland, Oregon, United States|Penn State Hershey Medical Center, Hershey, Pennsylvania, United States|Children'S Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Childrens Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States|Dell Childrens Medical Center of Central Texas, Austin, Texas, United States|Driscoll Children'S Hospital, Corpus Christi, Texas, United States|Texas Oncology - Medical City Dallas, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|El Paso Children'S Hospital Corporation, El Paso, Texas, United States|Texas Childrens Hospital, Houston, Texas, United States|University of Texas Health Science Cente, San Antonio, Texas, United States|Primary Children'S Hospital, Salt Lake City, Utah, United States|Children'S Hospital of the, Norfolk, Virginia, United States|Seattle Children'S Hospital, Seattle, Washington, United States|Providence Sacred Heart Medical Center & Children'S Hospital, Spokane, Washington, United States|St Vincent Hospital, Green Bay, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Alberta'S Children Hospital, Calgary, Alberta, Canada|Bc Children'S Hospital, Vancouver, British Columbia, Canada|The Hospital For Sick Children, Toronto, Ontario, Canada|Chu Sainte-Justine, Montreal, Quebec, Canada|McGill University Health Centre/Glen Site/Cedars Cancer Centre, Montreal, Quebec, Canada|McMaster University Medical Centre, Hamilton, Canada|San Jorge Childrens Hospital, San Juan, Puerto Rico|University Pediatric Hospital, San Juan, Puerto Rico	https://ClinicalTrials.gov/show/NCT02723994
226	Quality of Life in Pediatric Patients With Acute Lymphoblastic Leukemia Receiving Maintenance Chemotherapy	Recruiting	No Results Available	Quality of Life	Behavioral: Physical Activity	Connecticut Children's Medical Center, Hartford, Connecticut, United States	https://ClinicalTrials.gov/show/NCT03132948
227	Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia	Recruiting	No Results Available	ALL, Childhood B-Cell	Genetic: alloCART-19|Drug: Cyclophosphamide|Drug: Fludarabine	Children's Hospital of Fudan University, Shanghai, Minhang, China	https://ClinicalTrials.gov/show/NCT04173988
228	Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL	Recruiting	No Results Available	ALL, Childhood|Lymphoblastic Leukemia, Acute, Childhood|Lymphoblastic Leukemia, Acute	Drug: Marqibo	Childrens Hospital Los Angeles, Los Angeles, California, United States|Children's Hospital Orange County, Orange, California, United States|UCSF School of Medicine, San Francisco, California, United States|The Children's Hospital, University of Colorado, Aurora, Colorado, United States|Children's National Medical Center, Washington, District of Columbia, United States|University of Miami, Miami, Florida, United States|All Children's Hospital, Saint Petersburg, Florida, United States|Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, United States|Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, Maryland, United States|National Cancer Institute, Pediatric Oncology Branch, Bethesda, Maryland, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|CS Mott Children's Hospital, Ann Arbor, Ann Arbor, Michigan, United States|Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, United States|Children's Hospital New York-Presbyterian, New York, New York, United States|Levine Children's Hospital, Charlotte, North Carolina, United States|Cincinnati Children's Hospital, Cincinnati, Ohio, United States|Rainbow Babies & Children's Hospital, Cleveland, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Oregon Health & Science University, Portland, Oregon, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Cook Children's Medical Center, Fort Worth, Texas, United States|Texas Children's Cancer Center, Baylor, Houston, Texas, United States|Primary Children's Hospital, Salt Lake City, Utah, United States|Seattle Children's Hospital, Seattle, Washington, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Sydney Children's Hospital, Randwick, New South Wales, Australia|The Children's Hospital at Westmead, Westmead, New South Wales, Australia|Lady Cilento Children's Hospital, South Brisbane, Queensland, Australia|Royal Children's Hospital, Melbourne, Parkville,, Victoria, Australia|British Columbia Children's Hospital, Vancouver, British Columbia, Canada|Hospital for Sick Children, Toronto, Ontario, Canada|Sainte-Justine University Hospital Center, Montréal, Québec, Canada	https://ClinicalTrials.gov/show/NCT02879643
229	CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies	Recruiting	No Results Available	B-Cell Acute Lymphoblastic Leukemia, Adult|B-cell Lymphoma Refractory|B-cell Lymphoma Recurrent	Drug: Fludarabine|Drug: Cyclophosphamide|Biological: CD19-CD34 CAR transduced T cells	Loyola University, Maywood, Illinois, United States	https://ClinicalTrials.gov/show/NCT04214886
230	Dose-escalating Trial With UniCAR02-T Cells and CD123 Target Module (TM123) in Patients With Hematologic and Lymphatic Malignancies	Recruiting	No Results Available	Acute Myeloid Leukemia (AML)|B-cell Acute Lymphoblastic Leukemia (b-ALL)|Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)	Drug: Cyclophosphamide (Non-IMP)|Drug: Fludarabine (Non-IMP)|Drug: TM123 (IMP)|Drug: UniCAR02-T (IMP)	Universitätsklinikum Ulm, Ulm, Baden-Württemberg, Germany|Universitätsklinikum Würzburg, Würzburg, Bayern, Germany|Philipps-Universität Marburg, Marburg, Hessen, Germany|Universitätsklinikum Dresden, Dresden, Sachsen, Germany|Universitätsklinikum Leipzig, Leipzig, Sachsen, Germany|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany	https://ClinicalTrials.gov/show/NCT04230265
231	ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)	Recruiting	No Results Available	Acute Lymphoblastic Leukemia	Genetic: Pharmacogenomics|Other: Busulfan plasma level measurements	Hôpital Cantonal de Genève, Département de Pédiatrie, Geneva, Cansearch Laboratory, Switzerland|Universitäts-Kinderspital beider Basel (UKBB), Onkologie/Hämatologie, Basel, Switzerland|HUG Hôpitaux Universitaire de Genève, Unité d'onco-hématologie pédiatrique, Geneva, Switzerland|Universitäts-Kinderspital, Zurich, Switzerland	https://ClinicalTrials.gov/show/NCT02670564
232	Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies	Recruiting	No Results Available	T-cell Acute Lymphoblastic Leukemia|T-cell Acute Lymphoblastic Lymphoma|Acute Myeloid Leukemia|NK Cell Lymphoma	Biological: CD7-specific CAR gene-engineered T cells	Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China	https://ClinicalTrials.gov/show/NCT04033302
233	Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies	Recruiting	No Results Available	Acute Lymphocytic Leukemia|Chronic Lymphocytic Leukemia|Non Hodgkin's Lymphoma	Drug: Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells	Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China	https://ClinicalTrials.gov/show/NCT04796675
234	A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma	Recruiting	No Results Available	Relapsed B-cell Acute Lymphoblastic Leukemia, Childhood|Refractory B-cell Acute Lymphoblastic Leukemia, Childhood|Relapsed/Refractory B-cell Lymphoma, Childhood	Biological: CAR-T19/CAR-T22	Xiangya Hospital Central South University, Changsha, Hunan, China	https://ClinicalTrials.gov/show/NCT04204161
235	Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL)	Recruiting	No Results Available	ALL	Biological: Tisagenlecleucel	Childrens Hospital Los Angeles Divisionof Hematology/Oncology, Los Angeles, California, United States|Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States|Children s Mercy Hospital, Kansas City, Missouri, United States|Cincinnati Children s Hospital Medical Center Cin. Children's Hosp Med Ctr, Cincinnati, Ohio, United States|UT Southwestern Medical Center, Dallas, Texas, United States|University of Utah Clinical Trials Office, Salt Lake City, Utah, United States	https://ClinicalTrials.gov/show/NCT04225676
236	Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|B Acute Lymphoblastic Leukemia|Lymphocytic Neoplasm|Lymphoma	Procedure: Allogeneic Bone Marrow Transplantation|Biological: Anti-Thymocyte Globulin|Drug: Bendamustine|Biological: Filgrastim-sndz|Drug: Fludarabine|Biological: Inotuzumab Ozogamicin|Drug: Melphalan|Drug: Methotrexate|Procedure: Peripheral Blood Stem Cell Transplantation|Biological: Rituximab|Drug: Tacrolimus	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03856216
237	UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL	Recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia|B-cell Non Hodgkin Lymphoma	Drug: CD19CAR-CD3Zeta-4-1BB-Expressing Allogeneic T-Lymphocyte Cells	Children's Hospital Colorado, Aurora, Colorado, United States	https://ClinicalTrials.gov/show/NCT04544592
238	The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia|Mantle Cell Lymphoma|Follicular Lymphoma	Drug: CD19-CART	Hematology Department of the Second Affiliated Hospital of Suzhou University, Suzhou, Jiangsu, China	https://ClinicalTrials.gov/show/NCT04184414
239	Safety and Efficiency of γ9δ2 T Cell Against Post-transplant Acute Leukemia/Myelodysplastic Syndrome Relapse	Recruiting	No Results Available	Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes	Drug: Ex-vivo expanded γ9δ2 T-cells infusion	Chinese PLA General Hospital, Beijing, China	https://ClinicalTrials.gov/show/NCT04764513
240	Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Blasts More Than 5 Percent of Bone Marrow Nucleated Cells|CD22 Positive|Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive	Drug: Bosutinib|Biological: Inotuzumab Ozogamicin|Other: Laboratory Biomarker Analysis	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT02311998
241	Treatment of Hematological Malignancy With Novel CAR-T Cells.	Recruiting	No Results Available	B-cell Non Hodgkin Lymphoma|B-cell Acute Lymphoblastic Leukemia|Multiple Myeloma	Biological: Novel CAR-T	Hunan Provincial People's Hospital, Changsha, Hunan, China	https://ClinicalTrials.gov/show/NCT04191941
242	Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia	Recruiting	No Results Available	Acute Myeloid Leukemia in Remission|Acute Lymphoblastic Leukemia in Remission|Myelodysplastic Syndromes	Drug: Allogeneic Stem Cell Transplantation	LKH-Univ. Klinikum Graz, Graz, Austria|Medizinische Universität Wien, Universitätsklinik für Innere Medizin I Einrichtung für Stammzelltransplantation KMT, Wien, Austria|Turku University Central Hospital, Turku, Finland|University Hospital Düsseldorf, Düsseldorf, Germany|Universitätsklinikum Essen, Essen, Germany|Universitätsklinikum Frankfurt am Main   Medizinische Klinik II, Frankfurt, Germany|Universitätsklinikum Freiburg, Freiburg, Germany|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitätsklinikum Leipzig Dep. Innere Medizin, Neurologie und Dermatologie Medizinische Klinik und Poliklinik I - Hämatologie und Zelltherapie, Hämostaseologie, Leipzig, Germany|Universitätsklinikum Münster, Münster, Germany|Universitätsklinikum Tübingen, Tübingen, Germany|ASST Papa Giovanni XXIII, Bergamo, Italy|Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russian Federation|Hospital Universitari Germans Trias I Pujol, Badalona, Spain|Hospital Clínico y Provincial de Barcelona, Barcelona, Spain|Hospital de la Santa Creu I Sant Pau, Barcelona, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Universitario y Politécnico de La Fe, Valencia, Spain	https://ClinicalTrials.gov/show/NCT04232241
243	FT819 in Subjects With B-cell Malignancies	Not yet recruiting	No Results Available	Lymphoma, B-Cell|Chronic Lymphocytic Leukemia|Precursor B-Cell Acute Lymphoblastic Leukemia	Drug: FT819|Drug: Cyclophosphamide|Drug: Fludarabine|Drug: IL-2		https://ClinicalTrials.gov/show/NCT04629729
244	Pilot Imaging Study of Leukemia	Not yet recruiting	No Results Available	Acute Lymphocytic Leukemia|Acute Myeloid Leukemia|Ambiguous Lineage Leukemia or Lymphoma|Myelodysplastic Syndrome	Drug: FLT	Children's National Health System, Washington, District of Columbia, United States|Emory University, Atlanta, Georgia, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States	https://ClinicalTrials.gov/show/NCT03633955
245	Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL	Not yet recruiting	No Results Available	Hepatic Veno-Occlusive Disease|Nephroblastoma|Acute Lymphoblastic Leukemia	Other: Blood test for genetic analysis	Univesity Hostipal of Amiens, Amiens, France|University Hospital of Bordeaux, Bordeaux, France|University of Brest, Brest, France|University Hospital of Dijon, Dijon, France|Centre Oscar Lambret, Lille, France|University Hospital of Limoges, Limoges, France|Hôpital La Timone, Marseille, France|University Hospital of Nantes, Nantes, France|University Hospital of Nice, Nice, France|Institut Curie, Paris, France|Hôpital Trousseau, Paris, France|University Hospital of Poitiers, Poitiers, France|University Hospital of Rennes, Rennes, France|University Hospital of La Réunion, Saint-Denis, France|University Hospital of Tours, Tours, France|Gustave Roussy, Villejuif, France	https://ClinicalTrials.gov/show/NCT04168788
246	Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia	Recruiting	No Results Available	Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia	Drug: Decitabine|Drug: Dexamethasone|Drug: Palbociclib|Drug: Sorafenib	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03132454
247	CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Diffuse Large B Cell Lymphoma|Primary Mediastinal Lymphoma	Biological: CD19-CAR_Lenti T cell	IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy	https://ClinicalTrials.gov/show/NCT04787263
248	Personalized Targeted Preparative Regimen Before T-depleted Allogeneic HSCT in Children With Chemoresistent Acute Leukemias	Recruiting	No Results Available	Refractory Acute Myeloid Leukemia|Refractory Acute Lymphoblastic Leukemia	Drug: Preparative regimen	Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation	https://ClinicalTrials.gov/show/NCT04000698
249	A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant	Recruiting	No Results Available	Acute Myeloid Leukemia (AML)|Acute Lymphoid Leukemia (ALL)|Myelodysplastic Syndromes (MDS)	Other: Personalized rATG (P-rATG)|Radiation: Hyper fractionated total body irradiation|Drug: Thiotepa|Drug: Cyclophosphamide|Drug: GCSF|Drug: Busulfan|Drug: Melphalan|Drug: Fludarabine	Memorial Sloan Kettering Cancer Center, New York, New York, United States	https://ClinicalTrials.gov/show/NCT04872595
250	Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients	Recruiting	No Results Available	Induction Chemotherapy|Acute T-Lymphocytic Leukemia|T-cell Lymphoblastic Lymphoma Leukemia|T-cell/Myeloid Mixed Phenotype Acute Leukemia	Drug: Decitabine combined with HAAG Regimen	The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China	https://ClinicalTrials.gov/show/NCT04446130
251	CAR-20/19-T Cells in Pediatric and Young Adult Patients With Relapsed/Refractory B Cell ALL	Recruiting	No Results Available	Acute Lymphoblastic Leukemia, in Relapse|Acute Lymphoblastic Leukemia With Failed Remission|Acute Lymphoblastic Leukemia Recurrent|Acute Lymphoblastic Leukemia Not Having Achieved Remission|Acute Lymphoblastic Leukemia, Pediatric|Acute Lymphoblastic Leukemia	Biological: CAR-20/19-T cells	Medical College of Wisconsin, Milwaukee, Wisconsin, United States	https://ClinicalTrials.gov/show/NCT04049383
252	Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Relapsed Pediatric ALL|Refractory Acute Lymphoblastic Leukemia	Biological: pCAR-19B cells	Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China	https://ClinicalTrials.gov/show/NCT04888468
253	Intraocular Pressure in Children With Acute Lymphoblastic Leukemia (ALL) Treated With High Dose Steroids	Recruiting	No Results Available	ALL, Childhood|Steroid-Induced Glaucoma	Device: Intraocular pressure measurment	Schneider Children's Medical Center of Israel, Petach Tikva, Israel	https://ClinicalTrials.gov/show/NCT04593745
254	Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia, in Relapse|Acute Lymphoblastic Leukemia, Refractory|Pediatric ALL	Biological: CD19-CAR(Mem) T-cells|Drug: Cyclophosphamide|Drug: Fludarabine|Drug: Mesna|Device: CliniMACS|Procedure: Leukapheresis	St. Jude Children's Research Hospital, Memphis, Tennessee, United States	https://ClinicalTrials.gov/show/NCT04881240
255	HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation	Not yet recruiting	No Results Available	Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Myeloproliferative Syndromes|Myelodysplastic Syndromes	Other: Haplo donor stem cell transplantation|Other: HLA 10/10 MUD stem cell transplantation		https://ClinicalTrials.gov/show/NCT03655145
256	PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT	Recruiting	No Results Available	Graft-versus-host-disease|Stem Cell Transplant Complications|Acute Myeloid Leukemia|Acute Lymphoid Leukemia	Drug: Ruxolitinib|Drug: Tacrolimus|Drug: Mycophenolate Mofetil	National Hematology Research Center, Moscow, Russian Federation|RM Gorbacheva Research Institute, Saint Petersburg, Russian Federation	https://ClinicalTrials.gov/show/NCT04669210
257	Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia	Recruiting	No Results Available	T Lymphoblastic Leukemia/Lymphoma|Mixed Phenotype Acute Leukemia|Acute Myeloid Leukemia	Biological: Humanized CD7 CAR-T cells	The First Affiliated Hospital of Soochow University, Suzhou, (Select), China	https://ClinicalTrials.gov/show/NCT04762485
258	Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma	Recruiting	No Results Available	B-cell Adult Acute Lymphoblastic Leukemia|B-cell Chronic Lymphocytic Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Hematopoietic/Lymphoid Cancer|Refractory Chronic Lymphocytic Leukemia	Biological: anti-CD19 CAR-T|Drug: Fludarabine|Drug: Cyclophosphamide	The First Affilicated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China	https://ClinicalTrials.gov/show/NCT03110640
259	Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|High Risk Myelodysplastic Syndrome|Myelodysplastic Syndrome	Drug: Cyclophosphamide|Drug: Fludarabine|Drug: Fludarabine Phosphate|Biological: Granulocyte Colony-Stimulating Factor|Procedure: Hematopoietic Cell Transplantation|Procedure: Intensity-Modulated Radiation Therapy|Drug: Mycophenolate Mofetil|Drug: Tacrolimus	City of Hope Medical Center, Duarte, California, United States	https://ClinicalTrials.gov/show/NCT04262843
260	Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies	Recruiting	No Results Available	B-Lymphoid Malignancies|Acute Lymphocytic Leukemia|Chronic Lymphocytic Leukemia|Non-hodgkin Lymphoma	Drug: Fludarabine|Drug: Cyclophosphamide|Drug: Mesna|Biological: iC9/CAR.19/IL15-Transduced CB-NK Cells|Drug: AP1903	University of Texas MD Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03056339
261	CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS&AL	Recruiting	No Results Available	Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes|Acute Leukemia	Drug: CD8+ Memory T Cell Selection|Drug: Thio Tepa|Drug: Fludarabine|Radiation: Hyperfractionated TBI	Stanford Medical Center, Stanford, California, United States	https://ClinicalTrials.gov/show/NCT04151706
262	Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide	Recruiting	No Results Available	Acute Myeloid Leukemia|Chronic Myeloid Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes	Drug: EAGD T-cell infusion (Phase I)|Drug: EAGD T-cell infusion (Expansion)	University of Kansas Cancer Center, Westwood, Kansas, United States	https://ClinicalTrials.gov/show/NCT03533816
263	Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN	Recruiting	No Results Available	Blastic Plasmacytoid Dendritic Cell Neoplasm|Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Myeloproliferative Neoplasm	Drug: IMGN632	Banner Health MD Anderson Cancer Center, Gilbert, Arizona, United States|City of Hope Medical Center, Duarte, California, United States|Moffitt Cancer Center, Tampa, Florida, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Duke Cancer Institute, Durham, North Carolina, United States|Baylor Scott & White University Medical Center, Dallas, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States|Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, Washington, United States|Recherche Clinique-Hématologie, Amiens, France|CHU de Besancon, Hopital Jean Minjoz, Besançon, France|Hôpital St Antoine, Paris, France|Instituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy|Instituto Europeo di Oncologia, Milano, Italy|Hospital Universitari I Politècnic La Fe, Valencia, Spain	https://ClinicalTrials.gov/show/NCT03386513
264	A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351	Recruiting	No Results Available	Hematologic Malignancy|Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes	Drug: CPX-351	Georgetown University Medical Center, Washington, District of Columbia, United States|Northside Hospital - Blood and Bone Marrow Transplant Group of Georgia, Atlanta, Georgia, United States|University of Kansas Cancer Center, Westwood, Kansas, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Weill Cornell Medical College, New York, New York, United States|New York Medical/Westchester, Valhalla, New York, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Oregon Health and Science University, Portland, Oregon, United States|Baylor University Medical Center, Dallas, Texas, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|West Virginia University Medicine, Morgantown, West Virginia, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Vancouver General Hospital, Vancouver, British Columbia, Canada|University Health Network/Princess Margaret Cancer Center, Toronto, Ontaro, Canada	https://ClinicalTrials.gov/show/NCT03555955
265	CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies	Recruiting	No Results Available	B Cell Lymphoma|Acute Lymphoblastic Leukemia, Pediatric|Lymphoma	Drug: Fludarabine|Drug: Cyclophosphamide|Drug: Autologous CD22 CAR T	Stanford Medical Center, Stanford, California, United States	https://ClinicalTrials.gov/show/NCT04088864
266	CAR-T Immunotherapy Targeting CD19- ALL	Recruiting	No Results Available	B-cell Leukemia	Biological: 4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR	Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China|Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China|Zhongxi Children Hospital, Shijiazhuang, Hebei, China	https://ClinicalTrials.gov/show/NCT04016129
267	Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL	Recruiting	No Results Available	Leukemia	Drug: Venetoclax|Drug: Standard Chemotherapy	Dana Farber Cancer Institute, Boston, Massachusetts, United States|MD Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03319901
268	A Study of Engineered Donor Grafts (TregGraft/Orca-T) in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies	Recruiting	No Results Available	Acute Myeloid Leukemia|Acute Lymphoid Leukemia|Myelodysplastic Syndromes|Acute Leukemia	Biological: TregGraft (Orca-T)	Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|UC Davis, Sacramento, California, United States|Stanford Health Care, Stanford, California, United States|The University of Kansas Hospital, Kansas City, Kansas, United States|Oregon Health & Sciences University - Knight Cancer Institute, Portland, Oregon, United States|Sarah Cannon Research Institute, Nashville, Tennessee, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT04013685
269	4SCAR-T Therapy Post CD19-targeted Immunotherapy	Recruiting	No Results Available	CD19 Negative B-cell Malignancies	Biological: Infusion of 4SCAR-T specific to CD22/CD123/CD38/ CD10/CD20	Shenzhen Children's Hospital, Shenzhen, Guangdong, China|The Seventh Affilliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, China|Shijiazhuang Zhongxi Children Hospital, Shijiazhuang, Hebei, China	https://ClinicalTrials.gov/show/NCT04430530
270	Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant	Recruiting	No Results Available	Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Hematologic Malignancy	Drug: Fludarabine Phosphate|Drug: Melphalan|Radiation: Intensity-Modulated Radiation Therapy|Radiation: Total Marrow Irradiation|Procedure: Allogeneic Hematopoietic Stem Cell Transplantation|Procedure: Peripheral Blood Stem Cell Transplantation|Procedure: Allogeneic Bone Marrow Transplantation|Drug: Tacrolimus|Drug: Mycophenolate Mofetil|Other: Laboratory Biomarker Analysis	University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States	https://ClinicalTrials.gov/show/NCT02333162
271	Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for CD19-positive ALL	Recruiting	No Results Available	CD19-positive ALL	Biological: anti-CD19/CD22 CAR-T cells|Drug: Fludarabine|Drug: Cyclophosphamide	Henan Province of TCM, Zhengzhou, Henan, China	https://ClinicalTrials.gov/show/NCT04303520
272	A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation	Recruiting	No Results Available	Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Mixed Lineage Acute Leukemia|Mixed Phenotype Acute Leukemia|Acute Leukemia of Ambiguous Lineage	Drug: SNDX-5613|Drug: cobicistat	City of Hope Comprehensive Cancer Center, Duarte, California, United States|Florida Cancer Specialists and Research Institute, Sarasota, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Emory Winship Cancer Institute, Atlanta, Georgia, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Washington University in St. Louis School of Medicine, Saint Louis, Missouri, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Montefiore Medical Center, New York, New York, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT04065399
273	Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment Refractory/Intolerant CML Failing ≥3 Prior CML Therapies	Recruiting	No Results Available	Healthy (For Part A)|Chronic Myeloid Leukemia (for Part B and C)	Drug: Vodobatinib (K0706) capsules	The Oncology Institute of Hope and Innovation, Innovative Clinical Research Institute, Downey, California, United States|UCLA Hematologic Malignancy Program, Los Angeles, California, United States|University of Southern California, Los Angeles, California, United States|Board of Regents of the University System of Georgia, Augusta, Georgia, United States|IU Simon Cancer Center, Indianapolis, Indiana, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Memorial Sloan Kettering Cancer Center - MAIN, New York, New York, United States|New York Medical College, Valhalla, New York, United States|East Carolina University, Greenville, North Carolina, United States|Baylor University Medical Center, Dallas, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States|Huntsman Cancer Institute University of Utah, Salt Lake City, Utah, United States|ZNA Stuivenberg, Antwerpen, Belgium|Cliniques Universitaires Saint-Luc, Bruxelles, Belgium|UZ Leuven, Leuven, Belgium|Institut Paoli Calmettes, Marseille Cedex 9, Bouches-du-Rhône, France|Institut Bergonié, Bordeaux cedex, Gironde, France|CHU de Limoges - Hôpital Dupuytren, Limoges cedex, Haute Vienne, France|CHU Rennes - Hopital Pontchaillou, Rennes cedex 9, Ille Et Vilaine, France|CHU de Nantes - Hotel Dieu, Nantes cedex 1, Loire Atlantique, France|CHU Angers - Hôpital Hôtel Dieu, Angers, Maine Et Loire, France|CHU de Nancy - Hôpital de Brabois Adultes, Vandœuvre-lès-Nancy, Meurthe Et Moselle, France|Hopital Claude Huriez - CHRU Lille, Lille cedex, Nord, France|Hôpital Saint-Louis, Paris cedex 10, Paris, France|Centre Léon Bérard, Lyon Cedex 08, Rhone, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, Rhone, France|Hôpital Avicenne, Bobigny cedex, Seine Saint Denis, France|CHU Amiens - Hopital Sud, Salouel, Somme, France|CHU Poitiers - Hôpital la Milétrie, Poitiers, Vienne, France|Semmelweis Egyetem, Budapest, Hungary|Debreceni Egyetem, Debrecen, Hungary|SzSzB Megyei Korhazak es Egyetemi Oktatokorhaz, Nyiregyhaza, Hungary|Pecsi Tudomanyegyetem, Pecs, Hungary|Prince Aly Khan Hospital, Mumbai, Maharashtra, India|Tata Memorial Hospital, Mumbai, Maharashtra, India|Sahyadri Specialty Hospital, Pune, Maharashtra, India|Meenakshi Mission Hospital & Research Centre, Madurai, Tamilnadu, India|Chittaranjan National Cancer Institute, Kolkata, West Bengal, India|Tata Medical Centre, Kolkata, West Bengal, India|Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori, Meldola, Forli - Cesena, Italy|Azienda Socio Sanitaria Territoriale di Monza (Presidio San Gerardo), Monza, Milano, Italy|Azienda Ospedaliera Universitaria "Policlinico - Vittorio Emanuele" (Presidio Ferrarotto Alessi), Catania, Italy|Azienda Ospedaliera Universitaria Careggi, Firenze, Italy|Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milano, Italy|Azienda Socio Sanitaria Territoriale Niguarda (Grande Ospedale Metropolitano Niguarda), Milano, Italy|Ospedale Sant'Eugenio, Roma, Italy|Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza, Roma, Italy|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Gyeonggi-do, Korea, Republic of|Spitalul Clinic Colentina, Bucuresti, Romania|Spitalul Clinic Coltea, Bucuresti, Romania|Institutul Oncologic "Prof. Dr. Ion Chiricuta" Cluj-Napoca, Cluj-Napoca, Romania|Spitalul Clinic Municipal Filantropia Craiova, Craiova, Romania|Spitalul Clinic Judetean de Urgenta Targu Mures, Târgu Mureș, Romania|Singapore General Hospital, Singapore, Singapore|ICO Badalona - Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|ICO Girona - Hospital Universitari de Girona Dr Josep Trueta, Girona, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Clinico Universitario Virgen de la Victoria, Málaga, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Hospital Universitario Virgen del Rocio, Sevilla, Spain|King's College Hospital, London, Greater London, United Kingdom|Hammersmith Hospital, London, Greater London, United Kingdom	https://ClinicalTrials.gov/show/NCT02629692
274	Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia	Recruiting	No Results Available	Acute Lymphoblastic Leukemia Recurrent|Acute Lymphoblastic Leukemia, in Relapse|Acute Myeloid Leukemia, in Relapse|Acute Myeloid Leukaemia Recurrent|Mixed Phenotype Acute Leukemia	Drug: INA03 administration	Institut Paoli-Calmettes, Marseille, Bouches-du Rhône, France|IUCT, Toulouse, France	https://ClinicalTrials.gov/show/NCT03957915
275	PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies	Recruiting	No Results Available	Acute Myelogenous Leukemia|B-cell Acute Lymphoblastic Leukemia|Blastic Plasmacytoid Dendritic Cell Neoplasm|Chronic Myeloid Leukemia, Blast Crisis	Biological: XmAb14045	Mayo Clinic Jacksonville, Jacksonville, Florida, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Winship Cancer Institute, Emory University, Atlanta, Georgia, United States|Blood and Marrow Transplant Group of Georgia, Atlanta, Georgia, United States|Northside Hospital, Atlanta, Georgia, United States|The University of Chicago Medical Center, Chicago, Illinois, United States|Wexner Medical Center at The Ohio State University, Columbus, Ohio, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States|Swedish Cancer Institute, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT02730312
276	Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia	Recruiting	No Results Available	Relapsed Pediatric ALL|Relapsed Pediatric AML|Refractory Acute Myeloid Leukemia|Refractory Acute Lymphoblastic Leukemia	Drug: Daunorubicin	Children's Mercy Hospital, Kansas City, Missouri, United States	https://ClinicalTrials.gov/show/NCT04562792
277	MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies	Recruiting	No Results Available	Related Donors Donating PBSC to a Family Member|Healthy Donors|Acute Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndrome	Biological: MGTA-145|Biological: Plerixafor	City of Hope National Medical Center, Duarte, California, United States|Stanford Health Care, Stanford, California, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Mayo Clinic Rochester, Rochester, Minnesota, United States|Washington University/St. Louis Children's Hospital, Saint Louis, Missouri, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|Ohio State Medical Center, James Cancer Center, Columbus, Ohio, United States|M.D. Anderson Cancer Center, Houston, Texas, United States|Be The Match Collection Center Seattle, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT04762875
278	Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide	Recruiting	No Results Available	Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Myelodysplastic Syndrome|Non-hodgkin Lymphoma|Chronic Lymphocytic Leukemia	Drug: Cyclophosphamide|Drug: Tacrolimus|Drug: Mycophenolate mofetil|Other: Haploidentical Stem Cell Transplantation	Loyola University Medical Center, Maywood, Illinois, United States	https://ClinicalTrials.gov/show/NCT03088709
279	Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia|B Lymphoblastic Lymphoma|Central Nervous System Leukemia|Mixed Phenotype Acute Leukemia|Testicular Leukemia	Drug: Calaspargase Pegol-mknl|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Daunorubicin Hydrochloride|Drug: Dexamethasone|Drug: Doxorubicin Hydrochloride|Biological: Inotuzumab Ozogamicin|Drug: Leucovorin Calcium|Drug: Mercaptopurine|Drug: Methotrexate|Drug: Pegaspargase|Drug: Prednisolone|Other: Questionnaire Administration|Radiation: Radiation Therapy|Drug: Thioguanine|Drug: Vincristine Sulfate	Children's Hospital of Alabama, Birmingham, Alabama, United States|USA Health Strada Patient Care Center, Mobile, Alabama, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Banner Children's at Desert, Mesa, Arizona, United States|Phoenix Childrens Hospital, Phoenix, Arizona, United States|Banner University Medical Center - Tucson, Tucson, Arizona, United States|Arkansas Children's Hospital, Little Rock, Arkansas, United States|Kaiser Permanente Downey Medical Center, Downey, California, United States|City of Hope Comprehensive Cancer Center, Duarte, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Miller Children's and Women's Hospital Long Beach, Long Beach, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Mattel Children's Hospital UCLA, Los Angeles, California, United States|Valley Children's Hospital, Madera, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Children's Hospital of Orange County, Orange, California, United States|Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Rady Children's Hospital - San Diego, San Diego, California, United States|Naval Medical Center -San Diego, San Diego, California, United States|UCSF Medical Center-Mission Bay, San Francisco, California, United States|Santa Barbara Cottage Hospital, Santa Barbara, California, United States|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, Colorado, United States|Connecticut Children's Medical Center, Hartford, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Alfred I duPont Hospital for Children, Wilmington, Delaware, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Children's National Medical Center, Washington, District of Columbia, United States|Broward Health Medical Center, Fort Lauderdale, Florida, United States|Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States|Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, United States|Palms West Radiation Therapy, Loxahatchee Groves, Florida, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States|Nicklaus Children's Hospital, Miami, Florida, United States|Miami Cancer Institute, Miami, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Arnold Palmer Hospital for Children, Orlando, Florida, United States|Nemours Children's Hospital, Orlando, Florida, United States|Sacred Heart Hospital, Pensacola, Florida, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida, United States|Saint Mary's Hospital, West Palm Beach, Florida, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States|Augusta University Medical Center, Augusta, Georgia, United States|Medical Center of Central Georgia, Macon, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, United States|University of Illinois, Chicago, Illinois, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Advocate Children's Hospital-Oak Lawn, Oak Lawn, Illinois, United States|Advocate Children's Hospital-Park Ridge, Park Ridge, Illinois, United States|Saint Jude Midwest Affiliate, Peoria, Illinois, United States|Southern Illinois University School of Medicine, Springfield, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|Saint Vincent Hospital and Health Care Center, Indianapolis, Indiana, United States|Blank Children's Hospital, Des Moines, Iowa, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States|Norton Children's Hospital, Louisville, Kentucky, United States|Children's Hospital New Orleans, New Orleans, Louisiana, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States|Eastern Maine Medical Center, Bangor, Maine, United States|Maine Children's Cancer Program, Scarborough, Maine, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Tufts Children's Hospital, Boston, Massachusetts, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|UMass Memorial Medical Center - University Campus, Worcester, Massachusetts, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, United States|Ascension Saint John Hospital, Detroit, Michigan, United States|Michigan State University Clinical Center, East Lansing, Michigan, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|Beaumont Children's Hospital-Royal Oak, Royal Oak, Michigan, United States|Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Columbia Regional, Columbia, Missouri, United States|Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States|Cardinal Glennon Children's Medical Center, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, United States|Children's Hospital and Medical Center of Omaha, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|Renown Regional Medical Center, Reno, Nevada, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Morristown Medical Center, Morristown, New Jersey, United States|Saint Peter's University Hospital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Newark Beth Israel Medical Center, Newark, New Jersey, United States|Saint Joseph's Regional Medical Center, Paterson, New Jersey, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, United States|Presbyterian Hospital, Albuquerque, New Mexico, United States|Albany Medical Center, Albany, New York, United States|Montefiore Medical Center - Moses Campus, Bronx, New York, United States|Maimonides Medical Center, Brooklyn, New York, United States|Roswell Park Cancer Institute, Buffalo, New York, United States|NYU Winthrop Hospital, Mineola, New York, United States|The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States|Mount Sinai Hospital, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|NYP/Weill Cornell Medical Center, New York, New York, United States|University of Rochester, Rochester, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|State University of New York Upstate Medical University, Syracuse, New York, United States|New York Medical College, Valhalla, New York, United States|Mission Hospital, Asheville, North Carolina, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States|Novant Health Presbyterian Medical Center, Charlotte, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Sanford Broadway Medical Center, Fargo, North Dakota, United States|Children's Hospital Medical Center of Akron, Akron, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Rainbow Babies and Childrens Hospital, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Dayton Children's Hospital, Dayton, Ohio, United States|ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Natalie Warren Bryant Cancer Center at Saint Francis, Tulsa, Oklahoma, United States|Legacy Emanuel Children's Hospital, Portland, Oregon, United States|Oregon Health and Science University, Portland, Oregon, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Penn State Children's Hospital, Hershey, Pennsylvania, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|BI-LO Charities Children's Cancer Center, Greenville, South Carolina, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States|T C Thompson Children's Hospital, Chattanooga, Tennessee, United States|East Tennessee Childrens Hospital, Knoxville, Tennessee, United States|The Children's Hospital at TriStar Centennial, Nashville, Tennessee, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, United States|Driscoll Children's Hospital, Corpus Christi, Texas, United States|Medical City Dallas Hospital, Dallas, Texas, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States|El Paso Children's Hospital, El Paso, Texas, United States|Cook Children's Medical Center, Fort Worth, Texas, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|Covenant Children's Hospital, Lubbock, Texas, United States|UMC Cancer Center / UMC Health System, Lubbock, Texas, United States|Vannie Cook Children's Clinic, McAllen, Texas, United States|Children's Hospital of San Antonio, San Antonio, Texas, United States|Methodist Children's Hospital of South Texas, San Antonio, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Scott and White Memorial Hospital, Temple, Texas, United States|Primary Children's Hospital, Salt Lake City, Utah, United States|University of Vermont and State Agricultural College, Burlington, Vermont, United States|University of Virginia Cancer Center, Charlottesville, Virginia, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, United States|Naval Medical Center - Portsmouth, Portsmouth, Virginia, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, United States|Carilion Children's, Roanoke, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, United States|Mary Bridge Children's Hospital and Health Center, Tacoma, Washington, United States|Madigan Army Medical Center, Tacoma, Washington, United States|West Virginia University Charleston Division, Charleston, West Virginia, United States|West Virginia University Healthcare, Morgantown, West Virginia, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States|John Hunter Children's Hospital, Hunter Regional Mail Centre, New South Wales, Australia|Queensland Children's Hospital, South Brisbane, Queensland, Australia|Women's and Children's Hospital-Adelaide, North Adelaide, South Australia, Australia|Monash Medical Center-Clayton Campus, Clayton, Victoria, Australia|Perth Children's Hospital, Perth, Western Australia, Australia|Alberta Children's Hospital, Calgary, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|British Columbia Children's Hospital, Vancouver, British Columbia, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|Janeway Child Health Centre, Saint John's, Newfoundland and Labrador, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario, Canada|Kingston Health Sciences Centre, Kingston, Ontario, Canada|Children's Hospital, London, Ontario, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|Hospital for Sick Children, Toronto, Ontario, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada|Starship Children's Hospital, Grafton, Auckland, New Zealand|Christchurch Hospital, Christchurch, New Zealand|University Pediatric Hospital, San Juan, Puerto Rico	https://ClinicalTrials.gov/show/NCT03959085
280	Romidepsin Maintenance After Allogeneic Stem Cell Transplantation	Recruiting	No Results Available	Cutaneous T-cell Lymphoma|T-Prolymphocytic Leukemia|T-Large Granulocytic Leukemia|T-Lymphoblastic Leukemia/Lymphoma|Peripheral T-Cell Lymphoma	Drug: Romidepsin|Drug: Busulfan|Drug: Fludarabine|Procedure: Stem Cell Transplant|Drug: Thymoglobulin	The Ohio State University Cancer Center, Columbus, Ohio, United States	https://ClinicalTrials.gov/show/NCT02512497
281	γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)	Recruiting	No Results Available	Non-Hodgkin's Lymphoma|Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma|Chronic Lymphoblastic Leukemia|Peripheral T Cell Lymphoma	Biological: Autologous γδT cells	Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin, China	https://ClinicalTrials.gov/show/NCT04028440
282	Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies	Recruiting	No Results Available	Peripheral T Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Anaplastic Lymphoma|Acute T Cell Leukemia|T-lymphoblastic Lymphoma	Drug: anti-TRBC1 CAR-T cell therapy	Xianmin Song, Shanghai, Shanghai, China	https://ClinicalTrials.gov/show/NCT04828174
283	Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia	Recruiting	No Results Available	Acute Biphenotypic Leukemia|Acute Leukemia of Ambiguous Lineage|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Acute Undifferentiated Leukemia|Blastic Plasmacytoid Dendritic Cell Neoplasm|Lymphoblastic Lymphoma|Mixed Phenotype Acute Leukemia|Acute Leukemia|Hematopoietic and Lymphoid Cell Neoplasm	Radiation: Total-Body Irradiation|Drug: Thiotepa|Drug: Fludarabine|Drug: Tacrolimus|Biological: Allogeneic CD34+-enriched and CD45RA-depleted PBSCs|Drug: Methotrexate|Drug: Cyclophosphamide|Biological: Peripheral Blood Stem Cell|Drug: Cyclosporine|Drug: Sirolimus	Moffitt Cancer Center, Tampa, Florida, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States|Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT03970096
284	Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases	Recruiting	No Results Available	Acute Myeloid Leukemia (AML)|Acute Lymphocytic Leukemia (ALL)|Chronic Myelogenous Leukemia|Plasma Cell Leukemia|Myelofibrosis|Myelodysplasia|Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|Marginal Zone B-Cell Lymphoma|Follicular Lymphoma|Lymphoplasmacytic Lymphoma|Mantle-Cell Lymphoma|Prolymphocytic Leukemia|Diffuse Large B Cell Lymphoma|Lymphoblastic Lymphoma|Burkitt's Lymphoma|Non-Hodgkin Lymphoma|Multiple Myeloma	Drug: Fludarabine|Drug: Cyclophosphamide|Radiation: Total Body Irradiation|Drug: Cyclosporine A|Drug: Mycophenylate mofetil|Biological: Umbilical cord blood	University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota, United States	https://ClinicalTrials.gov/show/NCT01962636
285	Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL	Recruiting	No Results Available	B-ALL	Drug: CD19/CD22 CAR-T	Federal Research Institute of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation	https://ClinicalTrials.gov/show/NCT04499573
286	MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)	Recruiting	No Results Available	Acute Lymphoblastic Leukemia Recurrent|B-cell Lymphoma Recurrent|B-cell Lymphoma Refractory|Chronic Lymphocytic Leukemia Recurrent|Chronic Lymphocytic Leukemia Refractory	Biological: MB-CART19.1	Universitätsklinikum Erlangen, Erlangen, Germany|Universitätsklinikum Münster - Klink für Kinderheilkunde und Jugendmedizin / Pädiatrische Hämatologie und Onkologie, Münster, Germany|Universitätsklinikum Münster - Medizinische Klinik A / KMT Zentrum, Münster, Germany	https://ClinicalTrials.gov/show/NCT03853616
287	Evaluation of Brain Changes in ALL Patients on Therapy	Not yet recruiting	No Results Available	Acute Leukemia	Diagnostic Test: MRI		https://ClinicalTrials.gov/show/NCT04767152
288	Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study	Recruiting	No Results Available	Philadelphia-Negative ALL|High-Risk Cancer	Drug: Blinatumomab	Rambam Medical Center, Haifa, Israel|Shaarei Tzedek Medical Center, Jerusalem, Israel|Rabin Medical Center, Petah Tikva, Israel|Tel Aviv Medical Center, Tel Aviv, Israel	https://ClinicalTrials.gov/show/NCT04334993
289	Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation	Recruiting	No Results Available	Acute Myelogenous Leukemia|Acute Lymphocytic Leukemia|Myelodysplastic Syndromes|Non-Hodgkin Lymphoma|Hodgkin Disease	Procedure: Stem cell transplantation|Drug: Itacitinib|Other: Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT)|Other: Human Activity Profile	Washington University School of Medicine, Saint Louis, Missouri, United States	https://ClinicalTrials.gov/show/NCT03755414
290	Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies	Recruiting	No Results Available	Recurrent Acute Leukemia|Recurrent B Acute Lymphoblastic Leukemia|Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hairy Cell Leukemia|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent T Acute Lymphoblastic Leukemia|Refractory Acute Leukemia|Refractory B Acute Lymphoblastic Leukemia|Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Hairy Cell Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory T Acute Lymphoblastic Leukemia|Systemic Mastocytosis	Drug: Acetaminophen|Drug: Dexamethasone|Drug: Diphenhydramine|Biological: Flotetuzumab|Drug: Ibuprofen|Drug: Ranitidine	City of Hope Medical Center, Duarte, California, United States	https://ClinicalTrials.gov/show/NCT04681105
291	Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR	Recruiting	No Results Available	Acute Lymphoblastic Leukemia, Adult|Acute Lymphoblastic Leukemia, Pediatric|Chronic Lymphocytic Leukemia|Diffuse Large B Cell Lymphoma|Follicular Lymphoma|Mantle Cell Lymphoma	Biological: CD19.CAR T Cells|Drug: Fludarabine|Drug: Cyclophosphamide	University Hospital Heidelberg, Heidelberg, Germany|University Hospital Heidelberg, Heidelberg, Germany	https://ClinicalTrials.gov/show/NCT03676504
292	HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant	Recruiting	No Results Available	Juvenile Myelomonocytic Leukemia|Recurrent Acute Biphenotypic Leukemia|Recurrent Acute Undifferentiated Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Refractory Acute Lymphoblastic Leukemia|Refractory Adult Acute Lymphoblastic Leukemia|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm|Recurrent Myelodysplastic Syndrome|Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm|Refractory Myelodysplastic Syndrome|Acute Undifferentiated Leukemia|Mixed Phenotype Acute Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Myelodysplastic Syndrome|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Acute Biphenotypic Leukemia|Chronic Myeloid Leukemia|Chronic Myelomonocytic Leukemia|Minimal Residual Disease|Recurrent Chronic Myelomonocytic Leukemia|Recurrent Mixed Phenotype Acute Leukemia|Leukemia	Biological: CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR|Drug: Fludarabine|Other: Laboratory Biomarker Analysis	Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT03326921
293	Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma	Recruiting	No Results Available	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Biphenotypic Leukemia|Acute Lymphoblastic Leukemia|Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia With Myelodysplasia-Related Changes|Acute Myeloid Leukemia With Variant MLL Translocations|B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Chemotherapy-Related Leukemia|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|ISS Stage II Plasma Cell Myeloma|ISS Stage III Plasma Cell Myeloma|Myelodysplastic Syndrome|Myelodysplastic Syndrome With Excess Blasts|Myelodysplastic Syndrome With Gene Mutation|Myelodysplastic/Myeloproliferative Neoplasm|Previously Treated Myelodysplastic Syndrome|Recurrent Acute Myeloid Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Hodgkin Lymphoma|Recurrent Non-Hodgkin Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Adult Acute Lymphoblastic Leukemia|Secondary Acute Myeloid Leukemia|Therapy-Related Myelodysplastic Syndrome	Biological: Allogeneic Natural Killer Cell Line NK-92|Biological: Anti-Thymocyte Globulin|Drug: Busulfan|Drug: Clofarabine|Drug: Cyclophosphamide|Drug: Fludarabine Phosphate|Other: Laboratory Biomarker Analysis|Drug: Melphalan|Biological: Rituximab|Radiation: Total-Body Irradiation|Procedure: Umbilical Cord Blood Transplantation	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT02727803
294	A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in the Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors	Recruiting	No Results Available	Acute Myeloid Leukemia (AML)|Acute Lymphoblastic Leukemia (ALL)|Neuroblastoma|Solid Tumors	Drug: Idasanutlin|Drug: Venetoclax|Drug: Cyclophosphamide|Drug: Topotecan|Drug: Fludarabine|Drug: Cytarabine|Drug: Intrathecal Chemotherapy	Phoenix Children's Hospital, Phoenix, Arizona, United States|Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States|Lucile Packard Children's Hospital at Stanford University; Thoracic Oncology, Palo Alto, California, United States|Arnold Palmer Hosp-Children, Orlando, Florida, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Penn State Hershey Children's Hospital, Hershey, Pennsylvania, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Huntsman Cancer Institute at The University of Utah, Salt Lake City, Utah, United States|Alberta Children'S Hospital, Calgary, Alberta, Canada|Centre Leon Berard, Lyon CEDEX 08, France|Institut Curie, Paris, France|CHU de Brabois, Vandoeuvre Les Nancy, France|Gustave Roussy, Villejuif CEDEX, France|Prinses Maxima Centrum, Utrecht, Netherlands|Hospital Sant Joan De Deu, Esplugues De Llobregas, Barcelona, Spain|Hospital Infantil Universitario Nino Jesus, Madrid, Spain|Birmingham Children's Hospital, Birmingham, United Kingdom|The Royal Victoria Infirmary; Paediatric and Adolescent Oncology Unit, Newcastle Upon Tyne, United Kingdom|Royal Marsden Hospital; Pediatric Unit, Surrey, United Kingdom	https://ClinicalTrials.gov/show/NCT04029688
295	PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN)	Recruiting	No Results Available	Neurofibroma, Plexiform|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Leukemia, Prolymphocytic, Acute|Sarcoma	Drug: PLX3397	National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States	https://ClinicalTrials.gov/show/NCT02390752
296	Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML	Recruiting	No Results Available	Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia	Drug: etoposide|Drug: cyclophosphamide|Radiation: total marrow irradiation|Procedure: allogeneic hematopoietic stem cell transplantation|Procedure: allogeneic bone marrow transplantation	City of Hope Medical Center, Duarte, California, United States	https://ClinicalTrials.gov/show/NCT02094794
297	Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT	Recruiting	No Results Available	Acute Myeloid Leukemia|Acute Lymphoid Leukemia|Myeloproliferative Disorders|Lymphoma|Multiple Myeloma|Other Hematologic Malignant Neoplasms	Biological: High dose irradiation conditioning + Treg/Tcon	University of Perugia, Perugia, PG, Italy	https://ClinicalTrials.gov/show/NCT03977103
298	Induced-T Cell Like NK Cells for B Cell Malignancies	Recruiting	No Results Available	B Cell Leukemia|B Cell Lymphoma|B-cell Acute Lymphoblastic Leukemia|B-cell Lymphoma Recurrent|B-cell Lymphoma Refractory	Biological: CAR-ITNK cells	Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China	https://ClinicalTrials.gov/show/NCT04747093
299	211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome	Recruiting	No Results Available	Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Acute Myeloid Leukemia in Remission|Chronic Myelomonocytic Leukemia|Myelodysplastic Syndrome With Excess Blasts|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Recurrent Mixed Phenotype Acute Leukemia|Refractory Mixed Phenotype Acute Leukemia	Biological: Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10|Drug: Cyclophosphamide|Radiation: Total-Body Irradiation|Procedure: Peripheral Blood Stem Cell Transplantation|Procedure: Bone Marrow Transplantation|Drug: Mycophenolate Mofetil|Biological: Recombinant Granulocyte Colony-Stimulating Factor|Drug: Fludarabine Phosphate|Drug: Tacrolimus	Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT03670966
300	Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting	Recruiting	No Results Available	Acute Bilineal Leukemia|Acute Biphenotypic Leukemia|Acute Myeloid Leukemia|Mixed Phenotype Acute Leukemia|T Acute Lymphoblastic Leukemia|Therapy-Related Acute Myeloid Leukemia	Drug: Azacitidine|Drug: Venetoclax	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT04128501
301	Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma	Recruiting	No Results Available	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Biphenotypic Leukemia|Acute Leukemia|Acute Lymphoblastic Leukemia|Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Chemotherapy-Related Leukemia|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Myelomonocytic Leukemia|Hodgkin Lymphoma|Langerhans Cell Histiocytosis|Minimal Residual Disease|Myelodysplastic Syndrome|Myelodysplastic Syndrome With Excess Blasts|Non-Hodgkin Lymphoma|Recurrent Hodgkin Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Myelodysplastic Syndrome|Small Lymphocytic Lymphoma|Therapy-Related Myelodysplastic Syndrome	Biological: Anti-Thymocyte Globulin|Drug: Busulfan|Drug: Clofarabine|Drug: Cyclophosphamide|Biological: Filgrastim-sndz|Drug: Fludarabine|Drug: Melphalan|Drug: Mycophenolate Mofetil|Biological: Rituximab|Drug: Tacrolimus|Radiation: Total-Body Irradiation|Procedure: Umbilical Cord Blood Transplantation	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03096782
302	Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies	Recruiting	No Results Available	Acute Biphenotypic Leukemia|Acute Erythroid Leukemia in Remission|Acute Leukemia in Remission|Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Acute Myeloid Leukemia in Remission|Acute Myeloid Leukemia With FLT3/ITD Mutation|Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM|Acute Myeloid Leukemia With Multilineage Dysplasia|Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214|Acute Undifferentiated Leukemia|Adult Acute Lymphoblastic Leukemia in Complete Remission|B Acute Lymphoblastic Leukemia With t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)|B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Burkitt Lymphoma|Childhood Acute Lymphoblastic Leukemia in Complete Remission|DS Stage II Plasma Cell Myeloma|DS Stage III Plasma Cell Myeloma|Myelodysplastic Syndrome|Recurrent Anaplastic Large Cell Lymphoma|Blasts Under 5 Percent of Bone Marrow Nucleated Cells|Recurrent Follicular Lymphoma|Recurrent Hodgkin Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma|Secondary Acute Myeloid Leukemia|T Lymphoblastic Lymphoma|Hematopoietic Cell Transplant Recipient	Drug: Cyclophosphamide|Biological: Filgrastim|Drug: Fludarabine Phosphate|Procedure: Laboratory Biomarker Analysis|Drug: Mycophenolate Mofetil|Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation|Procedure: Peripheral Blood Stem Cell Transplantation|Drug: Tacrolimus|Radiation: Total-Body Irradiation|Drug: Fludarabine	VA Puget Sound Health Care System, Seattle, Washington, United States|Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT01028716
303	Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies	Recruiting	No Results Available	Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK/T-cell Lymphoma|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|de Novo Myelodysplastic Syndromes|Essential Thrombocythemia|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Juvenile Myelomonocytic Leukemia|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Polycythemia Vera|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Primary Myelofibrosis|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent/Refractory Childhood Hodgkin Lymphoma|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation|Refractory Cytopenia With Multilineage Dysplasia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|T-cell Large Granular Lymphocyte Leukemia|Testicular Lymphoma|Waldenström Macroglobulinemia	Drug: Fludarabine phosphate|Drug: Thiotepa|Radiation: Total body irradiation|Biological: Therapeutic allogeneic lymphocytes|Drug: Cyclophosphamide|Procedure: Allogeneic hematopoietic stem cell transplantation (HSCT)|Procedure: Peripheral blood stem cell transplantation|Drug: Tacrolimus|Drug: Mycophenolate mofetil	Thomas Jefferson University, Philadelphia, Pennsylvania, United States	https://ClinicalTrials.gov/show/NCT01760655
304	Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia|Acute Myeloid Leukemia in Remission|Hematopoietic Cell Transplantation Recipient|Minimal Residual Disease|Myelodysplastic Syndrome|Secondary Acute Myeloid Leukemia	Drug: Fludarabine|Other: Laboratory Biomarker Analysis|Drug: Melphalan|Radiation: Total Marrow Irradiation	City of Hope Medical Center, Duarte, California, United States	https://ClinicalTrials.gov/show/NCT03494569
305	Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation	Recruiting	No Results Available	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Chronic Lymphocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid Cell Neoplasm|Hodgkin Lymphoma|Lymphoblastic Lymphoma|Myelodysplastic Syndrome|Myelofibrosis|Myeloproliferative Neoplasm|Non-Hodgkin Lymphoma	Drug: Letermovir|Biological: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine|Other: Placebo Administration	City of Hope Medical Center, Duarte, California, United States	https://ClinicalTrials.gov/show/NCT04060277
306	Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies	Recruiting	No Results Available	Acute Leukemia|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Adult Diffuse Large Cell Lymphoma|Anaplastic Large Cell Lymphoma|Burkitt Lymphoma|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Myelomonocytic Leukemia|Hodgkin Lymphoma|Lymphoblastic Lymphoma|Lymphoplasmacytic Lymphoma|Mantle Cell Lymphoma|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome|Prolymphocytic Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Follicular Lymphoma|Refractory Marginal Zone Lymphoma|Refractory Small Lymphocytic Lymphoma	Procedure: Allogeneic Hematopoietic Stem Cell Transplantation|Drug: Cyclophosphamide|Drug: Cyclosporine|Biological: Filgrastim|Drug: Fludarabine|Drug: Mycophenolate Mofetil|Drug: Mycophenolate Sodium|Radiation: Total-Body Irradiation|Drug: Treosulfan	Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT04195633
307	Allo HSCT Using RIC for Hematological Diseases	Recruiting	No Results Available	Acute Myelogenous Leukemia|Acute Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Plasma Cell Leukemia|Myelodysplastic Syndromes|Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|B-Cell Lymphoma|Follicular Lymphoma|Lymphoplasmacytic Lymphoma|Mantle-Cell Lymphoma|Prolymphocytic Leukemia|Lymphoblastic Lymphoma|Burkitt's Lymphoma|Non-Hodgkin's Lymphoma|Multiple Myeloma|Myeloproliferative Syndromes|Hematological Diseases	Drug: Allopurinol|Drug: Fludarabine|Drug: Cyclophosphamide|Drug: ATG|Radiation: TBI|Drug: Tacrolimus|Drug: MMF|Biological: Peripheral Blood Stem Cells|Biological: Related or Unrelated Bone Marrow Cells	Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States	https://ClinicalTrials.gov/show/NCT02661035
308	Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Aplastic Anemia|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Lymphoblastic Lymphoma|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Plasma Cell Myeloma|Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Recurrent Hodgkin Lymphoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Therapy-Related Myelodysplastic Syndrome	Drug: Cyclophosphamide|Biological: Filgrastim|Drug: Fludarabine Phosphate|Other: Laboratory Biomarker Analysis|Drug: Melphalan|Procedure: Peripheral Blood Stem Cell Transplantation|Biological: Rituximab|Drug: Tacrolimus|Radiation: Total-Body Irradiation	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT02960646
309	Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT	Recruiting	No Results Available	Multiple Myeloma|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Non Hodgkin Lymphoma|Acute Lymphocytic Leukemia|Hodgkin Lymphoma|Hodgkin Disease|Myelofibrosis|Myelodysplastic Syndromes|Myeloproliferative Neoplasm|Sickle Cell Disease|Mantle Cell Lymphoma	Other: Pre-biotic foods/drinks	University of Virginia, Charlottesville, Virginia, United States	https://ClinicalTrials.gov/show/NCT04629430
310	Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders	Recruiting	No Results Available	Acute Leukemia|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Lymphoma|Chronic Myelogenous Leukemia|Plasma Cell Leukemia|Myeloproliferative Neoplasms|Myelofibrosis|Myelodysplasia|Refractory Anemia|High Risk Anemia|Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|Marginal Zone B-Cell Lymphoma|Follicular Lymphoma|Lymphoplasmacytic Lymphoma|Mantle-Cell Lymphoma|Prolymphocytic Leukemia|Diffuse Large Cell Non Hodgkins Lymphoma|Lymphoblastic Lymphoma|Burkitt Lymphoma|High Grade Non-Hodgkin's Lymphoma, Adult|Multiple Myeloma|Juvenile Myelomonocytic Leukemia|Biphenotypic/Undifferentiated/Prolymphocytic Leukemias|MRD Positive Leukemia|Natural Killer Cell Malignancies|Acquired Bone Marrow Failure Syndromes	Biological: HSCT with TBI Regimen|Biological: HSCT with Non-TBI Regimen	Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States	https://ClinicalTrials.gov/show/NCT03314974
311	Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia	Not yet recruiting	No Results Available	Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Acute Biphenotypic Leukemia|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent T-Cell Prolymphocytic Leukemia|Refractory Acute Biphenotypic Leukemia|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory T-Cell Prolymphocytic Leukemia	Drug: Cytarabine|Drug: Fludarabine|Drug: Pegcrisantaspase	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT04526795
312	CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study	Recruiting	No Results Available	T Lymphoblastic Leukemia/Lymphoma|Extramedullary NK-T-cell Lymphoma, Nasal Type|Peripheral T-cell Lymphoma, Nonspecific|Angioimmunoblastic T-cell Lymphoma|Enteropathy-Associated T-Cell Lymphoma|Anaplastic Large Cell Lymphoma, ALK-negative|T-cell Lymphoblastic Leukemia	Biological: T cell injection targeting CD7 chimeric antigen receptor	First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China	https://ClinicalTrials.gov/show/NCT04480788
313	HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide	Not yet recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Myelogenous Leukemia|Mixed Phenotype Acute Leukemia|Acute Leukemia|Myelodysplastic Syndromes|Chronic Myelogenous Leukemia|Chronic Lymphocytic Leukemia|Lymphoma	Drug: Busulfan|Drug: Fludarabine|Radiation: Total-body irradiation|Drug: Cyclophosphamide|Drug: Melphalan|Procedure: PBSC Hematopoietic Stem Cell Transplantation (HSCT)|Procedure: Bone Marrow Hematopoietic Stem Cell Transplantation|Drug: Post-transplant Cyclophosphamide|Drug: Mesna|Drug: Tacrolimus|Drug: Mycophenolate Mofetil|Other: Patient-Reported Outcomes		https://ClinicalTrials.gov/show/NCT04904588
314	Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma	Not yet recruiting	No Results Available	CD19 Positive|CD22 Positive|Minimal Residual Disease|Progressive Disease|Recurrent B Acute Lymphoblastic Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Non-Hodgkin Lymphoma|Refractory B Acute Lymphoblastic Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Non-Hodgkin Lymphoma	Biological: Autologous CD19/CD22 Chimeric Antigen Receptor T-cells|Drug: Cyclophosphamide|Drug: Fludarabine	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT04029038
315	MSC and HSC Coinfusion in Mismatched Minitransplants	Recruiting	No Results Available	Leukemia, Myeloid, Acute|Leukemia, Lymphoblastic, Acute|Leukemia, Myelocytic, Chronic|Myeloproliferative Disorders|Myelodysplastic Syndromes|Multiple Myeloma|Leukemia, Lymphocytic, Chronic|Hodgkin's Disease|Lymphoma, Non-Hodgkin	Biological: Mesenchymal stem cells|Other: Isotonic solution	UZA, Edeghem, Antwerpen, Belgium|St-Luc UCL, Brussels, Brabant, Belgium|AZ Gasthuisberg Leuven, Leuven, Flamish Brabant, Belgium|UZ Gent, Gent, Flanders Ost, Belgium|AZ St-Jan, Brugge, Flanders West, Belgium|Cliniques Universitaires Mont-Godinne, Yvoir, Namur, Belgium|Hôpital Stuyvenberg, Antwerpen, Belgium|Bordet Institute, Brussels, Belgium|Vrije Universiteit Brussel, Brussels, Belgium|CHU-ULg, Liège, Belgium	https://ClinicalTrials.gov/show/NCT01045382
316	CD22 Redirected Autologous T Cells for ALL	Recruiting	No Results Available	B Cell Leukemias|B Cell Lymphomas	Biological: CART22 cells transduced with a lentiviral vector to express anti-CD22 scFv TCRz:41BB	Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States	https://ClinicalTrials.gov/show/NCT02650414
317	Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial	Recruiting	No Results Available	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IIIA Hodgkin Lymphoma|Ann Arbor Stage IIIB Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Ann Arbor Stage IVA Hodgkin Lymphoma|Ann Arbor Stage IVB Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid Cell Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Prognostic Stage IV Breast Cancer AJCC v8|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Stage IVA Prostate Cancer AJCC v8|Stage IVB Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma	Drug: Abemaciclib|Drug: Abiraterone|Drug: Afatinib|Biological: Bevacizumab|Drug: Bicalutamide|Procedure: Biospecimen Collection|Drug: Bortezomib|Drug: Cabazitaxel|Drug: Cabozantinib|Drug: Capecitabine|Drug: Carboplatin|Drug: Celecoxib|Drug: Cobimetinib|Drug: Copanlisib|Drug: Dabrafenib|Drug: Dacomitinib|Drug: Darolutamide|Drug: Dasatinib|Drug: Doxorubicin|Biological: Durvalumab|Drug: Enasidenib|Drug: Enzalutamide|Drug: Erlotinib|Drug: Everolimus|Drug: Fluorouracil|Drug: Idelalisib|Drug: Imatinib|Biological: Ipilimumab|Drug: Lenvatinib|Drug: Leucovorin|Drug: Lorlatinib|Drug: Losartan|Drug: Nab-paclitaxel|Drug: Neratinib|Biological: Nivolumab|Drug: Olaparib|Drug: Oxaliplatin|Drug: Palbociclib|Drug: Panobinostat|Biological: Pembrolizumab|Biological: Pertuzumab|Drug: Ponatinib|Other: Quality-of-Life Assessment|Drug: Regorafenib|Drug: Ruxolitinib|Drug: Sirolimus|Drug: Sorafenib|Drug: Sunitinib|Drug: Trametinib|Biological: Trastuzumab Emtansine|Drug: Tretinoin|Drug: Vemurafenib|Drug: Venetoclax|Drug: Vismodegib|Drug: Vorinostat	OHSU Knight Cancer Institute, Portland, Oregon, United States	https://ClinicalTrials.gov/show/NCT03878524
318	Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies	Recruiting	No Results Available	Relapsed or Refractory Haematological Malignancies Including|Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Chronic Lymphocytic Leukemia|High Risk Myelodysplastic Syndrome|Chronic Myelomonocytic Leukemia|Richter's Syndrome|B-cell Non-Hodgkin Lymphoma|T-cell Non-Hodgkin Lymphoma|Small Lymphocytic Lymphoma|Multiple Myeloma	Drug: AZD4573	Research Site, Aachen, Germany|Research Site, Bonn, Germany|Research Site, Essen, Germany|Research Site, Göttingen, Germany|Research Site, Heidelberg, Germany|Research Site, Rheinland-Pfalz, Germany|Research Site, Ulm, Germany|Research Site, Amsterdam, Netherlands|Research Site, Kraków, Poland|Research Site, Skórzewo, Poland|Research Site, Cardiff, United Kingdom|Research Site, Leicester, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Nottingham, United Kingdom|Research Site, Plymouth, United Kingdom|Research Site, Southampton, United Kingdom|Research Site, Sutton, United Kingdom	https://ClinicalTrials.gov/show/NCT03263637
319	Haplo Peripheral Blood Sct In GVHD Prevention	Recruiting	No Results Available	GVHD|AML|ALL|MDS|MPN|CMML|Hodgkin Lymphoma|Non Hodgkin Lymphoma|Blood Stem Cell Transplant Failure|Graft Vs Host Disease|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes|Myeloproliferative Disorder|Chronic Myelomonocytic Leukemia|Chemosensitive Hodgkin Lymphoma	Drug: FLUDARABINE|Drug: CYCLOPHOSPHAMIDE|Radiation: TBI|Drug: Melphalan|Drug: Sirolimus|Drug: Mycophenolate mofetil|Drug: RGI-2001	Massachusetts General Hospital, Boston, Massachusetts, United States	https://ClinicalTrials.gov/show/NCT04473911
320	Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes	Not yet recruiting	No Results Available	Acute Biphenotypic Leukemia|Acute Lymphoblastic Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid Cell Neoplasm|Myelodysplastic Syndrome|Myelodysplastic Syndrome With Excess Blasts	Biological: Omidubicel|Drug: Cyclophosphamide|Drug: Fludarabine|Drug: Thiotepa|Radiation: Total-Body Irradiation|Procedure: Umbilical Cord Blood Transplantation|Other: Laboratory Biomarker Analysis	Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT03399773
321	Treatment of Older Patients With B-precursor ALL With Sequential Dose Reduced Chemotherapy and Blinatumomab	Recruiting	No Results Available	B-Precursor ALL	Drug: Blinatumomab	University Hospital of Frankfurt (Main), Frankfurt (Main), Hessen, Germany|Uniklinik RWTH Aachen, Aachen, Germany|Charité - Campus Benjamin Franklin, Berlin, Germany|Vivantes Klinikum Neukölln, Berlin, Germany|Städtisches Klinikum Braunschweig, Braunschweig, Germany|Klinikum Bremen Mitte, Bremen, Germany|Evangelisches Krankenhaus Essen-Werden, Essen, Germany|Universitätsklinikum Halle, Halle (Saale), Germany|Uniklinik Hamburg Eppendorf, Hamburg, Germany|Evangelisches Krankenhaus Hamm, Hamm, Germany|Städtisches Klinikum Karlsruhe, Karlsruhe, Germany|Universitätsklinikum Schleswig-Holstein, Kiel, Germany|Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany|Universitätsklinikum Leipzig, Leipzig, Germany|Klinikum Großhadern, München, Germany|Klinikum rechts der Isar der TU München, München, Germany|Klinikum Oldenburg, Oldenburg, Germany|Universitätsklinik Tübingen, Tübingen, Germany|Universitätsklinikum Ulm, Ulm, Germany|Helios Klinikum Wuppertal, Wuppertal, Germany|Uniklinik Würzburg, Würzburg, Germany	https://ClinicalTrials.gov/show/NCT03480438
322	Anti-CD19 CAR T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and NHL	Recruiting	No Results Available	CD19-ALL|CD19-LNH	Biological: CD19-CAR T cell	Ospedale Pediatrico Bambino Gesù, Roma, Italy	https://ClinicalTrials.gov/show/NCT03373071
323	CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies	Not yet recruiting	No Results Available	Hematologic Diseases|Hematologic Malignancy|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Chronic Myelogenous Leukemia|Chronic Lymphocytic Leukemia	Device: CliniMACS|Procedure: Bone Marrow Transplant|Drug: Hyperfractionated Total Body Irradiation|Drug: Thiotepa|Drug: Cyclophosphamide|Drug: Busulfan|Drug: Melphalan|Drug: Fludarabine	Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States	https://ClinicalTrials.gov/show/NCT04282174
324	Dose-escalation Study of Oral Administration of LP-108 in Patients With Relapsed or Refractory Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML)	Recruiting	No Results Available	AML/MDS|CMML|Relapse|Refractory Acute Lymphoblastic Leukemia|Relapse Leukemia|Relapsed Adult AML	Drug: LP-108	University of Michigan, Ann Arbor, Michigan, United States|The Ohio State Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute, Columbus, Ohio, United States|MD Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT04139434
325	Phase I Clinical Trial of Autologous CD7-CAR T Cells in the Treatment of High-risk Acute T-cell Leukemia / Lymphoma	Recruiting	No Results Available	T Cell Lymphoma|T-cell Leukemia	Biological: chimeric antigen receptor T cell treatment	Beijing Boren Hospital, Beijing, Beijing, China	https://ClinicalTrials.gov/show/NCT04840875
326	Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation	Recruiting	No Results Available	Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes|Non-hodgkin Lymphoma|Hodgkin Lymphoma|Acquired Aplastic Anemia|Sickle Cell Disease	Other: Donor Search Prognosis Score	City of Hope, Duarte, California, United States|University of California, San Diego Medical Center, La Jolla, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Stanford Hospitals and Clinics, Stanford, California, United States|Children's National Medical Center, Washington, District of Columbia, United States|University of Florida, Gainesville, Florida, United States|University of Miami, Miami, Florida, United States|H. Lee Moffitt Cancer Center, Tampa, Florida, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Emory University, Atlanta, Georgia, United States|Northside Hospital, Atlanta, Georgia, United States|Loyola University, Maywood, Illinois, United States|Indiana University, Indianapolis, Indiana, United States|University of Maryland, Baltimore, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Karmanos Cancer Institute, Detroit, Michigan, United States|University of Minnesota, Minneapolis, Minnesota, United States|Mayo Clinic Rochester, Rochester, Minnesota, United States|University of Mississippi, Jackson, Mississippi, United States|Children's Mercy Hospital, Kansas City, Missouri, United States|Washington University in St. Louis, Saint Louis, Missouri, United States|Rosewell Park Cancer Institute, Buffalo, New York, United States|Mount Sinai Medical Center, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Levine Cancer Institute, Charlotte, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|The Ohio State University, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Children's Medical Center Dallas, Dallas, Texas, United States|Cook Children's Medical Center, Fort Worth, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|M.D. Anderson Cancer Center, Houston, Texas, United States|University of Utah, Salt Lake City, Utah, United States|University of Virginia, Charlottesville, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|University of Wisconsin, Madison, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States	https://ClinicalTrials.gov/show/NCT03904134
327	Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory NHL, RT, MM, T-PLL, Acute Leukemia (AML, ALL), MDS, MDS/MPN, and MF	Not yet recruiting	No Results Available	Non Hodgkin Lymphoma|Richter Transformation|Multiple Myeloma|T-cell-prolymphocytic Leukemia|Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Myeodysplastic Syndrome|MDS/MPN|Myelofibrosis	Drug: LP-118		https://ClinicalTrials.gov/show/NCT04771572
328	RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies	Recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia|Non-Hodgkin's Lymphoma, Relapsed|Non-Hodgkin's Lymphoma Refractory|Primary Mediastinal Large B Cell Lymphoma|Diffuse Large B Cell Lymphoma|Follicular Lymphoma|Mantle Cell Lymphoma|High-grade B-cell Lymphoma	Biological: RPM CD19-mbIL15-CAR-T cells	National Taiwan University Hospital, Taipei, Taiwan	https://ClinicalTrials.gov/show/NCT04844086
329	Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT	Not yet recruiting	No Results Available	Allogeneic Stem Cell Transplant Candidate|Acute Myeloid/Lymphoblastic Leukemia|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Lymphoproliferative Disorders	Biological: Cellular therapy product	University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States	https://ClinicalTrials.gov/show/NCT03939585
330	Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Aplastic Anemia|Bone Marrow Failure|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Follicular Lymphoma|Hodgkin Lymphoma|Mantle Cell Lymphoma|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Non-Hodgkin Lymphoma|Plasma Cell Myeloma	Biological: Anti-Thymocyte Globulin|Drug: Cyclophosphamide|Biological: Cytokine-treated Veto Cells|Drug: Fludarabine|Procedure: Peripheral Blood Stem Cell Transplantation|Radiation: Total-Body Irradiation	M D Anderson Cancer Center, Houston, Texas, United States	https://ClinicalTrials.gov/show/NCT03622788
331	Cord Blood Transplant With OTS for the Treatment of HIV Positive Hematologic Cancers	Recruiting	No Results Available	Acute Erythroid Leukemia|Acute Lymphoblastic Leukemia|Acute Megakaryoblastic Leukemia|Acute Myeloid Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid Cell Neoplasm|HIV Infection|Myelodysplastic Syndrome|Myelodysplastic Syndrome With Excess Blasts|Non-Hodgkin Lymphoma|Refractory Anemia	Drug: Fludarabine|Drug: Cyclophosphamide|Drug: Thiotepa|Radiation: Total-Body Irradiation|Procedure: Umbilical Cord Blood Transplantation|Other: Cellular Therapy	University of California San Francisco, San Francisco, California, United States|Children's National Medical Center, Washington, District of Columbia, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Case Western Reserve University, Cleveland, Ohio, United States|Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT04083170
332	Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies	Recruiting	No Results Available	Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Biphenotypic Acute Leukemia|Undifferentiated Leukemia|Prolymphocytic Leukemia|Myelodysplastic Syndromes|Chronic Myelogenous Leukemia|Myeloproliferative Neoplasm|Relapsed Large Cell Lymphoma|Mantle Cell Lymphoma|Hodgkin Lymphoma|Burkitt Lymphoma|Relapsed T-Cell Lymphoma|Relapsed Chronic Lymphocytic Leukemia|Relapsed Small Lymphocytic Lymphoma|Relapsed Marginal B-cell Lymphoma|Relapsed Follicular Lymphoma|Lymphoplasmacytic Lymphoma	Drug: Fludarabine|Drug: Melphalan|Radiation: Total Body Irradiation	H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, United States	https://ClinicalTrials.gov/show/NCT04191187
333	Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Aggressive Non-Hodgkin Lymphoma|Chronic Lymphocytic Leukemia|Diffuse Large B-Cell Lymphoma|Mantle Cell Lymphoma|Myelodysplastic Syndrome|Myelodysplastic/Myeloproliferative Neoplasm|Prolymphocytic Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Recurrent Waldenstrom Macroglobulinemia|Hematologic and Lymphocytic Disorder|Blastic Plasmacytoid Dendritic Cell Neoplasm	Procedure: Allogeneic Hematopoietic Stem Cell Transplantation|Drug: Cyclophosphamide|Drug: Cyclosporine|Drug: Mycophenolate Mofetil|Drug: Sirolimus	Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT03246906
334	Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia in Remission|Hematopoietic Cell Transplantation Recipient|JAK2 Gene Mutation|Loss of Chromosome 17p|Mantle Cell Lymphoma|Minimal Residual Disease|Myelodysplastic Syndrome|Non-Hodgkin Lymphoma|Plasma Cell Myeloma|RAS Family Gene Mutation|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Hematologic Malignancy|Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Therapy-Related Acute Myeloid Leukemia|Therapy-Related Myelodysplastic Syndrome|TP53 Gene Mutation	Procedure: Allogeneic Hematopoietic Stem Cell Transplantation|Biological: Irradiated Allogeneic Cells	Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States	https://ClinicalTrials.gov/show/NCT03272633
335	CD19/CD22 Chimeric Antigen Receptor(CAR) T Cells in Adults With Recurrent/Refractory B Cell Malignancies	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia|CD19 Positive|Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation|Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma of the Elderly|Minimal Residual Disease|Philadelphia Chromosome Positive|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma|T-Cell/Histiocyte-Rich Large B-Cell Lymphoma	Biological: Chimeric Antigen Receptor T-Cell Therapy|Drug: Cyclophosphamide|Drug: Fludarabine Phosphate|Other: Laboratory Biomarker Analysis|Other: Questionnaire Administration	Stanford University, School of Medicine, Palo Alto, California, United States	https://ClinicalTrials.gov/show/NCT03233854
336	Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer	Recruiting	No Results Available	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Leukemia in Remission|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Acute Myeloid Leukemia With FLT3/ITD Mutation|Acute Myeloid Leukemia With Gene Mutations|Aplastic Anemia|B-Cell Non-Hodgkin Lymphoma|CD40 Ligand Deficiency|Chronic Granulomatous Disease|Chronic Leukemia in Remission|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Congenital Amegakaryocytic Thrombocytopenia|Congenital Neutropenia|Congenital Pure Red Cell Aplasia|Glanzmann Thrombasthenia|Immunodeficiency Syndrome|Myelodysplastic Syndrome|Myelofibrosis|Myeloproliferative Neoplasm|Paroxysmal Nocturnal Hemoglobinuria|Plasma Cell Myeloma|Polycythemia Vera|Recurrent Non-Hodgkin Lymphoma|Refractory Non-Hodgkin Lymphoma|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndrome|Severe Aplastic Anemia|Shwachman-Diamond Syndrome|Sickle Cell Disease|T-Cell Non-Hodgkin Lymphoma|Thalassemia|Waldenstrom Macroglobulinemia|Wiskott-Aldrich Syndrome	Drug: Cyclophosphamide|Drug: Fludarabine Phosphate|Other: Laboratory Biomarker Analysis|Procedure: Peripheral Blood Stem Cell Transplantation|Radiation: Total-Body Irradiation	Roswell Park Cancer Institute, Buffalo, New York, United States	https://ClinicalTrials.gov/show/NCT03333486
337	Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803	Recruiting	No Results Available	Acute Myeloid Leukemia|Myelodysplastic Syndrome|Acute Lymphoblastic Leukemia|Chronic Myeloid Leukemia|Chronic Lymphocytic Leukemia|Non Hodgkin Lymphoma|Hodgkin Lymphoma|Myeloproliferative Syndromes|Plasma Cell Myeloma|Colon Carcinoma|Adenocarcinoma of Rectum|Soft Tissue Sarcoma|Ewing's Sarcoma|Rhabdomyosarcoma	Biological: Natural Killer (NK) Cells|Biological: ALT803	University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States	https://ClinicalTrials.gov/show/NCT02890758
338	A Phase 1 Dose-Escalation and Cohort-Expansion of VLS-101 in Hematologic Malignancies	Recruiting	No Results Available	Chronic Lymphocytic Leukemia|Mantle Cell Lymphoma|Follicular Lymphoma|Marginal Zone Lymphoma|Diffuse Large B-cell Lymphoma|Richter Transformation Lymphoma|Burkitt Lymphoma|Lymphoplasmacytoid Lymphoma|T-cell Non-Hodgkin Lymphoma|Acute Lymphoid Leukemia|Acute Myeloid Leukemia|Waldenstrom Macroglobulinemia	Drug: VLS-101 Schedule 1|Drug: VLS-101 Schedule 2|Drug: VLS-101 Schedule 3	City of Hope National Medical Center, Duarte, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|UCLA Department of Medicine - Hematology/Oncology, Los Angeles, California, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Northwell Health/CLL Research and Treatment Program, New Hyde Park, New York, United States|Weill Cornell Medical College - New York - Presbyterian Hospital, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Oregon Health & Science University, Portland, Oregon, United States|MD Anderson Cancer Center, Houston, Texas, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States|University of Virginia, Charlottesville, Virginia, United States|Swedish Cancer Institute, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT03833180
339	Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease	Recruiting	No Results Available	Acute Biphenotypic Leukemia|Acute Myeloid Leukemia in Remission|Ann Arbor Stage I Burkitt Lymphoma|Ann Arbor Stage I Non-Hodgkin Lymphoma|Ann Arbor Stage II Burkitt Lymphoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Lymphoblastic Lymphoma|Mantle Cell Lymphoma|Myelodysplastic Syndrome|Myelofibrosis|Plasma Cell Myeloma|Prolymphocytic Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Follicular Lymphoma|Recurrent Lymphoplasmacytic Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Ann Arbor Stage II Non-Hodgkin Lymphoma|Ann Arbor Stage III Burkitt Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Burkitt Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|High Risk Acute Myeloid Leukemia|Refractory Anemia|Hematopoietic and Lymphoid Cell Neoplasm	Drug: Cyclophosphamide|Drug: Cyclosporine|Procedure: Double-Unit Umbilical Cord Blood Transplantation|Drug: Fludarabine|Other: Laboratory Biomarker Analysis|Drug: Mycophenolate Mofetil|Radiation: Total-Body Irradiation|Procedure: Umbilical Cord Blood Transplantation|Drug: Thiotepa	University of Colorado Hospital, Aurora, Colorado, United States|VA Puget Sound Health Care System, Seattle, Washington, United States|Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT00719888
340	Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation	Not yet recruiting	No Results Available	Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Myelodysplastic Syndrome|Myelofibrosis|Myeloproliferative Neoplasm|Recurrent Acute Myeloid Leukemia|Recurrent Hodgkin Lymphoma|Recurrent Non-Hodgkin Lymphoma|Refractory Acute Myeloid Leukemia|Therapy-Related Acute Myeloid Leukemia	Biological: Anti-Thymocyte Globulin|Drug: Busulfan|Drug: Cyclophosphamide|Drug: Cyclosporine|Drug: Fludarabine Phosphate|Drug: Methotrexate|Procedure: Peripheral Blood Stem Cell Transplantation|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Drug: Tacrolimus|Radiation: Total-Body Irradiation	Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT03602898
341	Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies	Recruiting	No Results Available	B-cell Acute Lymphoblastic Leukemia|Lymphoma|Myeloid Leukemia|Multiple Myeloma|Hepatoma|Gastric Cancer|Pancreatic Cancer|Mesothelioma|Colorectal Cancer|Esophagus Cancer|Lung Cancer|Glioma|Melanoma|Synovial Sarcoma|Ovarian Cancer|Renal Carcinoma	Biological: CAR-T cell immunotherapy	The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China	https://ClinicalTrials.gov/show/NCT03638206
342	Unrelated Donor Stem Cell Transplantation	Recruiting	No Results Available	Severe Aplastic Anemia|Paroxysmal Nocturnal Hemoglobinuria|Acute Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndromes|Myeloproliferative Syndromes|Chronic Myelogenous Leukemia|Hodgkin's Lymphoma|Non-Hodgkin's Lymphoma|Multiple Myeloma|Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|Large Granulocytic Leukemia	Procedure: Allogeneic transplantation	Scripps Green Hospital, La Jolla, California, United States	https://ClinicalTrials.gov/show/NCT01364363
343	Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm	Recruiting	No Results Available	Adult Acute Myeloid Leukemia in Remission|Acute Biphenotypic Leukemia|Early Relapse of Acute Myeloid Leukemia|Late Relapse of Acute Myeloid Leukemia|Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Blastic Plasmacytoid Dendritic Cell Neoplasm|Acute Myeloid Leukemia|Adult Acute Lymphoblastic Leukemia|Interleukin-3 Receptor Subunit Alpha Positive|Minimal Residual Disease|Refractory Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia	Drug: cyclophosphamide|Biological: Autologous CD123CAR-CD28-CD3zeta-EGFRt-expressing T Lymphocytes|Other: laboratory biomarker analysis|Biological: Allogeneic CD123CAR-CD28-CD3zeta-EGFRt-expressing T-lymphocytes|Drug: Fludarabine Phosphate	City of Hope Medical Center, Duarte, California, United States	https://ClinicalTrials.gov/show/NCT02159495
344	CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Blood Cancer Undergoing Donor Stem Cell Transplant	Recruiting	No Results Available	Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Acute Lymphoblastic Leukemia in Remission|Acute Myeloid Leukemia in Remission|Chronic Lymphocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Cytomegalovirus Positive|Donor|Hematopoietic Cell Transplant Recipient|Hodgkin Lymphoma|Myelodysplastic Syndrome|Myelodysplastic/Myeloproliferative Neoplasm|Non-Hodgkin Lymphoma|Myelofibrosis|Hematopoietic and Lymphoid Cell Neoplasm	Biological: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine	City of Hope Medical Center, Duarte, California, United States	https://ClinicalTrials.gov/show/NCT03560752
345	A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies	Recruiting	No Results Available	Malignancies|Acute Lymphoblastic Leukemia (ALL)|Acute Myeloid Leukemia (AML)|Non-Hodgkin's Lymphoma|Neuroblastoma	Drug: chemotherapy|Drug: venetoclax	Univ California, San Francisco /ID# 163460, San Francisco, California, United States|Children's Hospital Colorado /ID# 161551, Aurora, Colorado, United States|Children's Healthcare of Atlan /ID# 161552, Atlanta, Georgia, United States|Dana-Farber Cancer Institute /ID# 163440, Boston, Massachusetts, United States|Memorial Sloan Kettering Cancer Center-Koch Center /ID# 163444, New York, New York, United States|Cincinnati Children's Hospital /ID# 161550, Cincinnati, Ohio, United States|Children's Hospital of Philadelphia /ID# 163445, Philadelphia, Pennsylvania, United States|St Jude Children's Research Hospital /ID# 163447, Memphis, Tennessee, United States|Primary Children's /ID# 164399, Salt Lake City, Utah, United States|Seattle Children's Hospital /ID# 163459, Seattle, Washington, United States|Medical College of Wisconsin /ID# 163461, Milwaukee, Wisconsin, United States|Sydney Children's Hospital /ID# 163148, Randwick, New South Wales, Australia|Queensland Children's Hospital /ID# 163146, South Brisbane, Queensland, Australia|Women and Childrens Hospital /ID# 163147, North Adelaide, South Australia, Australia|Royal Children's Hospital /ID# 163104, Melbourne, Victoria, Australia|Hospital for Sick Children /ID# 163726, Toronto, Ontario, Canada|CHU Sainte-Justine /ID# 163725, Montreal, Quebec, Canada|Centre Leon Berard /ID# 163707, Lyon CEDEX 08, Rhone, France|Hopital de la Timone /ID# 161465, Marseille, France|Robert Debre Hopital, FR /ID# 161464, Paris, France|Hopital Armand Trousseau /Id# 163728, Paris, France|CHU Toulouse - Hôpital des enfants /ID# 163727, Toulouse CEDEX 9, France|Charite Campus Virchow-Klinikum /ID# 161730, Berlin, Germany|Universitaetsklinikum Essen /ID# 164207, Essen, Germany|Universitaetsklinikum Freiburg /ID# 164206, Freiburg, Germany|Univ Hosp Schleswig-Holstein /ID# 161729, Kiel, Germany|Erasmus MC - Sophia /ID# 161579, Rotterdam, Netherlands|Prinses Maxima Centrum /ID# 162670, Utrecht, Netherlands|University Children's Hospital /ID# 163037, Zurich, Switzerland|Great Ormond St Hospital NHS /ID# 169238, London, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 162938, Newcastle Upon Tyne, United Kingdom	https://ClinicalTrials.gov/show/NCT03236857
346	Phase I Dose Escalation Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies	Recruiting	No Results Available	B Acute Lymphoblastic Leukemia|CD19 Positive|Minimal Residual Disease|Philadelphia Chromosome Positive|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Refractory Acute Lymphoblastic Leukemia	Biological: Chimeric Antigen Receptor T-Cell Therapy|Drug: Cyclophosphamide|Drug: Fludarabine Phosphate|Other: Laboratory Biomarker Analysis|Other: Questionnaire Administration	Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States	https://ClinicalTrials.gov/show/NCT03241940
347	UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep	Recruiting	No Results Available	Acute Leukemia|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia/Lymphoma|Burkitt's Lymphoma|Natural Killer Cell Malignancies|Chronic Myelogenous Leukemia|Myelodysplastic Syndrome|Large-cell Lymphoma|Hodgkin Lymphoma|Multiple Myeloma|Relapsed Chronic Lymphocytic Leukemia|Relapsed Small Lymphocytic Lymphoma|Marginal Zone B-cell Lymphoma|Follicular Lymphoma|Lymphoplasmacytic Lymphoma|Mantle-cell Lymphoma|Prolymphocytic Leukemia|Bone Marrow Failure Syndromes|Myeloproliferative Neoplasms/Myelofibrosis|Biphenotypic/Undifferentiated/Prolymphocytic Leukemias|MRD Positive Leukemia|Leukemia or MDS in Aplasia|Relapsed T-Cell Lymphoma|Relapsed Multiple Myeloma|Plasma Cell Leukemia	Drug: Fludarabine|Drug: Cyclophosphamide|Drug: MMF|Drug: Sirolimus|Radiation: TBI|Biological: Umbilical cord blood cell infusion|Biological: ATG	Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States	https://ClinicalTrials.gov/show/NCT02722668
348	Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning	Recruiting	No Results Available	Acute Myeloid Leukemia in Remission|Myelodysplastic Syndromes|Chronic Myeloid Leukemia in Remission|Myeloproliferative Syndrome|Myeloproliferative Disorder|Acute Lymphoid Leukemia in Remission|Multiple Myeloma|Chronic Lymphoid Leukemia|Non Hodgkin Lymphoma|Hodgkin Lymphoma	Drug: Thymoglobulin|Drug: Melphalan|Drug: Fludarabine|Drug: Cyclophosphamid	ZNA Stuivenberg, Antwerp, Belgium|AZ Sint Jan Brugge, Brugge, Belgium|IJ Bordet, Brussels, Belgium|UZ Brussel, Brussels, Belgium|UCL St Luc, Brussels, Belgium|UZ Gent, Gent, Belgium|UZ Leuven, Leuven, Belgium|CHU de Liège, Liège, Belgium|AZ Delta Roeselare, Roeselare, Belgium|CHU UCL Namur Godinne, Yvoir, Belgium	https://ClinicalTrials.gov/show/NCT03852407
349	Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies	Recruiting	No Results Available	Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Triple-Negative Breast Carcinoma|Recurrent Acute Lymphoblastic Leukemia|Recurrent Mantle Cell Lymphoma|Refractory Chronic Lymphocytic Leukemia|Stage III Lung Non-Small Cell Cancer AJCC v7|Stage IIIA Lung Non-Small Cell Cancer AJCC v7|Stage IIIB Lung Non-Small Cell Cancer AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Lung Non-Small Cell Cancer AJCC v7|Unresectable Lung Non-Small Cell Carcinoma	Other: Laboratory Biomarker Analysis|Biological: ROR1 CAR-specific Autologous T-Lymphocytes	Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT02706392
350	Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant	Recruiting	No Results Available	Acute Myeloid Leukemia in Remission|Adult Acute Lymphoblastic Leukemia in Complete Remission|Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission|Chronic Myelomonocytic Leukemia in Remission|Graft Versus Host Disease|Hodgkin Lymphoma|Minimal Residual Disease|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Non-Hodgkin Lymphoma|Plasma Cell Myeloma|Severe Aplastic Anemia|Waldenstrom Macroglobulinemia	Procedure: Allogeneic Hematopoietic Stem Cell Transplantation|Drug: Cyclophosphamide|Drug: Fludarabine Phosphate|Other: Laboratory Biomarker Analysis|Drug: Melphalan Hydrochloride|Drug: Mycophenolate Mofetil|Drug: Sirolimus|Radiation: Total-Body Irradiation	Roswell Park Cancer Institute, Buffalo, New York, United States	https://ClinicalTrials.gov/show/NCT03192397
351	Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders	Recruiting	No Results Available	Chronic Kidney Disease|Acute Myeloid Leukemia (AML)|Acute Lymphoblastic Leukemia (ALL)|Chronic Myelogenous Leukemia (CML)|Chronic Lymphocytic Leukemia (CLL)|Non-Hodgkin's Lymphoma (NHL)|Hodgkin Disease|Multiple Myeloma|Myelodysplastic Syndrome (MDS)|Aplastic Anemia|AL Amyloidosis|Diamond Blackfan Anemia|Myelofibrosis|Myeloproliferative Disease|Sickle Cell Anemia|Autoimmune Diseases|Thalassemia	Procedure: Haploidentical Bone Marrow/Kidney	Massachusetts General Hospital, Boston, Massachusetts, United States	https://ClinicalTrials.gov/show/NCT01758042
352	Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell	Recruiting	No Results Available	Myeloid Leukemia, Chronic|Acute Myelogenous Leukemia|Myelodysplastic Syndromes (MDS)|Lymphoma, Non-Hodgkin|Acute Lymphoblastic Leukemia (ALL)|Myeloproliferative Syndrome|Acute Myeloid Leukemia|Acute Leukemia|Chronic Myelogenous Leukemia	Biological: Conventional T cells (Tcon) and Regulatory T cells (Treg)	Stanford University School of Medicine Palo Alto, California, United States, Palo Alto, California, United States	https://ClinicalTrials.gov/show/NCT01660607
353	CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies	Recruiting	No Results Available	Acute Lymphoid Leukemia|B-Cell Leukemia|Leukemia, Lymphocytic, B Cell|B-Cell Lymphoma|Lymphoma, Non-Hodgkin	Biological: CD19/CD22 CAR T-Cells|Drug: Fludarabine|Drug: Cyclophosphamide	National Institutes of Health Clinical Center, Bethesda, Maryland, United States	https://ClinicalTrials.gov/show/NCT03448393
354	ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT	Recruiting	No Results Available	ALL, Childhood|Minimal Residual Disease	Drug: Blinatumomab	St. Anna Kinderspital, Vienna, Austria(AUT), Austria|University Hospital Gasthuisberg (UZ Leuven), Leuven, Belgium|Motol University Hospital Prague, Praha, Czechia|Rigshospitalet Copenhagen, Copenhagen, Denmark|Hôpital Robert Debré, Paris, Paris, France|Saint Sophia Children's Hospital Athens, Athens, Greece|Ospedale S. Gerardo Monza, Monza, Italy|IRCCS Ospedale Pediatrico Bambino Gesù Roma, Roma, Italy|Oslo University Hospital, Oslo, Norway|Nicolaus Copernicus University Collegium Medicum, Bydgoszcz, Poland|Lublin, Medical Academy, Lublin, Poland|University of Medical Sciences Poznan, Poznań, Poland|Klinika Transplantacji Szpiku, Wrocław, Poland|University Children's Hospital, Bratislava, Slovakia|Hospital Universitario Vall d'Hebron, Barcelona, Spain	https://ClinicalTrials.gov/show/NCT04785547
355	Yoga Fatigue Study	Recruiting	No Results Available	Acute Myeloid Leukemia (AML)|Acute Lymphocytic Leukemia in Relapse|Burkitt's Lymphoma Stage III|Burkitt's Lymphoma Stage IV|Type 3 Diffuse Large B-Cell Lymphoma	Behavioral: Individualized Yoga Intervention Group|Other: iPad Activity Control Group	Connecticut Children's Medical Center, Hartford, Connecticut, United States|University of Calgary, Calgary, Alberta, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada	https://ClinicalTrials.gov/show/NCT02134782
356	CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT	Recruiting	No Results Available	Acute Leukemia|Acute Myeloid Leukemia|Myelodysplastic Syndromes|Acute Lymphoblastic Leukemia|Mixed Lineage Leukemia|Lymphoblastic Lymphoma|Burkitt Lymphoma|Juvenile Myelomonocytic Leukemia	Device: CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback	Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States	https://ClinicalTrials.gov/show/NCT03810196
357	Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL	Recruiting	No Results Available	Non-Hodgkin Lymphoma|Burkitt Lymphoma|Diffuse Large B-Cell Lymphoma|Primary Mediastinal B-cell Lymphoma|CD20+ Lymphoblastic Lymphoma|Follicular Lymphoma, Grade III	Drug: Obinutuzumab|Drug: Liposomal ARA-C|Drug: Ifosfamide|Drug: Carboplatin|Drug: Etoposide	New York Medical College, Valhalla, New York, United States	https://ClinicalTrials.gov/show/NCT02393157
358	Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Myelogenous Leukemia|Myelodysplastic Syndrome|Chronic Myelogenous Leukemia|Non-Hodgkin Lymphoma|Hodgkin Lymphoma	Radiation: Radiation|Drug: Cyclophosphamide|Biological: Donor Lymphocyte Infusion (DLI)|Biological: Haploidentical Stem Cell Transplantation	Cohen Children's Medical Center, New Hyde Park, New York, United States	https://ClinicalTrials.gov/show/NCT02566395
359	CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant	Recruiting	No Results Available	Chronic Myeloid Leukemia (CML)|Acute Myelogenous Leukemia (AML)|Myelodysplastic Syndrome (MDS)|Juvenile Myelomonocytic Leukemia (JMML)|Acute Lymphoblastic Leukemia (ALL)|Lymphoma (Hodgkin's and Non-Hodgkin's)	Device: CliniMACS CD34+ Reagent System|Drug: Thiotepa|Drug: Cyclophosphamide|Drug: Alemtuzumab|Drug: Tacrolimus|Drug: Melphalan|Drug: Busulfan|Drug: Fludarabine|Drug: Methylprednisolone	Columbia University Medical Center, New York, New York, United States	https://ClinicalTrials.gov/show/NCT02061800
360	Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine	Recruiting	No Results Available	Acute Lymphoblastic Leukemia|Acute Myelogenous Leukemia|Myelodysplastic Syndromes|Chronic Myelogenous Leukemia|Lymphoma,Non-Hodgkin|Lymphoma, Hodgkin|Lymphoma, Follicular|Marginal Zone Lymphoma|Large Cell Lymphoma|Mantle-Cell Lymphoma|Gray Zone Lymphoma|Burkitt Lymphoma|High Risk Undifferentiated Acute Leukemia	Drug: Bendamustine|Drug: Cyclophosphamide	The University of Arizona Cancer Center, Tucson, Arizona, United States	https://ClinicalTrials.gov/show/NCT02996773
361	Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors	Recruiting	No Results Available	Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Hodgkin Lymphoma|Non-Hodgkin Lymphoma|Myelodysplastic Syndrome|Myeloproliferative Syndrome|Rhabdomyosarcoma|Ewing Sarcoma|Primitive Neuroectodermal Tumor|Osteosarcoma|Neuroblastoma	Procedure: TCRαβ+/CD19+ depleted Haploidentical HSCT|Drug: Zoledronate	University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States	https://ClinicalTrials.gov/show/NCT02508038
362	Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant	Recruiting	No Results Available	Acute Biphenotypic Leukemia|Acute Leukemia|Acute Leukemia of Ambiguous Lineage|Acute Lymphoblastic Leukemia|Acute Undifferentiated Leukemia|Allogeneic Hematopoietic Stem Cell Transplantation Recipient|Blastic Plasmacytoid Dendritic Cell Neoplasm|Blasts Under 25 Percent of Bone Marrow Nucleated Cells|Blasts Under 5 Percent of Bone Marrow Nucleated Cells|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome With Excess Blasts-1|Myelodysplastic Syndrome With Excess Blasts-2	Radiation: Total-Body Irradiation|Drug: Thiotepa|Drug: Fludarabine|Drug: Cyclophosphamide|Drug: Busulfan|Procedure: Allogeneic Bone Marrow Transplantation|Drug: Tacrolimus|Drug: Methotrexate|Procedure: Naive T Cell-Depleted Hematopoietic Stem Cell Transplantation	Children's Hospital of Los Angeles, Los Angeles, California, United States|Children's National Medical Center, Washington, District of Columbia, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, United States|Dana Farber / Boston Children's Hospital, Boston, Massachusetts, United States|UH Rainbow Babies and Children's Hospital (University Hospitals Cleveland Medical Center), Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States|Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT03779854
363	Safety of Expanded Haploidentical Natural Killer Cells for Leukemia	Recruiting	No Results Available	Leukemia, Acute Myeloid|Leukemia, Acute Lymphoblastic	Biological: Expanded Haploidentical Natural Killer cells|Drug: IL-2	Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Minsk Region, Belarus	https://ClinicalTrials.gov/show/NCT04327037
364	TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies	Recruiting	No Results Available	Acute Lymphoblastic Leukemia (ALL)|Acute Myeloid Leukemia (AML)|Myelodysplastic Syndromes (MDS)|NK-Cell Leukemia|Hodgkin Lymphoma|Non Hodgkin Lymphoma (NHL)|Juvenile Myelomonocytic Leukemia (JMML)|Chronic Myeloid Leukemia (CML)	Drug: Cyclophosphamide|Biological: Fludarabine|Drug: Thiotepa|Drug: Melphalan|Biological: G-csf|Drug: Mesna|Device: CliniMACS|Biological: ATG (rabbit)|Drug: Blinatumomab|Biological: TCRα/β+|Biological: CD19+|Biological: CD45RA-depleted DLI	St. Jude Children's Research Hospital, Memphis, Tennessee, United States	https://ClinicalTrials.gov/show/NCT03849651
365	Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation	Recruiting	No Results Available	Acute Lymphoblastic Leukemia (ALL)|Acute Myeloid Leukemia (AML)|Myeloid Sarcoma|Chronic Myeloid Leukemia (CML)|Juvenile Myelomonocytic Leukemia (JMML)|Myelodysplastic Syndrome (MDS)|Non-Hodgkin Lymphoma (NHL)	Drug: Anti-thymocyte globulin (rabbit)|Drug: Blinatumomab|Drug: Cyclophosphamide|Drug: Fludarabine|Drug: G-CSF|Drug: Melphalan|Drug: Mesna|Drug: Rituximab|Drug: Tacrolimus|Drug: Thiotepa|Biological: HPC,A Infusion|Device: CliniMACS|Drug: Sirolimus	St. Jude Children's Research Hospital, Memphis, Tennessee, United States	https://ClinicalTrials.gov/show/NCT02790515
366	CART19 Cells Treatment of MRD of B Cell Malignancies and Then Auto-HSCT	Recruiting	No Results Available	Leukemia, Lymphocytic, Acute, B-Cell|Leukemia, Lymphocytic, Chronic, B-Cell|Lymphoma, B-Cell	Biological: CART19 cell and auto-HSCT	Weihong Chen, Shenzhen, Guangdong, China	https://ClinicalTrials.gov/show/NCT03685786
367	CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS	Recruiting	No Results Available	Leukemia, Acute Lymphocytic (ALL)|Leukemia, Acute Myelogenous (AML)|Myelodysplastic Syndromes	Biological: Chimeric antigen receptor T cells|Biological: peptide specific dendritic cell	Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China	https://ClinicalTrials.gov/show/NCT03291444
368	Phase Ib Clinical Study of Keynatinib	Recruiting	No Results Available	Lymphoma, B-Cell	Drug: Keynatinib	Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China|Peking University Third Hospital, Beijing, Beijing, China|Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China|West China Hospital，Sichuan University, Chengdu, Sichuan, China	https://ClinicalTrials.gov/show/NCT04807881
369	3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer	Recruiting	No Results Available	Brain and Central Nervous System Tumors|Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Lymphoproliferative Disorder|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Unspecified Adult Solid Tumor, Protocol Specific	Device: 3'-deoxy-3'-[18F]fluorothymidine	Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States	https://ClinicalTrials.gov/show/NCT00935090
370	Auto Stem Cell Transplant for Lymphoma Patients	Recruiting	No Results Available	Non-Hodgkin Lymphoma|Hodgkin Lymphoma	Drug: Etoposide|Drug: BCNU|Drug: AraC|Drug: Melphalan|Procedure: Peripheral blood stem cell transplantation|Biological: G-CSF|Drug: Cyclophosphamide|Radiation: Total Body Irradiation	Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States	https://ClinicalTrials.gov/show/NCT03125642
371	A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors	Recruiting	No Results Available	Hematologic Malignancies|Solid Tumor	Drug: TTI-621|Drug: TTI-621 plus Rituximab|Drug: TTI-621 plus Nivolumab	City of Hope National Medical Center, Duarte, California, United States|Stanford Cancer Institute, Palo Alto, California, United States|Colorado Blood Cancer Institute, Denver, Colorado, United States|Mayo Clinic, Jacksonville, Florida, United States|Moffitt Cancer Center, Tampa, Florida, United States|Mayo Clinic, Rochester, Minnesota, United States|Hackensack Meridian Health John Theurer Cancer Center, Hackensack, New Jersey, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York, United States|Columbia Univeristy, New York, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Cleveland Clinic, Cleveland, Ohio, United States|Oregon Health and Sciences University, Portland, Oregon, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Tennessee Oncology, Nashville, Tennessee, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, United States|University of Washington - Seattle Cancer Care Alliance, Seattle, Washington, United States|British Columbia Cancer Agency, Vancouver, British Columbia, Canada|Princess Margaret Cancer Center, Toronto, Ontario, Canada	https://ClinicalTrials.gov/show/NCT02663518
372	Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT	Recruiting	No Results Available	Hematologic Malignancies	Biological: Haplo HCT <55 years old|Biological: Haplo HCT ≥55 years old|Drug: GVHD Prophylaxis|Biological: Haplo HCT ≥55 and < 65 years old|Biological: Haplo HCT ≥65 and ≤75 years old	Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States	https://ClinicalTrials.gov/show/NCT02988466
373	Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase	Recruiting	No Results Available	Acute Pancreatitis	Drug: CM4620	St. Jude Children's Research Hospital, Memphis, Tennessee, United States	https://ClinicalTrials.gov/show/NCT04195347
374	Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia	Recruiting	No Results Available	CD 19+ Acute Leukemia	Biological: T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC)	Seattle Children's Hospital, Seattle, Washington, United States	https://ClinicalTrials.gov/show/NCT03186118
